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The differentiation of melanocytes from multipotential neural crest cells is 
an ideal system for studying the processes underlying lineage determination in 
development. Tyrosinase is a key enzyme in melanin biosynthesis and the 
activation of the tyrosinase gene is characteristic of differentiated 
melanocytes . In order to study the mechanisms underlying activation of 
melanocyte-specific genes during differentiation in chick embryos, a chicken 
genomic DNA library was screened for tyrosinase-encoding sequences using a 
mouse tyrosinase cDNA probe. Two identical hybridizing clones were 
identified. Restriction mapping and sequencing revealed that both clones 
contained a 4.3 kb genomic DNA fragment, CTYR4.3, that included 2125 nt of the 
5' flanking region, the first exon and part of the first intron of the chicken 
tyrosinase gene. 
The 5' flanking sequence of CTYR4.3, which is the most extensive to be 
reported for a lower vertebrate tyrosinase gene to date, was analysed further 
using computer-aided homology searches and primer extension. Alignment of the 
promoter sequences of CTYR4.3 with those of the human, mouse, quail and turtle 
tyrosinase genes revealed two evolutionary conserved regions. These regions 
may be functionally significant as they contain regulatory elements previously 
reported to play a role in melanocyte-specific expression of the tyrosinase 
gene in mammals. These include an initiator region and an associated SPl-
binding site, the M-box and an upstream enhancer element, TDE. In addition, 
other potential transcription factor binding motifs were identified, including 
an AP-1-binding site, a UV-responsive element and glucocorticoid-responsive 
elements. 
Although several TATA box motifs were identified, they were situated more than 
200 bp upstream of the transcription start sites mapped by primer extension 
analysis and therefore are unlikely to function as TFIID-binding sites. 
Transcription initiation appears to occur at heterogeneous start sites, and 
given the absence of a functional TATA box, may be mediated via the conserved 
initiator region and SPl-binding site. 
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To test the ability of the 5' flanking sequence of CTYR4.3 to drive 
transcription and to begin to assess the functional significance of the 
various conserved elements, transient transfection assays were carried out. 
Constructs were generated in which 2.1 kb, 1.1 kb, 0.5 kb and 0.2 kb fragments 
of the 5' flanking sequence were linked to a luciferase reporter gene. These 
constructs were introduced into cultures of chicken retinal pigment epithelial 
cells (RPE), immortalised quail neural crest cells (MQTNC), and human liver 
cells (Hep G2) by calcium phosphate-mediated transfection. Transfections with 
all constructs resulted in luciferase activities significantly greater than 
those that were observed with the promoterless luciferase construct, thus 
confirming that the 5' flanking sequence of CTYR4.3 does possess promoter 
activity. However, the level of expression from the various constructs 
differed markedly in the different cell types. In the tyrosinase-negative Hep 
G2 cells, low levels of expression were observed with all constructs. In the 
tyrosinase-positive RPE cells, a high level of luciferase activity was 
obtained specifically with the smallest (0.2 kb) promoter construct. Since 
the 0.2 kb promoter fragment does not include the conserved initiator region, 
SPl-binding site, or M-box, the role of these elements in tissue-specific 
transcription initiation of the chicken tyrosinase gene is now questionable. 
These results suggest the existence of transcription regulatory mechanisms 
that are unique to avians and possibly other lower vertebrates. In contrast 
to the results obtained for RPE cells, the highest luciferase activity was 
obtained with the full length 2.1 kb promoter construct in the immortalised 
quail neural crest-derived cells. These results may have developmental 
significance since they suggest that the chicken tyrosinase gene promoter is 
regulated differently in RPE cells and neural crest-derived cells. 
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Tyrosinase is a key enzyme involved in the biosynthesis of pigment in 
vertebrates. The enzyme not only initiates the pathway of melanin synthesis by 
converting the amino acid substrate, tyrosine, to dihydroxyphenylalanine (DOPA), 
as its name suggests, but catalyses two further steps in the pathway that 
eventually result . in the production of melanin. In the absence of tyrosinase 
activity, no melanin is produced. Tyrosinase is the founder member of a family 
of proteins, known as the tyrosinase-related protein family, encoded by genes 
that are expressed exclusively within the pigment producing-cells (melanocytes) 
of the vertebrate body. Thus the mechanisms controlling tyrosinase gene 
expression represent an important level of regulation in the process of melanin 
synthesis. Moreover, the onset of expression within melanoblasts (precursors to 
melanocytes) of the genes encoding tyrosinase and its family members represents 
an important step in vertebrate melanogenesis. Research into the mechanisms 
underlying melanocyte-specific gene expression in mammals has been extensive over 
the last eight years, whereas that of lower vertebrates has only recently been 
initiated. 
The purpose of this review is to outline the role of tyrosinase in the process of 
melanogenesis and to introduce key areas of research. Section 1.1. includes a 
brief introduction to the processes involved in establishing the pigmentary 
system during embryonic development of vertebrates. Section 1.2. is dedicated to 
the tyrosinase-related gene family. Section 1.3. will review current literature 
on the regulation of transcription of the tyrosinase gene in mammals and lower 
vertebrates. 
I.I. DEVELOPMENTAL BIOLOGY OF VERTEBRATE MELANOCYTES 
Melanogenic cells in the vertebrate adult are found primarily in the epidermis of 
the skin and its derivatives, in the choroid and iris, collectively known as the 
uvea, and in the retinal pigment epithelium (RPE) of the eye. Melanocytes in the 
skin function to distribute melanin to the keratinocytes, which then shields 
these cells and underlying tissues from the mutagenic effects of UV radiation. 
It is also thought that melanin interacts with and inactivates the potentially 
harmful free radicals which are frequently produced in epithelial cells (Sarna et 
al, 1986). Melanin produced by ocular melanocytes serves a similar role, but 
also functions to absorb scattered light and thereby eliminate the interference 
of background light at the retina. 
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Melanocytes are derived from neural crest cells, pluripotent progenitor cells 
that arise during neuralation from the closing folds of the neural tube. The 
exception are the RPE cells that develop from the neuroepithelium of the optic 
cup. Neural crest cells migrate out from the dorsal surface of the neural tube 
at or after closure of the tube, along well characterised pathways and give rise 
to a diverse array of cell types. The neural crest cell migration pathways and 
derivatives are summarised in Fig. 1.1 and Table 1.1. In mammals and avians, 
neural crest cells that are destined to become melanocytes embark upon the 
dorsolateral pathway, proliferate and disperse in the subectodermal space 
(reviewed by Weston, 1970; Le Douarin, 1982; Erickson, 1986; Newgreen and 
Erickson, 1986) and then invade and colonise the ectoderm (epidermis) where they 
may become localised in hair follicles or feather germs. Despite extensive 
research (reviewed by Erickson et al, 1993), it has still not been established at 
which stage neural crest cells become committed to the melanocyte lineage, that 
is, lose their pluripotency to become melanoblasts. Melanoblasts also migrate to 
sites other than skin and eye, for instance, to the Harderian gland (a lachrymal 
gland) and in mammals, to the cochlea of the inner ear (Deal, 1970; Steel and 
Barkway, 1989). Interestingly, extracutaneous pigmentation in the Silkie fowl is 
extensive, with the mesenteries and many of the internal organs populated by 
neural crest-derived melanocytes (Eastlick and Wortham, 1946). 
The process of melanogenesis in neural crest-derived and RPE cells is initially 
the same. The cells begin to synthesize melanin which is laid down in organelles 
known as melanosomes. The process of melanin biosynthesis involves a complex 
biochemical pathway (See Fig. 1.2.) in which tyrosine is converted to either 
eumelanin, the black and brown pigment, or phaeomelanin which is a yellow-
reddish , pigment. Melanosomes contain an inner matrix which acts as a 
scaffold on which melanin is deposited. They are thought to be closely related 
to lysosomes as some of their structural membrane proteins are identical (Zhou et 
al, 1993). Four stages of melanosome maturation may be described (Fitzpatrick et 
al, 1969). Stages I and II are used to describe unmelanised, immature 
premelanosomes. A melanoblast synthesises only melanosomes of these two initial 
stages. Fully differentiated melanocytes also contain stages III and IV 
melanosomes, in which melanin is progressively accumulating. In epidermal 
melanocytes, fully melanised stage IV melanosomes are transported down the 
dendritic processes of the melanocytes and transferred to neighboring 
keratinocytes (Fig. 1.3). 
Table 1.1 
Some derivatives of the neural crest 
Derivative 










Cell type or structure derived 
Neurons, including sensory ganglia, 
sympathetic and parasympathetic ganglia, 
and plexuses 
Neuroglial cells 
Schwann ce 11 s 
Adrenal medulla 
Calcitonin-secreting cells 
Carotid body type 1 cells 
Epidermal pigment cells 
Facial and anterior ventral skull cartilage 
and bones 
Corneal endothelium and stroma 
Tooth papillae 
Dermis, smooth muscle, and adipose tissue of 
skin of head and neck 
Connective tissue of salivary, lachrymal, 
thymus, thyroid, and pituitary glands 
Connective tissue and smooth muscle in 
arteries of aortic arch origin 







PA TH 1 cells travel 
ventrally through the 
anterior sclerotome 
Caudal 
PATH 2 cells take a 
dorsolateral route 
between the epidermis 
and the dermarnyotorne 
Fig.I.I: Neural crest cell migration in the trunk of the chick embryo. Path 1: 
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Cells travel ventrally through the anterior of the sclerotome (that portion of 
the somite that generates vertebral cartilage). Those cells initially opposite 
the posterior potions of the sclerotomes migrate along the neural tube until they 
come to an opposite anterior region. · These cells contribute to the sympathetic 
and parasympathetic ganglia as well as to the adrenal medullary cells and dorsal 
root ganglia. Path 2: Somewhat later, cells enter a dorsolateral route beneath 
the ectoderm. These cells become pigment-producing melanocytes. After Gilbert 
(1994). 
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Fig. 1.2: The melanin biosynthesis pathway from tyrosine. Enzymatic reactions 
attributed to tyrosinase, TRP-1 and TRP-2 are indicated. DOPA, 3,4-dihydroxy-
phenylalanine; QijlCA, 5,6-dihydroxyindole-2-carboxylic acid; OHi, 5,6 -dihydroxy-













Fig. 1.3 : The position and role of melanocytes in the epidermis . The layers of 
t he epidermis are shown. The basal epidermal cells are mitotically active, 
whereas the fully keratinised cells characteristic of external skin are shed off . 
The keratinocytes obtain pigment from the transfer of melanosomes from the 
processes of melanocytes that reside in the basal layer . After Gilbert (1994) . 
Analyses using electron microscopy (Hirobe, 1982) have shown that the structural 
components of the melanosome (i.e. unit membranes and inner matrices) are 
assembled in the Golgi or endoplasmic reticulum. The melanogenic enzymes take a 
separate route via the Golgi where they are post-translationally modified. The 
mature enzymes are then delivered to stage I and II melanosomes in coated 
vesicles (vesicular globular bodies), within which melanogenesis is thought to 
have been initiated. These fuse, after which pigment deposition begins and 
melanosome maturation ensues (Fig. 1.4.). 
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Although epidermal melanocytes and RPE cells share a common melanogenic process, 
they differ not only in embryonic origin but also in their morphology and 
functioning. Unlike neural crest-derived melanoblasts, RPE precursor cells do 
not migrate and therefore are not susceptible to mutations that affect the homing 
and survival of migrating neural crest cells. Epidermal melanocytes lie on a 
basement membrane and extend dendritic processes between the layers of 
keratinocytes. In humans, each melanocyte is associated with 30 to 40 
keratinocytes (Lucky and Nordlund, 1985) to which they transfer their 
melanosomes. These melanocytes are therefore sparsely distributed in the basal 
layer of the epidermis compared with RPE cells which occur as a continuous layer 
of pigmented cuboidal cells, making up the outermost layer of the retina (see 
Figs 1.3 and 1.5). Neither RPE cells nor uveal melanocytes transfer their 
melanosomes. Thus ocular melanocytes cease melanogenesis when they become 
congested with melanosomes (Boissy et al, 1988; Hu and Mah, 1979). Finally, 
certain unique functions have been ascribed to RPE cells. They are responsible 
for the phagocytosis and disposal of membranous discs from the rods and cones of 
the adjacent retinal photoreceptor cells. As an epithelial cell layer, the cells 
are tightly connected to one another by junctional complexes and thus they form 
an effective blood-retina barrier. Furthermore, it was recently discovered that 
the RPE cell layer plays an essential role in the establishment of the multi-
layered neural retina during embryonic development, and its subsequent 
maintenance (Raymond and Jackson, 1995). Interestingly, extracutaneous 
melanocytes have also been shown to play a role in morphogenesis of the inner 
ear, where their presence is essential for normal development of the stria 
vascularis (Steel and Barkway, 1989). 
c~\ N 
t Ill ';;!> 
Fig. 1.4: Melanosome formation in epidermal melanocytes. Stage I and II 
melanosomes (I, II) originate from Golgi vacuoles (Gv) or from rough endoplasmic 
reticulum (RER) . Tyrosinase is transferred via vesicles (v) derived from Golgi 
saccules (Gs) into these melanosomes, which then mature to become stage III and 
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Fig. 1.5 : The position of RPE cells in the eye. (a) The layers of the eye. The 
retinal pigment epithelium forms part of the retina, which is the innermost layer 
of the eye. (b ) The layers of the retina. RPE cells comprise a simple cuboidal 
epithelial cell layer which underlies the photosensitive layer of the neural 
retina. After Ross and Romrell (1989). 
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1.2. THE TYROSINASE GENE FAMILY 
Evidence of a tyrosinase gene family first came to light when attempts to isolate 
the mammalian cDNA sequence encoding tyrosinase led to the identification of 
three related sequences that mapped to different chromosomal loci. Each family 
member encodes an enzyme involved in melanin biosynthesis. These include the 
prototype, tyrosinase, and two related proteins, tyrosinase-related protein 
(TRP)-1 and dopachrome tautomerase or TRP-2. As reviewed by Jackson et al 
(1994), these proteins share an amino acid homology of 40%, they are of similar 
length (529, 537 and 519 amino acids for tyrosinase, TRP-1 and TRP-2, 
respectively) and have a number of structural features in common, which are 
detailed in Fig. 1.6A 
Over the last decade, the genes encoding the three family members have been 
isolated from human and mouse cDNA and genomic DNA libraries. Details of the 
mutant phenotypes and the enzymatic functions proposed for the proteins encoded 
by each family member, are discussed below. That there are only three members in 
the tyrosinase gene family has been confirmed by PCR using degenerate primers 
designed by I. Jackson and J. Horn (Jackson et al, 1994). These primers 
recognise DNA sequences required for amino acid identity among the family and 
~ 
enable the simultaneous amplification of all family members (Fig. l.~). Only 
three species of DNA corresponding to the three family members have been 
amplified from mouse and human cDNA. Comparison of gene structures and DNA 
sequences, has revealed a greater homology between TRP-1 and TRP-2 genes than 
between tyrosinase and the TRP sequences (Budd and Jackson, 1995; Morrison et al, 
1994; Sturm et al, 1995). 
1.2.1. Tyrosinase 
Tyrosinase is encoded at the albino locus (c-locus) on chromosome 7 in the mouse 
and (TYR locus) on chromosome 11 in humans (Barton et al, 1988). A variety of 
mutations at the albino locus results in hypopigmentation in the coat and eyes of 
mice (Silvers, 1979), and a condition in humans referred to as tyrosinase-
negative oculocutaneous albinism (OCA). The link between OCA and a mutation in 
the tyrosinase gene was first demonstrated by Tomita et al (1989), and to date 
more than 30 distinct mutations in the tyrosinase gene have been shown to result 





EGF-like/ Cu Cys-rich Cu TM 
Cys-rich 
Fig. 1.6. Characteristic features of the proteins encoded by the tyrosinase gene 
family. (a) Schematic representation of the tyrosinase family protein domains 
which include a signal sequence at the N-terminus and a hydrophobic melanosome 
transmembrane (TM) domain near the C-terminus (Shibahara et al, 1991; Tsukamoto 
et al, 1992); two copper-binding sites (Cu) that are conserved in similar 
positions to sites in tyrosinases of lower vertebrates and prokaryotes and in 
arthropod haemocyanins (Muller et al, 1988); and two cysteine-rich (cys-rich) 
sequences that flank the first copper-binding site. One of these sequences has 
an epidermal growth factor-like (EGF) motif, the significance of which is unknown 
except that this motif is found in a variety of proteins that are membrane-bound 
or secreted through a membrane, and may participate in protein-protein 
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Fig. 1.6: (b) Amino acid sequence alignment demonstrating the sequence similarity 
between mouse tyrosinase (top row), TRP-2 (middle row) and TRP-1 (bottom row). 
Identical amino acids are indicated by I and amino acids that are chemically 
similar by:. The 15 conserved cysteine residues are shaded, the two copper-
binding sites are boxed and the transmembrane domain is enclosed by brackets. 
The relative position of the Jackson-Horn degenerate PCR primers are indicated by 
arrows. (Figure adapted from Jackson et al, 1992). 
14 
Tyrosinase has been found to be responsible for three enzyme activities in the 
melanin biosynthesis pathway (see Fig.1.2). Tyrosine hydroxylase and DOPA 
oxidase activities of tyrosinase, first described by Lerner and his colleagues 
(1949),,, are utilized in the first two steps of eu- and phaeomelanin biosynthesis 
the -fOIM•f 
andArepresent6the rate-limiting activit~ of the pathway. A third activity has 
been assigned more recently to tyrosinase, namely DHI oxidase, and is utilised in 
a subsequent step in the pathway leading specifically to the formation of 
eumelanin (proposed by Korner and Pawelek, 1982; confirmed by Tripathi et al, 
1992). 
1.2.2. Tyrosinase-related protein 1 
The gene encoding mouse TRP-1 was the first of the tyrosinase gene family to be 
isolated (Shibahara et al, 1986) and maps to the brown locus (b-locus) on 
chromosome 4 in the mouse (Jackson, 1988) and (CAS-2 locus) on chromosome 9 in 
humans, (Chintamaneni et al, 1991). Mouse b-locus mutants have brown coats 
instead of the wild-type black, implying that a functional TRP-1 enzyme is 
required for the synthesis of black melanin rather than brown (Zdarsky et al, 
1990; Bennett et al, 1990). The exact catalytic function of TRP -1 in the melanin 
biosynthesis pathway, however, is still in question. Several functions have been 
proposed and disputed , including a low level of tyrosinase activity (Jimenez et 
al, 1989), a catalase/hydrogen peroxidase (Halaban and Moellmann, 1990), a 
DOPAchrome tautomerase (Winder et al, 1993), DHICA conversion activity as well as 
interacting with and stabilizing the enzyme, tyrosinase (Kobayashi et al, 1994). 
Interestingly, del Marmol et al (1993) have shown that for cultured melanogenic 
cells, TRP -1 expression is restricted to those that produce either eumelanin or 
mixed melanins, as opposed to phaeomelanin only. \ finally, TRP-1 may play a 
structural role in the melanosome, as the melanocytes of b-mutant mice are 
abnormal i.e. they are spherical rather than ovoid in shape and contain an 
unusually large number of membranes that appear to be tangled, rather than 
arranged in a simple rolled manner (Rittenhouse, 1968). 
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1.2.3. Tyrosinase-related protein 2 
The gene encoding TRP -2 is the most recently identified member of the tyrosinase 
gene family and maps to the slaty (slt) locus on chromosome 14 of the mouse 
(Jackson et al, 1992) and human-chromosome 13 (Bouchard et al, 1994; Sturm et al, 
1994). Homozygote slaty mice have coats that are dark grey-brown rather than 
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black. The TRP-2 gene encodes an enzyme with dopachrome tautomerase activity 
(Tsukamoto et al, 1992; Kroumpouzos et al, 1994; Yokoyama et al, 1994). In the 
presence of this enzyme, dopachrome, which usually converts spontaneously to 5,6 
dihydroxyindole (OHi), is converted to a carboxylated form of OHi, namely DHICA. 
DHICA-melanins have been found to differ from OHi-derived melanins in several 
properties: whereas OHi-melanin is black and insoluble, DHICA-melanin is golden 
brown, soluble and stable when subjected to a variety of extreme conditions such 
as boiling or lyophilisation. 
Interestingly, although TRP-2 is involved at a later step than tyrosinase in the 
melanin biosynthesis pathway, Steel et al (1992) have found using in situ 
hybridization on sections of mouse embryos, that TRP-2 is the first melanocyte-
specific gene to be expressed in cells destined to become melanogenic and is 
expressed both in migrating differentiating neural crest cells and in the optic 
vesicle. It can therefore be used as an early marker to detect melanoblasts that 
have not yet begun to form pigment. Tyrosinase and TRP-1 genes are expressed 
several days later in melanoblast development. 
1.2.4. The tyrosinase gene family in lower vertebrates 
DNA sequences encoding tyrosinase have been cloned from many vertebrates 
including partial genomic sequences from the quail, snapping turtle 
(Yamamoto et al, 1992), and frog (Miura et al, 1995), and cDNA sequences from the 
frog (Takase et al 1992), chicken (Mochii et al, 1992; April et al, 1996), and 
medaka fish (Inagaki et al, 1994). In contrast, much less is known about the TRP 
genes in other vertebrates. This was the subject of discussion in a workshop 
report on the evolution and expression of tyrosinase-related proteins by Jackson 
(1994). TRP-1 cDNA sequences have been cloned for goldfish (Peng et al 1994). 
Whilst neither of the TRP gene sequences have yet been reported for avians, 
Austin and Boissy (1995) have recently shown that avian homologues do exist and 
are actively transcribed in avian melanocytes. Using chickens that are affected 
with "vitiligo-like depigmentation" (a disorder that appears to involve 
autoimmune reactions), they demonstrated that a species of autoantibody generated 
in chickens, cross-reacts with mammalian TRP-1. Furthermore they showed that 
anti-mouse TRP-1 and -2 antibodies recognise chicken proteins and that using 
mammalian TRP-1 and -2 probes chicken TRP mRNAs could be identified on Northern 
blots. Most promising is that two novel DNA species have been amplified from a 
chicken melanocyte cDNA library using the Jackson-Horn degenerate PCR primers for 
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the tyrosinase gene family (C.S. April, personal communication). These may well 
represent TRP-1 and -2 gene sequences. Recently, in a similar attempt to clone 
the gene family from axolotl using the degenerate primers, Mason and Mason (1995) 
obtained only one species of ONA, which on sequencing, was identified as a 
partial cONA sequence encoding TRP-1. 
1.2.5. The Pmel 17 gene family, a second family of pigment cell-specific genes 
The Pmel 17 gene, which maps to the silver locus (Kwon et al, 1995) was thought 
to be a fourth member of the tyrosinase gene family as it is expressed 
exclusively in melanocytes and was initially cloned by screening a melanocyte 
cONA library with polyclonal antibodies against tyrosinase (Kwon et al, 1987). 
Subsequent amino acid sequence analysis of Pmel 17 has revealed very little 
homology to the deduced proteins of the tyrosinase gene family and has prompted 
Kwon (1993) to propose a second family of genes that regulates melanin 
biosynthesis, namely the pmel 17 gene family. A chicken melanosomal matrix 
protein, MMP115 (Mochii et al, 1991), is thought to be a second member of this 
family, by virtue of the similarity in primary protein structure to that of Pmel 
17 gene product. MMP115, however, is not the chicken homologue of the human Pmel 
17 protein. It is not yet clear just how this second family of genes regulates 
melanin biosynthesis. The localisation of these proteins to the melanosome 
matrix and/or membrane (Kwon et al, 1995) suggests a structural role. In 
addition, since the Pmel 17 gene product has been suggested to promote the 
conversion of 5,6-dihydroxyindole-2-carboxylic acid to melanin (Chakraborty et 
al, 1994; Hou et al, 1994), this family has been proposed to play a role in the 
more distal steps of the melanin synthesis pathway than those involving the 
tyrosinase gene family (Kwon, 1993). 
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1.3. FACTORS REGULATING TRANSCRIPTION OF THE TYROSINASE GENE 
Since the first report of the human (Kikuchi et al, 1989) and mouse (Yamamoto et 
al, 1989) tyrosinase genomic sequences, the 5' flanking regions of the mammalian 
tyrosinase genes have been extensively analysed for potential regulatory elements 
(Kluppel et al, 1991; Ponnazhagan and Kwon, 1992; Ganss et al, 1994; Porter and 
Meyer, 1994; Shibata et al, 1992; Bentley et al, 1994; Yasumoto et al, 1994). 
However, to date, there has been very little reported on the regulation of 
tyrosinase gene expression in lower vertebrates. Partial genomic clones for 
quail, snapping turtle and frog tyrosinase have been isolated (Yamamoto et al, 
1992; Miura et al, 1995) and include 519, 699 and 750 nt of 5' flanking sequence 
upstream of the ATG translation start site, respectively. Preliminary analyses 
of the regulatory potential of these 5' flanking sequences have only recently 
begun to emerge (Akiyama et al, 1994; Miura et al, 1995). 
The control of tyrosinase gene expression is a complex process in which many 
factors have been identified to play a role. For the purposes of this review, it 
is necessary to dissect this complex process in order to detail both the 
individual cis-acting DNA elements and the trans-acting regulatory proteins 
involved. These factors have been grouped according to the regulatory function 
that they have been found to mediate. It should be made clear at the outset, 
however, that certain factors may have more than one regulatory function and that 
these groups of factors do not act in isolation. The wild-type level of 
tyrosinase gene expression found jn vjvo is the result of interplay between such 
groups of factors. 
Five classes of regulatory factors may be identified. Firstly, the basal 
promoter elements, that is, the elements within the 5' upstream sequence that 
determine the site of transcription initiation for RNA polymerase II. Secondly, 
the elements and DNA-binding factors that mediate tissue-specific expression: 
expression of the tyrosinase gene family is melanocyte-specific and thus these 
genes are particularly suited to studying the mechanisms underlying tissue-
specific restriction of gene expression. Direct sequence comparisons of the 
promoter regions of these genes have revealed conserved sequences. Analyses of 
the regulatory potential of these 5' flanking sequences within both pigment-
producing and non-pigment-producing cell types have been carried out to establish 
the significance of any common elements. The factors controlling the time of 
onset of expression during embryonic development of the tyrosinase gene, 
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represent a third class. For instance, there may be specific elements that must 
be included in the promoter of a transgene to achieve the correct onset of 
expression in a transgenic mouse. Having established a minimum promoter sequence 
containing the elements necessary for the correct temporal and spatial 
expression, still further elements may be required to achieve wild-type levels of 
gene expression. Finally, specific elements may be required to enable modulation 
of tyrosinase gene expression in response to humoral factors or external stimuli 
that are known to influence the amounts of melanin synthesized by fully 
differentiated melanocytes, such as melanocyte-stimulating hormone and UV 
irradiation. 
1.3.1. DNA sequences essential to transcription initiation of tvrosinase 
To identify the transcription start site for RNA polymerase II in the mammalian 
tyrosinase sequence, the 5' ends of mammalian tyrosinase mRNAs have been mapped 
using primer extension and RNAse protection (Ruppert et al, 1988; Yamamoto et al, 
1989; Kikuchi et al, 1989; Giebel et al, 1991; Ponnazhagan et al, 1994). Each 
independent analysis has revealed several (two to four) transcription initiation 
sites, with a common site positioned at 80 nt upstream from the ATG translation 
start site. Akiyama et al (1994) report a transcription start site for quail 
tyrosinase at the CACT sequence 81 nt upstream of the ATG, although they do not 
indicate whether the location of this site was derived empirically or by 
extrapolation from the data derived for the human and mouse tyrosinase genes. 
The 5' ends of turtle and frog tyrosinase transcripts have not yet been 
determined. 
It is well established that the binding of a TATA element by transcription factor 
TFIID serves to direct accurate transcription initiation by RNA polymerase II at 
a site approximately 30 bp downstream of the TATA element. TATA-like sequences 
(TATATA) have been identified in both the human and mouse 5' flanking sequences 
at approximately 32 nt upstream of the start site at -80 (Ruppert et al, 1988; 
Yamamoto et al, 1989; Kikuchi et al, 1989; Giebel et al, 1991; Ponnazhagan et al, 
1994), but these promoters lack a canonical TATA motif i.e. TATAAA. 
It has recently become apparent from the studies of Smale and coworkers, that a 
transcriptional initiator (Inr) element may be used as an alternative to the TATA 
box in mammalian gene promoters (O'Shea-Greenfield and Smale, 1992; Javahery et 
al, 1994; Kaufmann and Smale, 1994). The Inr has been defined as a sequence that 
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overlaps the transcription initiation site and determines the promoter strength. 
According to a report by Javahery et al (1994) almost every functional Inr that 
has been described fits the highly degenerate consensus sequence PyPyANT/APyPy, 
with the nt A positioned at +land usually a C positioned at -1. 
Interestingly, the findings in a recent report by Bentley et al (1994), suggest 
that in the absence of a canonical TATA box, the location of the transcription 
start site in the tyrosinase promoter may be determined by both the binding of 
transcription factors to an Inr-containing region and SPl-binding at an adjacent 
upstream site. The Inr region was identified as a sequence within the human 
tyrosinase promoter that was protected in a DNAse I footprinting assay and is 
conserved in the mouse, quail and turtle tyrosinase promoters. This conserved 
region overlaps the major transcription start site for the human and mouse 
tyrosinase genes and includes at its 3' end, a sequence (from -2/+5) that fits 
the degenerate consensus sequence for the Inr element with a perfect match in the 
mouse sequence (TCACTCC), but with one mismatch in the human sequence (TCACT~T). 
In addition, the Inr region includes a CATGTG motif, which fits the E-box 
consensus, CANNTG, and a non-consensus octamer element, GTGATAAT, which overlap 
each other. When mutations are introduced into either element, the level of 
transcription driven by the promoter is drastically reduced indicating that these 
sequences are essential for human tyrosinase promoter function (Bentley et al, 
1994). Studies have shown that the Inr E-box is recognised by two different 
bHLH-ZIP transcription factors (Bentley et al, 1994): USF, a ubiquitously 
expressed protein and the microphthalmia protein (Mi), which plays an essential 
role in pigment cell development (discussed in section 1.3.2.1.). The octamer 
element has been shown to bind the POU domain transcription factors, Oct-1 
(Bentley et al, 1994) and Brn-2/N-Oct3 (Eisen et al, 1995). Mi is able to 
transactivate the tyrosinase gene promoter via the E-box motif (Bentley et al, 
1994). Brn-2/N-Oct3, however, appears to down-regulate the tyrosinase gene 
promoter and furthermore can negate transactivation via the Inr E-box by Mi 
(Eisen et al, 1995). Interestingly, as binding at the two elements within the 
Inr by Brn-2/N-Oct3 and bHLH-ZIP proteins appears to be mutually exclusive, Brn-2 
may achieve its inhibitory effects by displacing bHLH-ZIP proteins or preventing 
their binding (Eisen et al, 1995). 
A non-consensus SPl-binding site (GGTGGGAGTGGT) was identified initially as a 
protected region using DNase I footprinting. It is situated 43 nt upstream of 
the Inr in the human promoter, and functions to enhance human tyrosinase gene 
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expression. While the SPl motif is not conserved in other vertebrates, they show 
using gel mobility shift assays that sequences in the same position relative to 
the Inr in mouse (AGGGGAGTGGT) and quail (AGGGGGTGGGA), are able to compete with 
the human sequence for SPl-binding. An analogous turtle sequence (AGGTGCAGGAGT), 
however, is not able to prevent SPl binding to the human sequence. Bentley et al 
(1994) speculate that since SPl-binding has not been shown to directly mediate 
tissue-specific expression from other gene promoters, it is unlikely to determine 
melanocyte-specific tyrosinase expression. However, they raise the possibility 
that in the absence of a canonical TATA box, SPl may play a role in the basal 
transcription initiation of tyrosinase by facilitating the binding of TFIID to 
the Inr. This function of SPl was recently demonstrated for a TATA-less gene 
promoter by Kaufman and Smale (1994). 
Ganss et al (1994) have analysed the proximal mouse tyrosinase promoter region 
from -270/-80 nt upstream of the transcription start site. Thus the mouse 
sequence homologous to the human tyrosinase promoter region containing the SPl-
binding site and Inr motif was not directly analysed. However, the promoter 
region analysed by DNase 1 footprinting extended to approximately -30 nt upstream 
of the transcription start site, and Ganss et al observed a protected site at -40 
to -30 which is in the vicinity of the SPl-binding site (see Fig. 1.7) and 
overlaps with one of the non-canonical TATA boxes identified for the mouse 
tyrosinase sequence. Given the importance of the Inr motif in the functioning of 
the human tyrosinase promoter and the sequence similarity of the homologous mouse 
sequence to the human Inr motif (13/15 bp match), the putative mouse Inr sequence 
may also play a role in basal transcription of the mouse tyrosinase gene. 
Furthermore, the fact that similar results were obtained when testing human 
tyrosinase promoter sequences in both human and mouse melanoma cells suggests 
that Inr-binding factors must be present in the mouse cells. 
Apart from testing the sequences from lower vertebrate tyrosinase genes 
homologous to the human tyrosinase SPl-binding site for their ability to compete 
for SPl-binding (Bentley et al, 1994), no further functional analyses of 
potential core elements in these promoters have been carried out. 
1.3.2. Factors that mediate pigment cell-specific expression of the tyrosinase 
gene 
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In the quest for cis-acting elements that mediate melanocyte-specific gene 
expression, a comparison of the promoter regions of the tyrosinase, TRP-1 and 
TRP-2 genes would reveal common motifs, which given the proposed great age of the 
family may well have been conserved because of their functional significance. 
One such element has been discovered in the 5' sequences of all the family 
members cloned to date. This 11 bp motif, termed the M-box by Lowings et al 
(1992) or p-MSE by Yamamoto et al (1992) is positioned between 40 and 160 nt 
upstream of the major transcription start site in the mammalian genes (Table 1.2) 
and slightly further upstream in the promoters analysed from lower vertebrate 
tyrosinase genes (quail, snapping turtle and frog). As is the case with the Inr, 
the M-box contains a central CATGTG motif. Functional analyses in mammals have 
shown the M-box to be an important component of the minimum promoter sequences 
required for melanocyte-specific expression of the tyrosinase gene family 
members. 
Another element, termed a pigment cell-specific promoter, has appeared 
consistently in reports by Shibahara and his colleagues on their studies of the 
mouse and human TRP-1 and human TRP-2 promoters. This element was so named 
because its sequence was first detected (at positions -33/-24 nt from the 
transcription start point) within a minimum TRP-1 promoter (-38/+154) that was 
found to be sufficient to direct transcription in melanoma (and not Hela) whole 
cell extracts. In each case, they have located this motif approximately -30nt 
upstream of the start of transcription where it overlaps with a non-canonical 
TATA-box. As this motif, unlike the M-box, is not strictly conserved in these 
promoters and has not been detected in similar comparisons by other 
investigators, it may possibly represent nothing more than partially conserved 
sequences in the vicinity of a functionally important TATA-like sequence. 
In addition to computer-aided sequence comparisons, investigators have used a 
combination of promoter deletion and linker scanner analyses (mutagenesis), DNase 
I footprinting, and gel mobility shift assays to determine the ability of 
specific promoter sequences to function as tissue-specific mediators. 
Using the above-mentioned techniques, the M-box has been independently identified 
by several groups as a positive regulatory element in both the mouse and human 
tyrosinase promoters (Bentley et al, 1994; Ganss et al, 1994; 
Table 1.2. 
Comparison of M-box sequences in mouse and human 
-52 AGGG AGTCATGTGCT GCCT -34 Mouse TRP-la 
-52 AGGG MTCATGTGCT GATC -34 Human TRP-lb 
- ll l AGTT AGTCATGTGCT TTGC -93 Mouse tyrosinasec 
-108 AGTC AGTCATGTGCT TTTC -90 Human tyrosinased 
-154 TTAG GGTCATGTGCT AACA -136 Mouse TRP-2e 
-139 TTTG GGTCATGTGCT AATG -126 Human TRP-2f 
Note: The M-box is in boldface. Numbering is from the start of transcription. 
After Budd and Jackson (1995). 
a Jackson et al (1991); Shibahara et al (1991) 
b Shibata et al (1992) 
c Yamamoto et al (1989) 
d Takeda et al (1989) 
e Budd and Jackson (1995) 




Yasumoto et al, 1994). Bentley et al, (1994) have identified five elements that 
regulate the human tyrosinase promoter extending to -300 nt upstream of the start 
of transcription (summarised in Fig. 1.7). Most importantly, they have shown 
that the ability to confer tissue specificity resides in the proximal 115 nt of 
this promoter sequence. In addition to the previously discussed SPl-binding site 
(-45/-37) and an Inr motif, this proximal region contains the M-box (-104/-94). 
By using linker-scanner mutation analyses, they found that mutation of the M-box 
in the context of the intact tyrosinase 5' flanking sequence, resulted in a 
fifty-fold decrease in promoter activity. 
It has long been established that as little as 270 bp of the mouse tyrosinase 
promoter is sufficient for cell type-specific expression in both cultured cells 
and in transgenic mice (Kluppel et al, 1991). Ganss et al (1994) analysed this 
promoter region (from -270/-80 nt upstream of the start of transcription) for 
cis-acting elements and they too identified the M-box as a positive regulatory 
element (see Fig. 1.7). 
Interestingly, when the function of the 270 bp mouse promoter and a human 
promoter sequence of similar length (-209/+56 relative to the start of 
transcription) was assessed using transient expression analysis, the human 
promoter sequence was shown to be significantly weaker than the mouse promoter, 
despite its sequence similarity to the mouse counterpart. Furthermore, human 
promoter fragments of 616 bp, 906 bp or 1.8 kb, were also not able to increase 
reporter gene expression to the level obtained using the 270 bp mouse promoter. 
Only constructs containing human promoter fragments longer than 1.8 kb could 
mediate a significant increase in reporter gene activity and this increase was 
achieved specifically in pigment-producing cells. The element responsible for 
this tissue-specific enhancer activity was identified within a 39 bp fragment, 
situated approximately 1.86 kb upstream from the transcription start site in the 
human tyrosinase promoter (Shibata et al, 1992). This element has now been 
termed the tyrosinase distal element (TOE) by Yasumoto et al (1994), who have 
subsequently shown that the enhancer function is encoded by a 20 nt sequence that 
contains an E-box motif (CATGTG) at its centre. Using mutation analysis, the 
CATGTG motif has been shown to play a critical role in both protein-binding by 
the TOE and pigment cell -specificity of the enhancer activity. The homologous 
region in the mouse 5' flanking sequence was unable to enhance promoter activity 
in melanoma cells, despite its sequence similarity (16 out of 20 nt match). This 
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Fig. 1.7: Relative positions of regulatory elements identified in the proximal 
promoter regions of the human, mouse and quail tyrosinase genes. The diagram is 
a synopsis of results from the promoter analyses reported by Bentley et al 
(1994), Ganss et al (1994), Ponnazhagan and Kwon (1992), Yamamoto et al (1992) 
and Yasumoto et al (1995). Note that except for the SPl-binding site, the 
functional significance of the elements presented for the quail gene has not been 
tested. cs, element is present in the complementary strand. 
is consistent with the fact that the mouse minimum promoter is able to activate 
expression of a reporter gene at a level which may be attained by the minimum 
human promoter only in the presence of the TOE. 
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The CATGTG motif is thus found within the TOE, the M-box and the Inr sequence. 
The relative roles of these three elements in the human tyrosinase promoter have 
been assessed independently by two groups: Yasumoto et al (1994) analysed the 
roles of the TOE and the M-box, and Bentley et al (1994) analysed the Inr and the 
M-box . All three elements are recognised and bound in vitro by the 
microphthalmia protein (Mi), an E-box-binding protein which is known to be 
involved in melanocyte differentiation. Both groups have found that the relative 
role of the M-box is not as significant as those of the Inr and TOE. Whilst the 
E-box motifs present in the Inr and the TOE are essential for the activation of 
tyrosinase expression by Mi, the M-box only enhances this activation and it alone 
is not capable of mediating tissue-specific expression of human tyrosinase. 
Results from a more recent report by Yasumoto et al (1995), show that a mouse 
tyrosinase promoter fragment (-82/+6) containing the Inr E-box but not the M-box, 
is sufficient for pigment cell-specific gene expression and for transactivation 
by Mi. They suggest therefore that as for the human promoter, the Inr E-box 
plays a more important role than the M-box in the mouse tyrosinase promoter. 
Sequences similar to the M-box have been identified in the promoters of lower 
vertebrate tyrosinase genes (Yamamoto et al, 1992; Miura et al, 1995). The M-box 
was initially referred to as a proximal melanocyte-specific element (p-MSE) by 
Yamamoto et al (1992), who identified it as an element common to mouse tyrosinase 
and TRP-1 5' flanking sequences. They then discovered sequences in the promoters 
of quail and turtle tyrosinase genes similar to p-MSE. More recently, Miura et 
al (1995) identified two p-MSE-like sequences in the frog tyrosinase promoter. 
These lower vertebrate homologues are not strictly conserved with the M-box over 
its 11 nt and some lack the central CANNTG motif. The functional significance of 
the quail p-MSE-like sequences has been indirectly investigated (Akiyama et al, 
1994). In this report it is shown that 519 bp of the quail tyrosinase 5' 
flanking sequence (i.e. the entire 5' flanking sequence reported thus far for 
quail tyrosinase) is able to drive the expression of a mouse tyrosinase cONA 
sequence exclusively in chicken melanocytes. According to the reports of Bentley 
et al (1994) and Yamamoto et al (1992), this quail promoter contains the 
following mammalian tyrosinase promoter homologues (see Fig. 1.7): the Inr, SPl-
binding site, the M-box and two further p-MSE-like sequences. A truncated quail 
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promoter of 369 bp which included only one p-MSE-like sequence, the Inr, SPl-
binding site, and M-box allows expression of the downstream gene in chicken 
melanocytes as well as in fibroblasts and hepatocytes, that is, the truncated 
promoter no longer directs gene expression tissue-specifically. Therefore, in 
contrast with the human tyrosinase promoter, a quail sequence containing the Inr, 
SPl-binding site and M-box, is insufficient to direct tissue-specific expression, 
and requires additional elements found within the adjacent 150 nt of 5' flanking 
sequence, one of which could be the upstream p-MSE-like sequence. Clearly, a 
more detailed analysis of the quail tyrosinase promoter is required to determine 
the region that constitutes the minimum essential promoter. 
Apart from the M-box, SPl-binding site and Inr, additional positive and negative 
regulatory regions have been found further upstream in the proximal promoters of 
the mammalian tyrosinase genes (see Fig. 1.7). For human tyrosinase, these 
elements are located upstream of the essential -115/+1 promoter region and would 
thus function to modulate the level of tyrosinase gene expression (Bentley et al, 
1994). 
An upstream activator element situated at nt positions -245/-230 in the mouse 
tyrosinase promoter, was identified by Ganss et al (1994) (see Fig. 1.7). This 
overlaps the position of a putative melanocyte-specific enhancer element (-240/-
216) termed tyrosinase element-I (TE-1) reported by Ponnazhagan and Kwon (1992). 
Interestingly, they were able to identify TE-1 by DNAse I footprinting using 
nuclear extracts of 816 melanoma cells, but did not detect DNA-binding at the M-
box under the same conditions. TE-1 shares sequence similarity with the 39 bp 
human enhancer element (TOE), but was unable to compete with the human enhancer 
for binding of human melanoma nuclear proteins in gel mobility shift assays 
(Yasumoto et al, 1994). A sequence similar to TE-1 was found in the quail 
tyrosinase gene promoter 106 nt upstream of the ATG site (Akiyama et al, 1994), 
but has not been specifically tested for its ability to act as a melanocyte-
specific enhancer of avian tyrosinase gene expression. 
A large negative regulatory element (-193/-125) was identified in the mouse 270 
bp minimum promoter (Ganss et al, 1994)(see Fig. 1.7). Interestingly, 
mutagenesis at various sites within this 70 bp region abolished negative 
regulation within melanoma cells but had no effect on expression in NIH3T3 
fibroblasts. This suggests that the tyrosinase gene is under negative control in 
pigment-producing cells. Ganss et al suggest a purpose for this puzzling 
repression: induction of expression by an external factor such as UV or a-MSH, 
may be mediated by removal of a repressor. 
1.3.2.1. The role of the E-box motif and the microphthalmia protein in 
melanocyte-specific gene expression 
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The E-box motif, CANNTG, is the consensus sequence of the binding site of a 
family of transcription factors distinguished by their basic/helix-loop-
helix/leucine zipper (bHLH-ZIP) structure (reviewed by Lopez, 1995). This family 
includes amongst others, the proto-oncogene, myc, the regulators of myc function, 
Mad, Max, and Mxil, as well as USF (upstream stimulatory factor) which is an 
adenovirus major late transcription factor, and myoD-related factors. These 
proteins depend on dimerisation for DNA-binding and exert their effects as 
homodimers or heterodimers. Dimerisation occurs via the HLH and ZIP domains and 
DNA binding via the basic domains. 
Given the significant role of the E-box motif in the regulatory elements 
identified for tyrosinase, TRP-1 and TRP-2 gene promoters, it was thought that 
this motif might provide a binding site for a melanocyte-specific transcription 
factor. A potential candidate is the product of the microphthalmia (mi) locus in 
mice, which was recently identified as a novel member of the bHLH-ZIP 
transcription factor family (Hodgkinson et al, 1993; Hughes et al, 1993). All 
mutations at the mouse mi locus affect melanocytes and in some cases other cell 
types including RPE cells, which are defective or absent, depending on the allele 
that is mutated. The most severe mutations result in mice that are 
microphthalmic, that is the eyes are poorly developed, anatomically reduced in 
size, and unpigmented. They are also deaf and have unpigmented coats due to a 
lack of melanocytes in the inner ear and skin. In addition, these mice are 
deficient in mast cells and have defective osteoclasts (Gruneberg, 1953; Silvers, 
1979). In situ hybridisation analyses on sections of mouse embryos show that mi 
gene expression is restricted to several cell types including melanoblasts of the 
developing eye, skin and inner ear (Hodgkinson et al, 1993). Alternative 
splicing gives rise to two mi gene products, one that includes an insert of 6 
amino acids (the plus form) and another isoform (the minus form) from which these 
amino acids are missing (Steingrimsson et al, 1994). Interestingly, the plus 
isoform binds DNA with 20% higher affinity than the minus form (Hemesath et al, 
1994) and appears to be unique to melanocytes (Hodgkinson et al, 1993). Thus the 
enhanced affinity may serve a function specific to melanocytes (Lopez, 1995). 
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Cloning of the cDNA sequences encoding mouse Mi and the human homologue of Mi, 
termed microphthalmia-associated transcription factor (MITF) (Hodgkinson et al, 
1993; Hughes et al, 1993; Tachibana et al, 1994) has enabled investigation of the 
potential of the Mi protein to function as a melanocyte-specific transcription 
factor in vitro. Cotransfection assays demonstrated that reporter gene 
expression driven by either a tyrosinase, TRP-1 or an M-box-containing SV40 
promoter, is increased in the presence of a Mi/MITF expression plasmid. Mutation 
of the M-box, Inr or TOE in the tyrosinase promoter or deletion of the M-box 
from the TRP-1 promoter significantly reduced this transactivation (Bentley et 
al, 1994; Ganss et al, 1994; Hemesath et al, 1994; Yasumoto et al, 1994; Yasumoto 
et al, 1995; Yavuzer et al, 1995). 
Dedifferentiation and a co-ordinated down-regulation of tissue-specific genes is 
often associated with cellular transformation. Given the potential of the 
microphthalmia protein to act as a melanocyte-specific transcription factor, 
Yavuzer et al (1995) investigated the role of microphthalmia, if any, in the 
downregulation of melanocyte-specific gene transcription in melanocytes that had 
been transformed using the adenovirus ElA proteins. Using quantitative PCR they 
found that Mi expression is reduced up to 50-fold in these cells as compared with 
untransformed controls. This is likely to be responsible for the concomitant 
repression of tyrosinase and TRP-1 gene promoter activities, which is shown to be 
reversed in the presence of ectopic Mi expression. ElA may also disrupt Mi 
activity by competing with Mi for binding of the retinoblastoma protein, pl05Rb. 
The interaction of another bHLH protein, MyoD, with pl05Rb was found to be 
essential for its ability to transactivate other promoters and Mi has been shown 
to interact with pl05Rb in vitro. 
Not all experimental data to date, however, support the role of Mi as the 
melanocyte-specific factor that binds the E-box motifs within the tyrosinase-
related gene promoters. For instance, several investigators have independently 
shown using gel mobility shift assays of nuclear extracts from pigmented cells, 
that it is USF, the ubiquitously expressed transcription factor, and not Mi that 
binds in vitro to the E-box-containing promoter elements of tyrosinase and TRP-1 
(Bentley et al, 1994; Yasumoto et al, 1994; Yavuzer et al, 1994). Several 
theories have been put forward to account for this surprising result. Firstly, 
the binding specificity of E-box motifs is known to be influenced by flanking 
sequences and thus may restrict access to certain b-HLH-ZIP proteins in vivo. 
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Hemesath et al (1994) argue that even if ubiquitous factors such as USF are able 
to bind these E-box motifs in vivo, it is possible that their transactivation 
domains may not be functionally equivalent to that of Mi and this could be 
important for tissue-specificity. This is supported by an observation of Lowings 
et al (1992), who found that tissue-specific expression could be obtained only if 
the M-box was placed upstream from the basal transcription elements of the TRP-1 
gene, but not if it was placed upstream of the thymidine kinase promoter. 
Alternatively, the conditions used in these assays were not sensitive enough to 
detect Mi DNA-binding activity, which may have been masked by binding of the more 
abundant USF. The only report to date of DNA-binding activity of Mi/MITF as 
analysed by gel mobility shift assays, is that of Yasumoto et al (1995). They 
used purified recombinant MITF protein (glutathione-S-transferase-MITF produced 
inf. coli) as opposed to nuclear extracts from pigmented cells. The MITF fusion 
protein was shown to bind the CATGTG motif of an oligonucleotide probe containing 
the tyrosinase M-box. 
1.3.3. Are there promoter elements essential for the correct temporal patterns of 
tyrosinase gene expression? 
The time of onset of expression of the tyrosinase gene during embryonic 
development has been analysed for the mouse using in situ hybridisation (Beermann 
et al, 1992; Steel et al, 1992). Pigment first appears in the retina at day 
11.5, but at approximately day 16.5 in the hair follicles. Expression of the 
tyrosinase gene which precedes the appearance of melanin has been detected in the 
pigmented epithelium of the retina at embryonic day 10.5 and later in migratory 
melanocytes at day 14.5. Beermann et al (1992) have shown that this temporal 
pattern of expression may be largely reproduced in transgenic mice carrying 
minigenes that contain 270 bp of the proximal tyrosinase promoter sequences 
previously shown to be sufficient for pigment cell specific expression (see Fig. 
1.8). Thus the 270 bp mouse tyrosinase promoter sequence contains the cis-acting 
elements that when bound by the pertinent transcription factors, function to 
activate gene expression in the eye and skin at the appropriate time in 
development. The earlier onset of expression in the eye versus the skin may be 
explained by one of two scenarios: either different or additional elements/DNA-
binding proteins may be required in the different tissues or possibly the same 
factors are used, but are accessible in the eye at an earlier stage than in the 
skin. As the minimum promoter contains the M-box and Inr CATGTG motifs it will 
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Fig. 1.8: Time of earliest expression of melanocyte-specific genes in (a) the 
retinal pigment epithelium and (b) melanocytes of the skin. The data shown 
represents the results reported by Beermann et al (1992) and Steel et al (1992). 
Beermann et al studied the expression of the tyrosinase gene (tyr) during 
embryonic development and found that the pattern of expression could be largely 
reproduced in mice carrying transgenes that contain either 5.5 kb or 270 bp of 
proximal tyrosinase promoter sequences. Steel et al determined the time of 
earliest expression of tyrosinase, TRP-1 and TRP-2, as well as the stage at which 
pigment was first detectable. Note that Steel et al failed to detect tyrosinase 
mRNA in the RPE at a time when pigment was detectable. They reason that this was 
most probably due to very few transcripts being present. The temporal pattern of 
expression of tyrosinase, TRP-1 and TRP-2 in the mouse is similar for RPE cells 
and skin melanocytes in that TRP-2 is expressed first in both tissues, followed a 
few days later by the activation of tyrosinase and TRP-1 expression. Days of 
gestation are given as e9.5, 10.5, etc. (Figure adapted from Beermann et al, 
1993.) 
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earlier in the eye than in skin. Whether elements distinct from those mediating 
tissue-specific expression are required for correct temporal expression remains 
to be seen. 
1.3.4. Elements that mediate position-independent expression of the endogenous 
tyrosinase gene and tyrosinase transgenes 
Evidence from transgenic mouse studies has brought to light a further level of 
gene regulation involving elements that mediate position-independent expression 
of randomly integrated transgenes. A transgene is said to be position-
independent when its expression is proportional to the number of copies 
integrated into the host genome, that is the construct contains the elements 
required to establish an open chromatin structure and to insulate the transgene 
from regulatory influences of the neighboring chromatin. 
Expression of tyrosinase transgenes containing up to 5.5 kb of 5' flanking 
sequences (and the elements required for correct temporal and spatial expression) 
has been shown to rescue the albino phenotype in transgenic mice (Beermann et al, 
1990; Yokoyama et al, 1990; Tanaka et al, 1990). The transgenic mice are 
pigmented but the level of pigmentation varies according to the level of 
transgene expression, which is in turn affected by the site of integration in the 
host genome. The poor expression of these transgenes which failed to reach the 
same level as that of the endogenous tyrosinase gene, is most probably due to the 
absence of strong regulatory elements and/or position effects exerted by 
neighboring chromatin on the randomly integrated transgenes. A yeast artificial 
chromosome (YAC) carrying a mouse genomic fragment including 80 kb of the 
tyrosinase gene coding region and 155 kb of 5' flanking sequence, however, was 
able to express tyrosinase at wild-type levels (Schedl et al, 1993), indicating 
that the regulatory elements required for full expression of the tyrosinase gene 
are located between 5.5 and 155 kb upstream of exon 1. 
Further evidence for important regulatory elements situated far upstream in the 
tyrosinase 5' flanking sequence, was reported by Porter et al (1991). They 
found that in mice with the chinchilla-mottled mutation, a rearrangement in the 
5' flanking sequence located more than 5 kb upstream of the tyrosinase gene 
causes aberrant expression of the endogenous tyrosinase gene. The rearrangement 
results in separation from the tyrosinase gene of a DNase I hypersensitive site 
and a potential nuclear matrix attachment region located at approximately -15 kb 
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(but subsequently recalculated to be at -12 kb by Ganss et al (1994)). 
Interestingly, this leads to a reduced expression of the tyrosinase gene, the 
genomic sequence of which is otherwise intact. Furthermore, expression is not 
homogeneously reduced in all melanocytes, as the coats of homozygous chinchilla-
mottled mice have stripes of light and dark grey, resulting from a variable 
ability of different melanocyte clones to achieve the appropriate chromatin 
conformation at the tyrosinase locus. 
To test the functional ability of the -12 kb region, a 3.6 kb fragment containing 
this region was linked to the smaller tyrosinase transgene constructs. It was 
found to both enhance expression from these constructs in transgenic mice, and to 
insulate the transgenes from some, but not all position effects (Ganss et al, 
1994; Porter and Meyer, 1994). The DNase I hypersensitive site has been shown to 
be specific to pigment-producing cells. Furthermore, a 200 bp element coincides 
with the DNase I hypersensitive site and analysis in transient transfection 
assays has shown that it functions as a melanocyte-specific transcriptional 
enhancer (Ganss et al, 1994). 
1.3.5. Cis-acting elements and trans-acting factors that mediate a 
transcriptional response to extracellular stimuli 
A number of agents have been found to regulate melanin synthesis in mammalian 
melanocytes or melanoma cells in vitro and in vivo by modulating tyrosinase 
activity. They may act at a transcriptional level to modulate the levels of 
tyrosinase mRNA levels and/or may activate pre-existing pools of inactive 
tyrosinase, for instance at a post-transcriptional level by regulating the rate 
of glycosylation which is required for tyrosinase maturation (Imokawa and 
Mishima, 1986; Park et al, 1993). 
This section is limited to a review of both those melanogenesis regulatory agents 
that act (directly or indirectly) to cause a change in tyrosinase mRNA levels, 
and the relevant cis-acting elements within the tyrosinase 5' flanking sequence 
that may mediate the transcriptional response. These agents include a-MSH, a 
physiologically relevant effector which acts via cAMP (Hoganson et al, 1989; Kwon 
et al, 1988) as well as other cAMP-elevating chemicals such as forskolin, 
isobutylmethylxanthine (IBMX), theophylline (Fuller and Lebowitz, 1980), 
dibutyryl cAMP (Johnson and Pastan, 1972) and cholera toxin (Kreiner et al, 1973; 
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O'Keefe and Cuatrecasas, 1974), UV irradiation (Friedman and Gilchrest, 1987), 
retinoic acid, glucocorticoids (Ito et al, 1991) and phorbol esters such as 12-0-
tetradecanoyl-phorbol-13-acetate (TPA) (Fuller et al, 1990). 
1.3.5.1. The stimulation of melanogenesis by cAMP-elevators 
There appear to be several mechanisms by which raised intracellular levels of 
cAMP can increase gene expression. Three types of cis-acting elements present in 
gene promoters have been found to mediate the response to cAMP: the cAMP-
responsive element (CRE), the AP-I-binding site and the AP-2 binding site (see 
Table 1.3 for consensus sequences). Usually, the cAMP response is mediated via 
a CRE. A transcription factor, CREB (CRE-binding protein), is activated through 
phosphorylation by Protein Kinase A (Karin, 1994) and then binds to a CRE. 
Alternatively, the AP-2 site has also been found to mediate responsiveness to 
cAMP, as well as to TPA and retinoic acid (lmagawa et al, 1987; Miller et al, 
1995). In addition, the cAMP response effect may be mediated through binding at 
an AP-1 site (also known as a TPA-responsive element). Recently, Englaro et al 
(1995) demonstrated that the treatment of 816 mouse melanoma cells with cAMP-
~~chois 
elevatorsAforskolin, IBMX and a-MSH could stimulate melanogenesis via 
phosphorylation of a member of the mitogen-activated protein (MAP) kinase family. 
The MAP kinase was shown to translocate to the nucleus where it is known to 
activate several transcription factors (Pulverer et al, 1991). Englaro et al 
(1995) showed that with cAMP elevators, the transcription factor AP-1 is 
activated. AP-1 may then bind the tyrosinase gene promoter at one of the AP-1-
like binding sites (see below) and thereby upregulate transcription of 
tyrosinase. The AP-1 transcription factor is a complex consisting of either 
homodimers of the jun family of proteins, or heterodimers of fas and jun 
components. Given that AP-1 also mediates a response to TPA distinct from cAMP-
elevators, the function of AP-1 may reside in the specific combination of fas and 
jun components comprising the AP -1 complex. Englaro et al (1995) show that the 
AP - I complex activated by cAMP -elevators consists mostly of JunD and Fra-2 (Fos-
related antigen-2), whereas a TPA-activated AP-I complex contains predominantly 
JunD and cFos. 
Sequence analysis of the mouse and human tyrosinase promoters has revealed the 
presence of a number of sequences with close homology to the CRE, AP-1- and AP-2-
binding sites (Giebel et al, 1991; Kikuchi et al, 1989; Ponnazhagan et al, 1994; 
Ponnazhagan and Kwon, 1992; Miller et al, 1995). Recently, Miller et al (1995) 
34 
showed that 0.769 kb of 5' flanking sequences of the mouse tyrosinase gene 
contained the elements necessary to mediate increased expression of an 
interleukin-2 (IL-2) reporter cDNA sequence in cultured 816 mouse melanoma cells, 
in response to treatment with theophylline. This 0.769 kb mouse sequence lacks 
AP-2-binding sites (which are found further upstream in the 5' flanking sequence) 
but contains two non -consensus CRE-like elements and a sequence similar to an AP-
I binding site (see Fig. 1.9). It is tempting to speculate that these elements 
may be the functional cAMP-responsive elements. However, these three putative 
elements are found within the minimum 270 bp mouse promoter that was shown to be 
unable to confer cAMP-inducibility to a CAT reporter gene when tested in 816 
melanoma cells treated with forskolin (Ganss et al, 1994). Thus, the as yet 
unidentified elements that are required to respond to cAMP must reside between nt 
positions -769 and -270 upstream of the transcription start site. 
1.3.5.2. The regulation of melanogenesis by retinoic acid and glucocorticoids 
Reports in the literature about the melanogenic effects mediated by retinoids in 
human and mouse cell lines are contradictory, in that both inhibitory and 
stimulatory effects have been reported (summarized in Miller et al, 1995). 
Miller et al (1995) used the mouse tyrosinase promoter/IL-2 reporter gene system 
to test RA for its potential to regulate transcription from the tyrosinase 
promoter in 816 melanoma cells. They found that RA increases gene expression 
driven by the 0.769 kb mouse tyrosinase promoter in 816 cells. To account for 
the opposing effects of RA reported in the literature, they propose that in cell 
lines where melanogenesis is inhibited by RA, tyrosinase gene expression may be 
increased but downstream events in melanogenesis may be inhibited by RA. RA is 
known to mediate its effects by binding to a nuclear RA receptor (RAR) which then 
functions to modulate gene transcription by binding a RA-responsive element 
(RARE) in the 5' flanking sequence of the gene. A RARE half-site has been 
identified within the 0.769 kb mouse tyrosinase promoter which may mediate the 
stimulatory effects of RA (Fig. 1.9). 
As with RA, glucocorticoids (steroid hormones) exert their effects by binding to 
and activating a specific nuclear hormone receptor, which then interacts directly 
with a glucocorticoid response element (GRE: 5'-GGTACANNNTGTTCT) within a target 
gene to modulate the rate of transcription of that gene (Beato, 1989). 
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Fig. 1.9: Positions of potential responsive-elements in the human tyrosinase gene 
promoter sequence. A map is shown of the human tyrosinase promoter fragments 
tested by Miller et al (1995) for responsiveness to treatment with theophylline, 
retinoic acid and TPA. The fragments included a "full-length" 2496 bp promoter 
sequence (unshaded region) and a truncated 769 bp promoter sequence (shaded 
region). Note that both the full-length and the truncated sequences possess CRE, 
RARE and TRE motifs but only the full-length promoter has AP-2-binding sites. 
Consensus sequences used in the study were as follows: AP-2 = CCCCAGGC; CRE = 
TGACGTCA; RARE= GGTTCAC; TRE = TGAGTCA. After Miller et al (1995). 
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cells and when applied topically, cause repigmentation in the skin of patients 
with vitiligo. Ito et al (1991) suggest that this may be achieved through 
transcriptional control as glucocorticoid receptors have been found in mouse and 
human melanoma lines and the treatment of 816 melanoma cells with dexamethasone 
(a synthetic glucocorticoid) resulted in an increase in tyrosinase mRNA when 
analysed by Northern blot hybridisation. Glucocorticoids may act to increase 
tyrosinase gene expression directly via GRE-binding as GRE-like sequences have 
been identified in the 5' flanking sequences of the mouse and human tyrosinase 
genes (Ito et al, 1991; Ponnazhagan and Kwon, 1992; Ponnazhagan et al, 1994). 
Alternatively, Ito et al (1991) propose that glucocorticoids may modulate 
tyrosinase gene expression indirectly by inhibiting AP-1 activity. This is based 
on the reports by several investigators that glucocorticoid receptors suppress 
AP-I activity by direct protein-protein interaction. 
1.3.5.3. The down-regulation of melanogenesis by TPA 
TPA is a non-physiological agent that has been routinely used as a mitogen for 
the establishment of long-term cultures of mammalian and avian melanocytes 
(Glimelius and Weston, 1981; Sieber-Blum and Sieber, 1981; Eisinger and Marko, 
1982). TPA has been found to inhibit melanogenesis partly by down-regulating 
tyrosinase mRNA levels (Fuller et al, 1990; Ando et al, 1995). Although TPA is a 
non-physiological agent it is still relevant to study the mechanism underlying 
TPA-induced inhibition of tyrosinase gene expression because it is generally 
recognised that artificial agents mimic the effects of certain (possibly 
unidentified) physiological effectors (Swope et al, 1995). 
Two elements found in the 5' flanking sequences of certain genes have been 
reported to mediate the effects of TPA: the TPA-responsive element (TRE) and the 
AP-2 binding sequence. The TRE was discovered to be an AP-1 binding site (Lee et 
al, 1987) and thus certain effects of TPA appear to be mediated via DNA-binding 
of AP-I complexes. As mentioned previously (in section 1.3.5.1.), putative AP-1 
and AP-2 target sequences have been identified in the mouse and human tyrosinase 
5' flanking sequences, within 2.5 kb from the ATG translation start site. 
The ability of these sequences to modulate tyrosinase gene promoter activity in 
response to TPA has recently been tested. As has been described for cAMP and RA, 
Miller et al (1995) used their mouse tyrosinase promoter/IL-2 reporter gene 
system to establish the response to TPA of two different lengths (2.5 kb or 0.769 
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kb) of tyrosinase gene promoter. After treating B16 melanoma cells (that were 
transfected with either construct) with TPA, they observed no change or at most a 
slight decrease in the levels of IL-2 gene expression. Thus the AP-1 and AP-2 
sites are non-responsive to TPA under these conditions. Possibly the 
concentrations of TPA used (2nM, 200nM and 2µM) were not optimal, as the slight 
decrease in the levels of IL-2 gene expression was observed only after treatment 
with 2nM TPA. In contrast, tyrosinase mRNA levels were markedly decreased in 
cells treated with 25nM TPA (Ando et al, 1995). Alternatively, functional TPA-
responsive elements may positioned further upstream (i.e. more than 2.5 kb 
upstream of the ATG site) in the tyrosinase gene promoter. 
Englaro et al (1995) have tested the ability of TPA to activate the AP-1 and AP-2 
transcription factors in B16 melanoma cells. Using gel mobility shift assays 
with labelled oligonucleotide probes containing the AP-1 or AP-2 site, and 
nuclear extracts from TPA-treated cells, they showed that AP-1 is activated to 
bind DNA, and not AP-2. This result at least confirms the proposal by Miller et 
al (1995), that AP-2 sites in the tyrosinase gene promoter do not seem to mediate 
TPA effects. 
1.3.5.4. The mechanisms involved in UVB-induced hyperpigmentation 
It has long been established that one of the primary functions of melanin is 
protection of the organism from damage by ultraviolet light and other forms of 
radiation. In fact, increased melanogenesis may be considered to be part of the 
SOS response in skin to UV irradiation (Eller et al, 1996). Increased melanin 
production in response to UVB irradiation is due to an increased activity of 
tyrosinase and other enzymes involved in the melanogenic pathway, and an increase 
in melanocyte proliferation (Jimbo and Uesugi, 1982). Northen blot analysis of 
tyrosinase mRNA levels in UV-irradiated human melanocytes in vivo, and both mouse 
melanoma cells and normal human melanocytes in culture has confirmed that UV-
induced tyrosinase activity is due in part to an increase in tyrosinase gene 
expression (Imokawa et al, 1995; Eller et al, 1996). 
Just how UV light is able to elicit a melanogenic response has been the subject 
of investigation by several investigators. Reports by Gilchrest and colleagues 
(Gilchrest et al, 1993; Eller et al, 1994; Eller et al, 1996) have shown that UV-
induced DNA damage and/or repair is an important signal in this response. 
Treatment of unirradiated pigment cells in culture with either DNA damaging 
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agents such as restriction enzymes or methyl methanesulfonate (MMS), or with 
thymine dinucleotides, the by-products of DNA excision repair, was sufficient to 
increase the melanin content and upregulate tyrosinase gene expression in these 
cells. UV irradiation of Cloudman ~91 melanoma cells has been found to enhance 
their response to MSH by increasing the number of MSH receptors on their cell 
surfaces (Bolognia et al, 1989; Chakraborty et al, 1991). Accordingly, MMS and 
thymine dinucleotides also increased the response of these cells to the 
stimulating effects of a-MSH, further mimicking the action of UV. Thus one 
mechanism by which tyrosinase gene expression may ultimately be upregulated in 
response to UV light is via increased binding of MSH (which is secreted by 
epidermal keratinocytes in vivo, and is most probably present in the foetal calf 
serum which is included in culture medium) at cell surface receptors, followed 
presumably by elevated levels of intracellular cAMP (described in section 
1.3.5.1.). 
An independent study by Imokawa et al (1995) has revealed a further melanogenic 
factor produced by human keratinocytes when exposed to UVB irradiation. This 
factor, endothelin-1 (ET-1), was originally found to be a vasoconstrictor 
produced and secreted by endothelial cells (Yanagisawa et al, 1988). It is now 
known that ET-1 belongs to a family of small peptides that are ligands for the G-
protein coupled heptahelical receptors, endothelin-A and -B (Rubanyi et al, 1994; 
Yanagisawa, 1994). ET-1 has been shown to be a mitogen for human epidermal 
melanocytes (Vada et al, 1991). Imokawa et al (1995) have subsequently 
demonstrated that ET-1 also possesses melanogenic potential. They showed that 
conditioned medium from keratinocytes exposed to UV light could upregulate 
melanin synthesis in human melanocytes in culture, but this activity was 
abolished when the conditioned medium was precleared using an anti-ET-1 antibody. 
Accordingly, the addition of exogenous ET-1 to the culture medium resulted in the 
stimulation of tyrosinase activity, melanin synthesis and tyrosinase mRNA 
synthesis. Furthermore, they provided evidence that ET-1 may well be a mediator 
of the UV-induced melanogenic response in vivo, as expression of both ET-1 and 
tyrosinase increases in skin after exposure to UVB irradiation. However, the 
mechanisms that link upregulated ET-1 ligand-receptor interaction and increased 
tyrosinase gene expression are yet to be established. 
Another mechanism by which gene expression may be induced via UV irradiation and 
DNA damage implicates a DNA damage-responsive element (DORE). Such an element 
has been discovered in the 5' flanking sequence of the yeast gene encoding a DNA 
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repair enzyme, photolyase (Sebastian and Sancar, 1991). Under normal conditions 
this 39 bp element is bound by a repressor protein, photolyase regulatory protein 
(PRP), but as a result of UV irradiation PRP is lost from yeast cells and 
therefore no longer represses photolyase gene expression. Eller et al (1996) 
report that sequences within the mouse and human tyrosinase 5' flanking regions 
(AGAAGATAAAAG; AGAGGATGAAAG) share homology with a portion of the yeast DORE 
(AGGGGTGAAAG). Functional analyses of these homologous sequences must still be 
carried out to assess their role in UV-induced upregulation of tyrosinase 
expression. That tyrosinase gene expression may be. upregulated by removal of a 
repressor is an attractive proposal, given the observation made by Ganss et al 
(1994) that the tyrosinase gene is under negative control in pigment-producing 
cells (mentioned in section 1.3.2.). 
A second responsive element distinct from the DORE, has been described (Ronai and 
Weinstein, 1990). This element termed the UV-responsive element (URE), was 
discovered as a protected sequence in the regulatory region of the polyoma virus 
genome, during an attempt to identify the factors from UV-irradiated host cells 
that enabled activation of transcription and replication of viral sequences. 
Interestingly, this DNase I-protected sequence 5'-TGACAACA-3', which has since 
been found in the 5' flanking sequences of several eukaryotic genes, shares 
homology with the consensus sequences for the CRE and AP-1 binding site (See 
Table 1.3). However, the use of competitive binding assays has revealed that 
some of the proteins that bind the URE are distinct from those that bind the CRE 
and AP-1 sequence. Ponnazhagan and coworkers have identified two URE-like motifs 
in the 5' flanking sequence of both the mouse and human tyrosinase genes 
(Ponnazhagan and Kwon, 1992; Ponnazhagan et al, 1994), however, whether these 
motifs are functional remains to be elucidated. 
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1.4. AIM OF THIS STUDY 
By virtue of its melanocyte-specificity, activation of tyrosinase gene expression 
is an ideal marker of melanocyte differentiation. The aim of the present study 
was to clone, sequence and characterise the promoter region of the chicken 
tyrosinase gene. This would provide a useful tool with which to investigate the 
mechanisms that underlie activation of melanocye-specific genes in precursor 
cells during determination of the melanocyte lineage in developing chicken 
embryos. 
As is reflected in the literature review, very little is known about the 
regulatory mechanisms that control expression of the tyrosinase gene in lower 
vertebrates. Nevertheless, information gleaned from the extensive analyses 
carried out on the promoter sequences of mammalian tyrosinase genes could be used 
to identify potential key regulatory elements in the 5' flanking sequences of the 
chicken gene. Therefore, the specific aim of this research was to use this 
information and methods such as primer extension and transient transfection 
assays, to establish the promoter regions that are required for tyrosinase gene 
expression in pigment-producing cells of the chicken and to determine whether 
there is any conservation of regulatory mechanisms between lower and higher 
vertebrates.I 
1 Some of the results included in this thesis have been published in GENE 
(Ferguson and Kidson, 1996). 
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2.1. INTRODUCTION 
The aim of the first part of this study was to isolate 5' flanking sequences 
of the chicken tyrosinase gene. The most commonly used method to isolate the 
genomic DNA of a desired gene involves screening a genomic DNA library with a 
probe derived from the corresponding cDNA sequence. When this study was 
initiated the chicken tyrosinase cDNA sequence had not been isolated, nor had 
any other members of the tyrosinase gene family from lower vertebrates. 
Therefore, several approaches were taken concurrently to obtain a suitable 
probe with which to screen a chicken genomic DNA library for sequences 
encoding tyrosinase. This chapter presents the eventual success in cloning 
and sequencing a genomic DNA fragment that contains the 5' flanking sequence 
of chicken tyrosinase, and touches on some of the technical problems that were 
experienced. 
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2.2 MATERIALS AND METHODS 
2.2.1. Genomic DNA isolation 
Genomic DNA was prepared from the livers of chick embryos (Black Australorp X 
New Hampshire Red breed) and newborn mice (a BALB/c albino breed, which has no 
gross rearrangements or deletions or insertions of DNA segments in the 
tyrosinase gene (Ruppert et al, 1988; Yokoyama et al, 1990)) as well as from 
Bl6 mouse melanoma cells according to a rapid DNA isolation method (Davis et 
al, 1986 pp 42-43). Samples were subsequently treated with 40 µg/ml of DNase-
free RNase A for 30 min at 37°C, to get rid of contaminating RNA. The RNase 
was removed by extraction with phenol: chloroform:isoamyl alcohol. The DNA 
was precipitated, resuspended in TE (10 mM Tris, pH 7.6; 0.1 mM EDTA, pH 8.0) 
and quantified. 
2.2.2. P.C.R. 
2.2.2.1. Description of PCR primers 
A 126 nt sequence that lies within exon 3 of tyrosinase cDNA encodes an amino 
acid sequence that is highly conserved between tyrosinases of different 
species (Muller et al, 1988). PCR primers were therefore synthesized using 
exon 3 sequences from mouse tyrosinase (see Fig. 2. 1) as follows: 
Forward primer (TSK-1): 5'-CACAATGCCTTACATATC-3' 
(at nt positions +1169 to +1186) 
Reverse primer (TSK-2): 5'-TCCACAAAAGCATGGTGAAG-3' 
(complementary to nt positions +1244 to +1264) 
The primers were synthesized by Prof. I. Parker (Dept Medical Biochemistry, 
UCT). 
2.2.2.2. PCR amplification 
A reaction mix was set up in a total volume of 25 µlas follows: 
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2.5 µl 10 x amplification buffer (Promega Corporation, Madison, WI, USA): 
50mM KCl, lOOmM Tris.HCl (pH 9), 15mM MgCl2, 0.1% gelatin (w/v), 14 
Triton X-100 
1.25 µl 4 mM dNTP mix 
2.5 µl 20 µMeach primer 
3.125 µl 10% formamide 
2 units Taq DNA polymerase (Promega Corporation) 
Template DNA, diluted in TE buffer, was added to the mix as follows: 
1.65 µg of genomic DNA (prepared as in section 2.2.1.), 0.35 µg mouse 
tyrosinase cDNA plasmid (positive control) or TE buffer (negative control). 
Reaction mixtures were overlaid with a drop of mineral oil to prevent 
evaporation, heated to 95°C for 5 min and subjected to 30 cycles of 
amplification in a Techne thermal cycler (Laboratory and Scientific 
Instruments, SA) programmed as follows: 
Cycles 1-29 
Cycle 30 
94°C for 1 min (to denature the DNA) 
50°C for 2 min (to anneal the primers) 
72°C for 3 min (to extend the annealed primers) 
94°C for 1 min 
50°C for 2 min 
72°C for 12 min (to ensure completion of the 
final extension step) 
PCR products were resolved on 3% agarose (Sigma) gels in TBE buffer (45 mM 
Tris-borate, lmM EDTA) and stained with 0.01% ethidium bromide. The plasmid 
pBR322 digested with HinfI (pBR322/Hinfl) was run alongside PCR products as a 
molecular weight marker. Southern transfers onto nylon membranes and membrane 
hybridisations were carried out as described in section 2.2.4. Blots were 
probed using the 1.9 kb fcoRI fragment of mouse tyrosinase cDNA from clone 
pmcTYRl, radiolabelled as in section 2.2.3. 
2.2.3. Preparation of mouse tyrosinase and tyrosinase-related cONA probes 
The mouse tyrosinase cDNA clones, pmcTYRl and pMTY811C were gifts from Gunther 
Muller (Heidelberg, Germany) and Byoung S. Kwon (Indianapolis, Indiana, USA), 
respectively . The mouse cDNA clone encoding TRP-1, pMT4, was a gift from 
Shigeki Shibahara (Sendai, Japan). A 1.9 kb EcoRI fragment from pmcTYRl, a 
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1.96 kb EcoRI/HindIII fragment from pMTY811C and a 1.6 kb HindIII fragment 
from pMT4 were gel purified. The cDNA sequences were then radiolabelled with 
[a-32p] to a specific activity of> 1 x 107 cpm/µg DNA by nick translation 
(see Appendix I). 
2.2.4. Southern blot hvbridisations of genomic DNA 
Genomic DNA samples were digested with a total of 2 units restriction 
enzyme/µg DNA at 37°C. Steps were taken to ensure even digestion of the high 
molecular weight DNA, as suggested by Sambrook et al (1989, pp 9.32). 
Digested DNA was separated on a 0.7% agarose gel in TBE buffer, run overnight 
at 6.5 V/cm. The DNA was denatured and transferred onto a nylon membrane 
(Hybond-N+, Amersham) by capillarity according to the manufacturer's 
instructions. Hybridisations were carried out according to Sambrook et al 
(1989, pp 9.52-9.55) in heat sealable plastic bags placed on a shaking 
platform in a shallow, heated waterbath. Blots were prehybridised for 1 h. 
Denatured probe was added to a final concentration of 5 x 105 cpm/ml and 
hybridisation was carried out at 60°C overnight. Post-hybridisation washes 
included a low stringency wash in 2 x SSC, 0.1% SOS at RT for 10 min, followed 
by a higher stringency wash in 0.1 x SSC, 0.1% SOS at 50°C for 10 min. Blots 
were then exposed to autoradiographic film (AGFA CURIX RPI) at -80°C. 
2.2.5. Screening of a chicken genomic DNA library 
A chicken genomic DNA library was generated from partial HaeIII and AluI 
digests of reticulocyte DNA, cloned into lambda Charon 4A bacteriophage 
(Dodgson et al, 1979). An aliquot of the library was a gift from J.D. Engel 
and colleagues, via Professor Albrecht E. Sippel (Heidelberg). 
The titre of the bacteriophage library was checked as it had been stored at 
4°C for several years and transported to South Africa at RT. The library stock 
originally contained 109 pfu/ml. The number of plaques obtained by plating a 
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Thus the titre, calculated to be 4.5 x 107 pfu/ml, had dropped by 100 fold in 
storage. 
2.2.5.1. Plaque hybridisation 
The method of Benton and Davis (1977) was used with modifications according to 
Sambrook et al (1989, pp 2.108-2.111, 2.114-2.117). To screen the genomic DNA 
library 4.5 x 105 pfu were plated on 40 agar plates. For each dish, plating 
bacteria(£. coli strain LE392) were infected with bacteriophage stock 
containing approximately 1.125 x 104 bacteriophage particles. Molten top 
agarose was added and the mixture was poured onto a 90-mm agar plate. After 8 
h of incubation at 37°C, distinct bacteriophage plaques were detected, the 
outer edges of which were just touching each other. Phage DNA from each plate 
was transferred to a nitrocellulose membrane (Schleicher and Schuell BA85), 
and denatured. Membranes onto which denatured phage DNA had been fixed, were 
prewashed at 42°C for 1.5 h to ensure removal of all bacterial debris from the 
surfaces of the membranes. Hybridisation was carried out in a small plastic 
container placed on a shaking platform in a shallow water bath set at 42°C. 
The membranes were prehybridised for 1 h in a solution containing 1% dextran 
sulphate (Sigma), 6 x SSC, 20 mM Tris (pH 7.4), 1 x Denhardt's solution, 40% 
deionised formamide and 100 µg/ml denatured salmon sperm DNA. A volume of 
3.25 ml of solution/membrane was used. Denatured probe was added to the 
container at a concentration of 5 x 105 cpm/ml of prehybridisation solution. 
Filters were hybridised at 42°C overnight for at least 16 h. Post 
hybridisation washes included four washes of 5 min each in 2 x SSC, 0.1% SOS 
at RT followed by one wash in 1 x SSC, 0.1% SOS at 55°C for 1 h. Damp 
membranes were placed between 2 layers of thin polyethylene plastic. 
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Autoradiography was performed at -80°C, using preflashed AGFA CURIX RPI film 
with intensifying screens. To strip radioactive signals from nitrocellulose 
membranes, damp membranes were immersed in a boiling solution of 0.5% SOS. 
The solution was allowed to cool to RT. Membranes were then re-exposed to 
autoradiographic film to check that all radioactive signals had been removed. 
The process was repeated if membranes were not sufficiently stripped. 
2.2.5.2. Collection of hybridising plaques and preparation of phage DNA 
Agar plugs containing phage plaques corresponding to hybridisation signals 
were removed from petri dishes by suction into a pasteur pipette. Each plug 
was placed in 1 ml SM diluent (O.lM NaCl, lOmM MgS04, IM Tris (pH 7.5), 0.01% 
gelatin) plus one drop of chloroform. Phage particles were allowed to diffuse 
from the agar into the diluent whilst standing the tube at RT for 1-2 h. For 
large-scale stocks of phage supernatant, plate lysate stocks of plaque-
purified phage were prepared exactly according to protocol II of Sambrook et 
al (1989, pp 2.66). 
To isolate DNA from positive bacteriophage, a combination of the methods 
reported by Yamamoto et al (1970) and Sambrook et al (1989, pp 2.73-2.81) was 
used. Details of the modified method may be found in Appendix I. 
2.2.6. Subcloning of CTYR4.3 into a plasmid vector 
CTYR4.3 was subcloned using a shotgun approach as follows: DNA from 
recombinant phage 23.1 was subjected to double digestion by fcoRI and BamHI. 
This gives rise to four fragments with both BamHI and EcoRI sticky ends, 
including CTYR4.3, as well as 1.58 kb, 5.1 kb and 14.1 kb fragments (see the 
map of lambda CG23.1, Fig. 2.7.c). The mixture of restriction fragments was 
ligated with fcoRI/BamHI-cut pUC19 vector DNA using T4 DNA ligase (Boehringer 
Mannheim). Competent f. coli LKIII cells were prepared according to Davis et 
al (1986, pp 90-92) and transformed with the heterogeneous mixture of 
recombinant plasmids. Plasmid DNA was prepared from transformed colonies 
using the mini-lysate technique (Sambrook et al, 1989, pp 1.29-1.31). To 
identify CTYR4.3-containing plasmids, the DNA was digested with fcoRI and 
BamHI and the sizes of the released inserts estimated on agarose gels. Large 
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amounts of recombinant CTYR4.3-pUC19 plasmid DNA were prepared using the 
alkaline lysis maxi-preparation procedure and purified by centrifugation in 
cesium chloride-ethidium bromide gradients according to Sambrook et al (1989, 
pp 1.38-1.39; 1.42). 
2.2.7. Seguencing strategy 
2.2.7.1. Generation of a nested set of deletions with Exonuclease III 
Exonuclease III digestion of CTYR4.3-pUC19 was carried out according to 
Sambrook et al (1989, pp 13.39-13.41) with a few modifications. The plasmid 
DNA was digested with restriction enzymes that generated an Exonuclease III-
susceptible end adjacent to the insert DNA (5a7I, Promega) and a 3' overhang 
to protect the vector DNA (SphI, Boehringer Mannheim) (Henikoff, 1984). 
Double-digested plasmid was purified by extraction with phenol-chloroform and 
resuspended in Exonuclease III buffer. A reaction mixture containing lOµg 
restricted DNA in 60 µ1 Exonuclease III buffer was preincubated at 37°C for 5 
min prior to adding 150 units Exonuclease III (Boehringer Mannheim)/pmol DNA. 
Aliquots of the reaction mixture (5 µ1) were removed at 1 min intervals for 12 
min. On removal, each aliquot was placed at 70°C for 10 min to inactivate the 
enzyme and then stored on ice. To remove remaining single-stranded tails, 
each aliquot was treated with 5 units Sl nuclease (Promega Corporation) at 
30°C for 30 min· after which Sl stop buffer was added and the enzyme heat-
inactivated at 70°C for 10 min. The deleted plasmids were blunt-ended by 
treating with Klenow DNA polymerase I (Boehringer Mannheim): 20 µ1 of each 
sample were transferred to 37°C and 0.2 units of enzyme in Klenow buffer was 
added. After a 5 min incubation period, a dNTP mixture was added to a final 
concentration of 0.50 µMand incubation continued for 15 min at RT. The 
deletion-containing plasmids were then recircularised by blunt-end ligation 
using T4 DNA ligase (Boehringer Mannheim) at RT for 2 hand introduced into 
competent£. coli LKIII cells. Exonuclease III-treated pUC19-CTYR4.3 plasmid 
DNA was prepared from transformed LKIII colonies by minilysate preparation, 
digested with fcoRI and HindIII (to release the progressively shortened 
CTYR4.3 inserts from pUC19) and analysed on agarose gels. 
2.2.7.2. Preparation and sequencing of double stranded DNA templates 
The success of double-stranded DNA sequencing was found to be largely 
dependent on the quality of plasmid DNA used as template. The plasmid mini-
preparation method (outlined in Appendix I) was strictly adhered to and only 
freshly prepared DNA templates were used for sequencing. 
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Dideoxy chain termination sequencing was carried out using a Sequenase version 
2.0 kit (United States Biochemical). Template DNA (approximately 4-5 µg of 
Exonuclease Ill-derived plasmid) was denatured in the presence of IM NaOH for 
5 min at RT, precipitated with 4 µl of 3M sodium acetate and 100 µl 
isopropanol at -70°C for 10 min, and pelleted by centrifugation. Denatured 
DNA template was annealed to 1 pmol primer (reverse M13/pUC universal primer: 
5'-GTCCTTTGTCGATACTG-3'; Promega) by incubating the mixture at 65°C for 5 min, 
at 37°C for 10 min and finally at RT for at least 5 min. Sequencing reactions 
were carried out according to the manufacturers' instructions, in the presence 
of 10% DMSO using 10 µCi/reaction of [a-35s]-dATP (Amersham). The reaction 
mixes were subjected to denaturing polyacrylamide gel electrophoresis (6% 
acrylamide, BM urea). The gel was transferred to Whatman 3MM paper and dried 
at 80°C for >1 h. Sequencing ladders were visualised after 36 h exposure to 
autoradiographic film. 
2.2.7.3. Nucleotide sequence data analysis 
Overlapping nucleotide sequences were assembled and analysed using the 
Genetics Computer Group Inc. (Madison, WI, USA) Sequence Analysis Software 
Package Version 8.0. DNA sequence alignments were obtained using the 
alignment search program of Altschul et al (1990). The nucleotide sequence 
data derived for CTYR4.3 was submitted to the international DNA sequence data 
collection and has been assigned the accession number L46805. 
2.3. RESULTS 
2.3.1. Preparation of a tyrosinase probe for screening a chicken genomic DNA 
library 
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At the time at which this study was initiated, the chicken tyrosinase cDNA 
sequence had not been isolated. Therefore, two approaches were taken 
concurrently to obtain a suitable probe with which to screen the genomic 
library for sequences encoding tyrosinase. Firstly, PCR was performed on 
chicken genomic DNA using mammalian primers to generate a chicken tyrosinase 
probe. Secondly, to determine whether a mouse tyrosinase cDNA sequence would 
cross-hybridise sufficiently to chicken tyrosinase to be used to screen the 
library, Southern blot hybridisations were carried out on chicken genomic DNA 
using mammalian tyrosinase and TRP-1 cDNA probes under various stringency 
conditions. 
2.3.1.1. Attempts to amplify a chicken tyrosinase cDNA sequence using PCR 
The information used to design PCR primers was derived from a report by Muller 
et al (1988). They compared the derived amino acid sequences of tyrosinases 
from the mouse, human, Neurospora crassa, Streptomyces glaucescens and 
Streptomyces antibioticus, and mouse tyrosinase-related protein-!, and 
identified two regions that are clearly conserved (see Fig. 2.1). Homologous 
region II (Fig. 2.1.b), the most highly conserved sequence among the 
tyrosinases, contains one of the two copper-binding sites found in the 
tyrosinase enzyme. Furthermore, deletion studies have shown that this region 
is essential to obtain a functional tyrosinase enzyme. The sequences used to 
generate the synthetic primers for PCR (TSK-1 and TSK-2) were chosen such that 
they fall within the cDNA sequence encoding homologous region II (indicated by 
horizontal arrows in Fig. 2.1.b), and would possibly anneal to an equally 
highly conserved chicken sequence. The primer sequences were derived directly 
from the mouse tyrosinase cDNA sequence, where they flank a 96 bp sequence in 
exon 3. 
To amplify a 96 bp chicken tyrosinase gene sequence, PCR was performed using 
the above primers and chick genomic DNA as template. The PCR conditions 
outlined in section 2.2.2.2. were found empirically to give the most 
successful results. The parameters that were altered in order to optimise the 
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reaction included the concentrations of DNA templates, primers, formamide and 
bovine serum albumin, as well as the thermal cycler programme settings. 
The PCR products obtained from a typical experiment are shown in Fig. 2.2.a. 
As expected, the positive control PCR reaction in which mouse tyrosinase cDNA 
was used as template (lane 1), resulted in a single product of 96 bp. Several 
products were amplified in the PCR reaction using chicken genomic DNA as 
template (lane 3), including a 96 bp fragment (indicated by arrow). Most 
alarming was that the negative control reaction from which template DNA was 
excluded, also gave rise to a faint product of approximately 96 bp (Fig 2.2.a, 
lane 6). To determine whether this unexpected product was a concatamer of 
primer sequences or a contaminant, the gel was Southern blotted and hybridised 
to the 1.9 kb pmcTYRl mouse cDNA probe. 
The resulting autoradiograph is shown in Fig. 2.2.b. In the negative control 
sample (lane 6) a single faint signal was detected corresponding to the 96 bp 
fragment. The primer-dimer products did not hybridise to the probe under the 
conditions, indicating that the mysterious product was not simply a concatamer 
of primer sequences, but a tyrosinase PCR product amplified from template DNA 
contaminating the negative control sample. Given that mouse tyrosinase 
plasmid was used as a positive control instead of mouse genomic DNA (in which 
tyrosinase gene sequences would be greatly diluted) and that the primers were 
designed using the mouse tyrosinase sequence, the most likely source of the 
contaminating template was the mouse plasmid DNA or ''amplicons" of mouse 
tyrosinase PCR product in the air which may have contaminated the samples 
whilst being set up (Kwok and Higuchi, 1989). 
It is very likely that the chicken genomic DNA sample would also have been 
contaminated by mouse template. The 96 bp product (Fig. 2.2.b, the 
hybridising band in lane 3) would therefore have included sequences amplified 
from both chicken and mouse tyrosinase templates. However, since the primers 
were mouse-specific, the contaminating mouse DNA would most probably have been 
favoured as a template. It should be noted that none of the additional 
products that were amplified in the chicken DNA sample cross-hybridised to the 
probe. Therefore these were most probably non-specific PCR products which may 
have resulted from the low annealing temperature (50°C) used to facilitate 
binding of the mouse primers to chicken genomic DNA. 
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Attempts were made to eliminate contaminating mouse DNA from both negative 
control reactions and those in which chicken genomic DNA templates were used. 
Subsequently, however, it was decided to abandon further attempts at cloning a 
chicken tyrosinase fragment by PCR and to proceed directly with screening a 
chicken genomic DNA library using mouse tyrosinase cDNA probes, as progress 
had been made in optimising the conditions under which a mouse probe would 
cross-hybridise to chicken genomic DNA on Southern blots. 
2.3.1.2. Detection of chicken tyrosinase DNA on Southern blots using mouse 
tyrosinase cDNA probes 
To determine whether a mouse tyrosinase cDNA sequence could cross-hybridise 
sufficiently to be used as a probe to screen a chicken genomic DNA library for 
tyrosinase sequences, Southern blots of chicken genomic DNA were hybridised to 
probes generated from different mouse cDNA clones. Several mouse melanocyte-
specific cDNA sequences were assessed as probes including the tyrosinase 
clones pmcTYRl (Muller et al, 1988) and pMTY811C (Kwon et al, 1988) and a 
clone, pMT4, encoding tyrosinase-related protein-I (Shibahara, 1986). The 
pmcTYRl cDNA probe resulted in the clearest signals and lowest levels of 
non-specific hybridisation (e.g. to molecular weight markers) using the low 
stringency conditions described below. 
The mouse cDNA probes were labelled using the nick-translation method. The 
"multi-prime" method, an alternative that was tried, generates probe of higher 
specific activity, but this caused a very high level of background 
hybridisation under the low stringency conditions employed. To further reduce 
background hybridisation, nick-translated probesat a concentration of 5 x 105 
cpm/ml of hybridisation buffer was used instead of the 106 cpm/ml advised in 
most protocols. Hybridisation was performed at 60°C, followed by a "high 
stringency" post-hybridisation wash using 0.1 x SSC at 50°C. (A high 
stringency wash at 68°C is usually employed for hybridisation to highly 
homologous DNA sequences.) Even with these low stringency conditions, 
autoradiographs had to be exposed to the blots for up to 8 days. 
A typical autoradiograph of a Southern blot hybridised to the 1.9 kb pmcTYRl 
cDNA probe can be seen in Fig 2.3.b . In all attempts only one faint band of 
approximately 4 kb was detectable in the chicken genomic DNA sample, 
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Fig. 2.1. Homologous regions between tyrosinases of different species, the 
TRP -1 encoded by pMT4 and haemocyanins . (A) Homologous region I. (B) 
Homologous region II . Conservation of amino acid sequences is shown by 
alignment of protein sequences of the tyrosinases of mouse, man, the 
t yrosinase -related protein encoded by clone pMT4, the tyrosinases of S. 
glaucescens, S. antibioticus, the fungus N. crassa and subunits E and D of 
haemocyanin of the spider E. californicum. The numbers indicate the position 
of the amino acids in the respective protein sequence. Sequences which are 
conserved by ~50% between all proteins listed or all tyrosinases, are boxed. 
The amino acid sequence is given in single letter code . The histidine (H) at 
position 306 of N. crassa (indicated by an asterisk) has been shown to be part 
of the catalytic centre. One of the copper-binding sites of haemocyanin is 
aligned in homologous region II . The positions of the copper-binding 
histidines are indicated by Cu. Relative positions of the primers used for 
PCR in this study , are indicated by horizontal arrows. (Figure adapted from 
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Fig. 2.2. Tyrosinase-encoding PCR products amplified from chicken and mouse 
DNA. (a) Electrophoretic analysis of PCR products amplified from mouse 
tyrosinase cDNA plasmid (lane 1), chicken genomic DNA (lane 3) and TE buffer 
(lane 6). Plasmid pBR322 digested with Hinfl was used as a molecular weight 
marker (lane 4). (b) Southern blot hybridisation analysis of the PCR products 
shown in (a). The 1.9 kb fcoRI fragment of mouse tyrosinase cDNA clone 
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Fig. 2.3. Detection of chicken tyrosinase genomic DNA on a Southern blot 
hybridised to radiolabelled mouse tyrosinase cDNA probe. (a) 20µg of chicken 
genomic DNA (lane 2), 816 mouse melanoma DNA (lane 3) and BALB/c mouse DNA 
(lane 4) were digested with fcoRI and separated on a 0.7% agarose gel. 50 ng 
of cold pmcTYRl sequence was used as an internal positive control for the 
Southern blot hybridisation procedure (lane 1, band not visible). (b) 
Autoradiograph corresponding to the gel shown in (a). The 1.9 kb fcoRI 
fragment of mouse tyrosinase cDNA clone pmcTYRl was used as probe and the 
autoradiograph was developed after 7 d exposure to the Southern blot. The 
position of the hybridising fragment in the chicken genomic DNA sample (lane 
2) corresponds with that of the smallest band in the mouse genomic DNA 
samples. 
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corresponding to the smallest of the three bands detected in the mouse genomic 
DNA samples (lanes 3 and 4). 
Since cross-hybridisation of chicken sequences even at low stringency was very 
weak, it was thought that the mass screening of the genomic library might 
prove to be very difficult. Therefore, to improve the probability of 
detecting a tyrosinase-containing sequence, attempts were made to generate a 
sub-genomic DNA library. A fragment containing the hybridising 4 kb chicken 
genomic DNA band was isolated from a duplicate agarose gel, the DNA was eluted 
and ligated directly with a suitable plasmid vector. Competent E.coli 
cultures were transformed with the recombinants and the resulting colonies 
screened. However, no hybridising colonies were detected, probably due to the 
loss of DNA sequences during elution and ligation, and therefore incomplete 
representation of sequences in the mini-library. 
Although this method of cloning was unsuccessful, optimal conditions were 
established under which the 1.9kb pmcTYRl probe cross-hybridises to chicken 
genomic DNA on Southern blots and therefore it was possible to proceed with 
screening the chicken genomic DNA library using this heterospecific tyrosinase 
probe. 
2.3.2. Isolation of hybridising clones from the chicken genomic DNA library 
The strategy adopted in order to isolate a clone containing exon 1 and 5' 
flanking sequences of tyrosinase, involved two rounds of screening. A primary 
screening was conducted using the full-length 1.9 kb mouse pmcTYRl cDNA 
sequence as probe to identify library phage recombinants that contain 
tyrosinase exonic sequences. The membranes on which hybridising recombinants 
were identified, were stripped and reprobed in a second round of screening 
with a shortened probe. The probe used in this case was the 0.57kb fcoRI-
HincII fragment of mouse pmcTYRl cDNA, which includes only a part of the 
sequence comprising exon 1 plus approximately 100 bp of 5' flanking sequence. 
Both probes are shown in Fig. 2.4. It was hoped that the recombinant phage 
DNA identified in the second round of screening would include sufficient 5' 
flanking sequence to enable the characterisation of the minimal tyrosinase 
promoter. The results are discussed in detail below. 
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To screen a library of mammalian DNA (genome complexity 3 x 109 bp), several 
hundred thousand recombinant plaques should be examined (Sambrook et al, 
1989). Therefore approximately 4.5 x 105 pfu were plated over 40 plates at a 
density of 1.125 x 104 pfu/plate. Phage DNA was transferred to nitrocellulose 
membranes and hybridised to the 1.9 kb full-length pmcTYRl mouse cDNA probe 
using the procedure optimised for Southern blot hybridisation (section 
2.3.1.2.) with a few modifications. To prolong the life of the nitrocellulose 
membranes, hybridisation was performed at 42°C in the presence of formamide. 
A post-hybridisation high stringency wash was carried out for 1 h (Sambrook et 
al, 1989) at 55°C using 1 x SSC. 
Using these hybridisation conditions, a total of six strongly positive signals 
were obtained as well as smaller, fainter positive signals (see Fig. 2.5). 
Large agarose plugs including 4 or 5 plaques were removed from the hybridising 
areas of the plates and stored at 4°C for further analysis. The six membranes 
each containing a strongly positive plaque, were stripped and rescreened using 
the 0.57 kb 5' mouse tyrosinase cDNA probe. Positive signals appeared in the 
same positions on the membranes as the signals obtained using the full length 
1.9 kb probe. 
Since the two strongest signals were found on membranes 11 and 23 in both 
rounds of screening, the hybridising phage were eluted from the agar plugs 
that were picked from plates 11 and 23, and plaque-purified. 
2.3.3. Characterisation of hybridising library clones 
DNA was extracted from two pure bacteriophage clones, termed lambdaCGll.l and 
lambdaCG23.l, and analysed by restriction enzyme digestion. As can be seen in 
Fig. 2.6.a, the patterns of restriction fragments obtained for clones 11.1 and 
23.1 indicate that the genomic DNA inserts are identical. The inserts were 
released from the Charon 4A vector by fcoRI digestion (lanes 1 and 2). The 
left and right arms of the Charon 4A vector are 19.6 kb and 11 kb, 
respectively. The remaining two fragments of approximately 9.3 kb and 7.5 kb 
in size, represent a chicken genomic DNA insert of 16.8 kb, which falls within 
the size range of fragments (15-21 kb) used to generate the library (Dodgson 
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Fig. 2.4: The mouse tyrosinase cDNA sequences from pmcTYRl (Muller et al, 
1988) that were used as probes to screen the chicken genomic DNA library. The 
1.9 kb fcoRI fragment of pmcTYRl containing the full-length tyrosinase cDNA 
was used to probe for library recombinants containing chicken tyrosinase gene 
exons. The 0.57 kb fcoRI/ Hincll fragment of pmcTYRl was used to detect 





Fig. 2.5: Hybridisation signals resulting from plaque blot number 23 of the 
genomic DNA library probed with the 1.9 kb EcoRI pmcTYRl fragment. A strong 
signal which represents the phage recombinant lambdaCG23.l, is indicated by 
the big arrow. A smaller, fainter positive signal is shown by a small arrow. 
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Fig. 2.6. Restriction enzyme analysis of phage DNA extracted from hybridising 
library recombinants, lambdaCGll.l and lambdaCG23.l. (a) Electrophoretic 
analysis of the digested phage DNA. lOµg of DNA from each sample were 
digested with either fcoRI (lanes 1 and 2), Hindlll (lanes 4 and 5) or both 
fcoRI and Hindlll (lanes 6 and 7). LambdaCGll.l DNA is in lanes 1, 4 and 6. 
LambdaCG23.l DNA is in lanes 2, 5 and 7. Lambda DNA cut with Hindlll was used 
as a molecular weight marker (lane 3). The fragments that subsequently cross-
hybridised to the mouse tyrosinase probe are indicated by arrows. L, left 
arm; R, right arm of lambda Charon 4A vector. (b) Southern blot hybridisation 
analysis of the digested phage DNA shown in (a). The probe used was the 0.57 
kb fcoRI-HincII fragment of pmcTYRl. Data derived from this analysis was used 
to construct the partial restriction enzyme map of lambdaCGll.l and 23.1, 
shown in Fig. 2.7.c.1 
1 Details used for restriction mapping are as follows: digestion of phage DNA with Bindrrr results in a 
l arge hybridising fragment of approximately 25.2 kb, comprising both the entire left ana of the vector plus a 
portion of the genomic DNA insert (1anes 4 and 5). Since on1y the 9.3 kb EcoRI fragment hybridises to the 
0.57 kb t y rosinase probe (lanes 1 and 2), it should be positioned on the left, so that it overlaps with the 
hybridising 25.2 kb HindIII fragment. This was confirmed by doub1e digestion of the phage DNA with EcoRI and 
Bindrrr. EcoRr cleaves the 25.2 kb Bindrrr fragment, such that it releases the left arm of the vector (19.6 
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Fig. 2.7.: Restriction mapping of the genomic clone lambdaCG23.1. The four 
fcoRI restriction fragments (shown in Fig. 2.6.a) were excised from a gel, 
electro-eluted and each fragment subjected to digestion by BamHI. (a) 
Electrophoretic analysis of the resulting fragments from the 19.6 kb L arm of 
the vector (lane 1), the 11 kb R arm of the vector (lane 2), the 9.3 kb 
hybridising fcoRI fragment of the genomic DNA insert (lane 3) and the 7.5 kb 
non-hybridising fcoRI fragment of genomic DNA insert (lane 4). Lambda DNA cut 
with HindIII was used as a molecular weight marker (lane 5). The 4.3 kb 
fragment that subsequently cross-hybridised to the mouse tyrosinase probe is 
indicated by an arrow. (b) Southern blot hybridisation analysis of the 
digested phage DNA shown in (a). The probe used was the 0.57 kb fcoRI-HincII 
fragment of pmcTYRl. (c) Partial restriction enzyme map of lambdaCG23.1. B, 
BamHI; E, fcoRI; H, HindIII.2 
2 Happing detai1s are as fo1lows: The 7.5 kb EcoRX fragment remained intact (1ane 4). The 9.3 kb fragment 
was cleaved into three smaller pieces of approximately 4.3 kb, 3.4 kb and 1.6 kb (lane 3). Since only the 
4.3 kb ~ragment cross-hybridises to the mouse cDNA probe, it aust be positioned on the 5' end of the chicken 
genomic DNA insert such that it a1so forms part of the fo11owing previous1y identified hybridising fragments: 
the 9.3 kb EcoRI, the 25.2 kb HindIII and 5.6 kb EcoRI-HindIII fragments. The two remaining fragments that 
make up the 9.3 kb EcoRI fragment i.e. the 3.4 kb and 1.6 kb fragments, represent BamHI-BamHI and BamHI-EcoRI 
fragments, respective1y. The sizes of the fragments derived from the L (14.1 kb and 5.5kb) and R arms (5.12 
kb, 3.93 kb, 1.49 kb and 0.5kb) of the vector agree with the sizes predicted from the Charon 4A map (shown in 
Appendix II). 
fragment of the genomic DNA insert cross-hybridised to the 0.57 kb 5' mouse 
probe (Fig. 2.6.b., lanes 1 and 2). 
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The position of the hybridising sequences within the 16.8 kb genomic DNA 
insert was determined by restriction enzyme mapping using fcoRI, BamHI and 
HindIII, followed by Southern blot hybridisation to identify which of the 
restriction enzyme fragments contain sequences that cross-hybridise to the 
mouse pmcTYRl probe (see Figs 2.6 and 2.7, detailed explanations in figure 
legends). Analysis of the fragments derived by double digestion with fcoRI 
and BamHI revealed a single hybridising fragment of 4.3 kb (shown by an 
arrowhead in Fig. 2.7.a and b, lane 3). A map of lambdaCG23.1 is shown in 
Fig. 2.7.c. The shaded box in this diagram represents the 4.3 kb fcoRI-BamHI 
fragment which was mapped to the extreme 5' end of the 16.8 kb genomic DNA 
insert. It was hoped that this fragment, termed CTYR4.3, would contain 
sufficient 5' flanking sequence '. to characterise the tyrosinase gene promoter. 
2.3.4. Analysis of the chicken genomic DNA subclone, CTYR4.3. 
At this stage, all that was known about CTYR4.3 was simply that it cross-
hybridised to a 0.57 kb pmcTYRl cDNA probe containing exon 1. No sequences 
encoding tyrosinase or the TRPs had yet been reported for a lower vertebrate 
and therefore it was important to sequence CTYR4.3 to establish whether the 
sequence represented chicken tyrosinase or a cross-hybridising chicken TRP 
gene sequence. Assuming that CTYR4.3 did encode chicken tyrosinase and that 
the first exon was of a similar size to exon 1 of the mammalian tyrosinase 
gene (0.9-0.95 kb), it was necessary to determine whether the remaining 3.4 kb 
of CTYR4.3 represented 5' flanking sequence and/or intronic sequences. 
Because the genomic DNA library was generated in a non-directed manner, the 
5'-3' orientation of these sequences within CTYR4.3 was unknown. 
CTYR4.3 was therefore subcloned into a pUC19 plasmid vector for further 
characterisation by restriction mapping and sequence analysis. 
2.3.4.1. Deten1ining the orientation and a partial restriction 111ap of CTYR4.3 
A map of CTYR4.3 is shown in Fig.2.8.b. During the process of restriction 
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Fig. 2.8: Comparison of the partial restriction enzyme maps of (a) Ctyl8 and 
(b) CTYR4.3. The position of the Xhol and Ball sites (which are boxed) in 
Ctyl8 made it possible to determine the 5'-3' orientation of the genomic DNA 
sequences in CTYR4.3. 
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tyrosinase cDNA clone, which they named Ctyl8. A partial restriction map of 
Ctyl8 (Fig. 2.8.a) indicated the presence of recognition sites for Xhol and 
Ball at nt positions +660 and +870 respectively. Assuming that exonl sequence 
of chicken tyrosinase approximates the mammalian exon 1 of 0.9 kb in size, it 
was deduced that these sites should fall within exon 1, and thus should be 
present in CTYR4.3. Mapping revealed the presence of single Xhol and Ball 
sites in CTYR4.3 approximately 200 bp apart. The position of the Xhol site 
was found to be more proximal to the fcoRI terminus of CTYR4.3 than the Ball 
site. 
These results proved almost conclusively that CTYR4.3 contains chicken 
tyrosinase genomic DNA and furthermore, enabled the orientation of the genomic 
components within CTYR4.3. Exon 1 is flanked by promoter sequences at the 
fcoRI terminus and intron 1 sequences at the BamHI terminus of CTYR4.3. The 
position within CTYR4.3 of additional restriction sites that were verified by 
similar mapping procedures, are also indicated. 
2.3.4.2. Generation of a nested set of CTYR4.3 deletions for sequencing 
A directed sequencing approach was adopted for CTYR4.3 which involved 
generating an overlapping set of deletions using Exonuclease III. A resulting 
set of CTYR4.3 deletions ranging in size from 3.5 kb to 0.25 kb is shown in 
Fig. 2.9. Each successive time point yielded a collection of subclones 
containing deletions extending further into the original CTYR4.3 insert. 
It was hoped that the resulting deletion clones could subsequently be used for 
promoter analysis to identify functional domains within the 5' flanking 
region. By virtue of its position within the fcoRI and BamHI sites of the 
pUC19 vector (see Appendix II), CTYR4.3 could only be manipulated from its 
BamHI terminus, adjacent to which 7 unique restriction enzyme recognition 
sites were available to produce Exonuclease III-resistant and -susceptible 
ends. As can be seen in Fig 2.10 this resulted in Exonuclease III derivatives 
that were progressively deleted from their 3' ends. While these constructs 
enabled sequencing of CTYR4.3 in one direction, they have limited use for 
functional analyses of the promoter. 
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Fig. 2.9: Electrophoretic analysis of CTYR4 .3 fragments derived by progressive 
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Fig. 2.10: Strategy showing the sequencing of CTYR4.3 from the 3' end using 
overlapping Exonuclease III-derived clones. Restriction maps of (a) CTYR4.3 
and (b) overlapping deletion mutants are included. E, fcoRI; H, Hincll; Pv, 
Pvull; Ps, Pstl; D, Dral; X, Xhol; Bl, Ball; B, BamHI. 
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Exonuclease III derivatives of CTYR4.3 were used as templates for double 
stranded sequencing by the dideoxy chain termination method of Sanger (1977). 
Overlapping sequences derived from twenty-five deletion clones (see Fig. 2.10) 
were used to assemble the 3122 nt sequence which is shown in Fig. 2.11. 
2.3.4.3. Nucleotide sequence of CTYR4.3 and deduced amino acid sequence of 
exon 1. 
The nucleotide sequence of CTYR4.3 provides conclusive evidence that this 
genomic DNA clone contains sequences that encode chicken tyrosinase and not 
one of the closely related TRPs. A comparison of CTYR4.3 with Ctyl8 (Mochii 
et al, 1992) in the region that they overlap (930 bp shown in Fig. 2.10), 
showed that these sequences are 100% homologous. Initially, however, the 
sequence derived for CTYR4.3 differed from Ctyl8 at two positions in exon 1 
(see Fig. 2.12.a). Three nucleotides were missing from CTYR4.3 at these 
sites, which would have given rise to a substantially altered amino acid 
sequence, causing a frameshift and the loss of an amino acid. It was 
subsequently found that this deviation was due to compressions in the 
sequencing ladder that were not fully resolved during synthesis and 
electrophoresis. The deviating region was resequenced substituting dITP and 
ddITP for dGTP and ddGTP, analogues that destabilize the DNA secondary 
structure associated with dC and dG residues (Barnes et al, 1983; Gough and 
Murray, 1983), and the sequence was found to be identical to Ctyl8 (see Fig. 
2.12.b). Although it would be difficult to detect errors in the 5' flanking 
sequence, the physical manipulations of CTYR4.3 based on sequence data, have 
shown it to be accurate thus far. For instance, the positions of restriction 
enzyme recognition sites identified within the nt sequence using the MAP 
function of GCG, have been shown to be authentic for all enzymes that were 
physically tested. 
The ATG codon placed at nt position +l in Fig. 2.11 is the presumed start 
codon of exon 1 based on the alignment of CTYR4.3 with the sequences reported 
for the chick, quail, snapping turtle and human tyrosinase. To find the 3' 
boundary of exon 1, the genomic sequence of CTYR4.3 was compared to the 
published cDNA sequence (Mochii et al, 1992). At nt position +820 (nt 
position +927 in the cDNA), homology ceases. Nucleotides +817 CAG:GTAAG +824 
fit the donor splice site consensus sequence MAG:GTRAGT, where M=A/C, R= A/G, 
and the colon denotes the site of cleavage (Breathnach and Chambon, 1981). 
69 
Thus, exon 1 ends at nt +819, and encodes the first 273 amino acids of chicken 
tyrosinase. The nt sequence derived for CTYR4.3 therefore includes 2125 nt of 
the promoter region, 819 nt of exon 1 and 178 nt (of the approximately 1345 nt 
included in CTYR4.3) of intron 1. A detailed sequence analysis of the 5' 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































R R S A V R P G M E M G P C G 
CTYR4.3 +94 AG*AAGGAGTGCTGTCCGCCCTGGGATGGAGATGGGA**CCTTGCGGG +141 
11 I I I I I I I I I I I I I I I I I I I 111111111111111 111111111 
Ctyl8 +102 AGGAAGGAGTGCTGTCCGCCCTGGGATGGAGATGGGACCCCTTGCGGG +249 
R K E C C P P W D G D G T P C G 
13 aa 
b dGTP dlTP 
ACGTG ATC 
Fig. 2.12. The use of dlTP to resolve compressions during dideoxy chain 
termination sequencing of CTYR4.3. {a) A comparison of the nucleotide 
sequences derived for CTYR4.3 and Ctyl8 before compressions were resolved. A 
total of three nt were missing from CTYR4.3. This caused a frameshift in the 
predicted amino acid (aa) sequence and the loss of one aa, so that 12 
different aa were substituted in the genomic sequence for the 13 aa in the 
published cDNA sequence. (b) A portion of the sequence ladder illustrating 
the complementary strand of nt +86 to +155 in Fig. 2.11. The positions of the 
resolved compressions are indicated by arrowheads. 
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· 2.4. DISCUSSION 
This chapter presents a chronological account of the successful isolation and 
characterisation of a chicken tyrosinase genomic DNA fragment, CTYR4.3. This 
proved not to be a simple exercise as a number of technical problems were 
experienced. These problems are presented and discussed in the latter part of 
this section. 
2.4.1. CTYR4.3 contajns 5' flanking seguences of the chicken tyrosinase gene 
The aim of the present study was to isolate 5' flanking sequences of the 
chicken tyrosinase gene. Therefore, a 0.57 kb fragment from the 5' end of the 
mouse tyrosinase cDNA clone, pmcTYRl, was used to screen a chicken genomic DNA 
library. Two strongly hybridising clones were isolated and found to .contain 
identical genomic DNA inserts of approximately 16.8 kb. The hybridising 
region of these positive phage recombinants was shown to lie within a 4.3 kb 
fcoRI-BamHI fragment which was termed CTYR4.3 and characterised further. 
Sequencing confirmed that the genomic subcione CTYR4.3 encodes chicken 
tyrosinase and includes 2125 nt of 5' flanking sequence, the first exon and a 
part of the first intron. 
The isolation of a genomic clone makes it possible to begin to determine the 
genomic structure of chicken tyrosinase. A comparison of CTYR4.3 with the 
cDNA sequences reported for chicken tyrosinase by Mochii et al (1992) and more 
recently April et al (1996) reveals that exon 1 is 819 nt in length and 
encodes an amino acid sequence of 273 residues. The size of exon 1 is 
consistent with that found for the human, mouse, quail and snapping turtle 
tyrosinase genes (Giebel et al, 1991; Ruppert et al, 1988; Yamamoto et al, 
1992). The exon 1 sequence included in a genomic clone reported recently for 
the Japanese pond frog, however, encodes an amino acid sequence of 277 
residues (Miura et al, 1995). Further inconsistencies have been found in the 
amphibian and in the Medaka fish tyrosinase gene sequences when compared to 
the sequences from the higher vertebrates. These are elaborated on in chapter 
3. 
There are no untranslated exons in the 5' flanking region of CTYR4.3, as the 
sequences immediately upstream of the ATG site in the cDNA and CTYR4.3 match 
directly . This is consistent with the absence of untranslated exons in the 
mammalian tyrosinase genes (Giebel et al, 1991). Since the 2125 nt of CTYR4.3 
positioned 5' to the ATG site do not represent intronic sequences, one would 
expect to find the transcription start site(s) within this region. 
Interestingly, the members of the mammalian tyrosinase gene family differ 
markedly in their 5' gene structure. While the tyrosinase gene contains 
approximately 130 nt of 5' untranslated sequence between the most distal 
transcription start site and the ATG site, TRP-2 RNA transcripts transcripts 
contain approximately 700 nt of 5' untranslated sequence (Budd and Jackson 
1995; Sturm et al, 1995) and TRP-1 transcripts include an untranslated exon 
(Jackson et al, 1991; Shibata et al, 1992). 
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The genomic clones that have been reported for tyrosinase genes of lower 
vertebrates to date, contain limited 5' flanking sequences. The quail clone 
includes 519 nt of 5' flanking sequence while genomic sequences cloned from 
the Japanese snapping turtle and pond frog include 699 nt and 748 nt of 5' 
flanking sequences, respectively (Yamamoto et al, 1992; Miura et al, 1995). 
Thus, the 2125 nt of 5' flanking sequence present in CTYR4.3 is the most 
extensive to be reported for a lower vertebrate tyrosinase gene to date. The 
functional analysis of this 2125 nt region will be presented in detail in the 
following chapter. 
2.4.2. An analysis of technical problems encountered 
Unexpected technical difficulties were experienced during attempts to generate 
a series of nested deletions that could be used to facilitate sequencing and 
for subsequent promoter analysis. CTYR4.3 was originally subcloned into the 
Ml3mpl8 vector and samples subjected to progressive deletion using Exonuclease 
III. Gel analysis of linearised Exonuclease III derivatives revealed a series 
of plasmids of expected size ranging from ±11.3 kb to 7.5 kb (representing 
4.1-0.3 kb of CTYR4.3 plus 7.2 kb of Ml3 vector). Sequencing, however, 
revealed several anomalies. Using the primer supplied with the Sequenase kit, 
nearly identical sequences were obtained for all Exonuclease III derivatives 
that were sequenced. This was unexpected as sequences primed from this site 
should represent the progressively digested DNA. Furthermore, a computer-
aided DNA homology search of GenBank showed that the derived sequence 
corresponded to a portion of the Ml3mpl8 vector (nt positions +578 to +372) 
situated more than 5732 nt downstream of the priming site. These anomalies 
were specific to the Exonuclease III derivatives because sequencing of a 
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CTYR4.3 template that had not been treated with Exonuclease III, gave rise to 
a unique sequence. 
I 
This sequence was unrelated to the Ml3 vector and 
represented a bona fide chicken tyrosinase intron 1 sequence. 
A possible explanation for these results could be that unusual recombinations 
in the Ml3 vector may have taken place whilst generating Exonuclease III-
susceptible and -protected ends with SphI and Sa7I or during the first minute 
of Exonuclease III digestion. Evidence of recombination was not apparent from 
the sizes of the HindIII-linearised Exonuclease III derivatives as derived 
from the gel. But subsequent attempts to excise the deleted CTYR4.3 inserts 
from their Ml3 vectors by digestion with fcoRI and HindIII were unsuccessful, 
indicating that the fcoRI recognition site had been lost. 
Similar phenomena were reported by da Silva Tatley (1992) and Saul et al 
(1989) whose attempts to determine nt sequences by Ml3-sequencing were 
thwarted by inserts not being stably maintained in the Ml3 phages. The 
decision was made to abandon further attempts at Ml3-sequencing, and to 
subclone CTYR4.3 into the pUC19 plasmid vector (subsequently used by da Silva 
Tatley, 1992) and generate a new series of nested deletions which would then 
be sequenced by double stranded sequencing methods. 
To ensure that the pUC19 Exonuclease III derivatives were intact, the CTYR4.3 
sequences were excised from prospective clones by digestion with EcoRI and 
HindIII and analysed by gel electrophoresis. A nested set of intact deletion 
clones was derived from this experiment, which enabled the successful 
sequencing of CTYR4.3. It was surprising to find, however, that once again 
DNA recombination had occurred in a large proportion of the prospective clones 
analysed, thus preventing the excision of CTYR4.3 inserts by EcoRI/HindIII 
digestion. Therefore, up to 34 clones from each time point aliquot had to be 
analysed to obtain sufficient undamaged clones for sequencing. Damage to the 
vector DNA of these clones may have been due to inefficient protection of the 
vector DNA by the SphI-derived 3' overhang, although some protection must have 
been offered by this protruding 3' end otherwise the DNA would have been 
equally susceptible to Exonuclease III digestion from both ends which would 
have resulted in substantially shortened clones. 
As was shown in the results, the Exonuclease III derivatives that were 
eventually used for sequencing, were progressively deleted from their 3' ends 
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and therefore have limited use for functional analyses of the promoter. To be 
able to manipulate CTYR4.3 from its 5' (fcoRI) end, cloning procedures were 
undertaken that reversed the orientation of CTYR4.3 relative to the Sa7I and 
SphI sites in the multiple cloning cassette of pUCI9. After several 
unsuccesful attempts to generate nested deletions of this "reversed" 
construct, it was decided not to pursue these endeavours. It was reasoned 
that the information derived from the nt sequence (i.e. positions of both 
restriction enzyme recognition sites and evolutionarily conserved tyrosinase 
promoter motifs) would enable the construction of a set of appropriate 
promoter-deletions. 
Finally, a word concerning the approaches taken to screen a chicken genomic 
DNA library. In the absence of a chicken TYR cDNA sequence, clones containing 
CTYR4.3 were identified from within a library of chicken genomic DNA fragments 
by their ability to cross-hybridise to a mouse tyrosinase cDNA probe ie. a 
heterospecific probe. Attempts to generate a homospecific probe ie. a chicken 
tyrosinase chicken cDNA probe by PCR were unsuccessful. This can .be largely 
attributed to the primers that were used. These primers were designed to 
anneal to and amplify a portion of the tyrosinase sequence encoding an amino 
acid sequence that is both essential for a functional tyrosinase enzyme and 
the most highly conserved region evolutionarily. However, the primer design 
did not allow for differences between the chicken and mouse nucleotide 
sequences encoding this region. A better approach would have been to use a 
set of degenerate primers (White et al, 1989) which might also have decreased 
the chances of amplifying a contaminating mouse sequence, as they would no 
longer be "mouse-specific". 
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3.1 INTRCXJUCTION 
As a first step towards determining the requirements for melanocyte-specific 
tyrosinase gene expression in a lower vertebrate, the proximal 5' flanking 
sequence of the chicken tyrosinase gene was cloned (as described in the previous 
chapter). This chapter details the further analyses that were undertaken to 
gauge the significance of this 5' flanking sequence as a potential promoter, and 
the search for evidence of regulatory mechanisms in common with those of higher 
vertebrate tyrosinase gene promoters. 
Characterisation of the 5' flanking sequence cloned in CTYR4.3 involved three 
types of analyses. Firstly, with the nucleotide sequence of CTYR4.3 in hand, it 
was possible to conduct computer-aided searches and sequence alignments to 
identify potential transcription factor binding sites including those resembling 
key regulatory elements that have been identified in the mouse and human 
tyrosinase gene promoters. Secondly, to determine whether the 2125 nt of the 5' 
flanking untranslated sequence in clone CTYR4.3 does contain information 
necessary for transcription of chicken tyrosinase, it was important to show that 
transcription start sites are present within this sequence. The position of 
such a site(s) would represent the 3' boundary of the gene's regulatory region. 
Therefore, primer extension analysis was used to map the 5' ends of RNA 
transcripts of chicken tyrosinase to reveal the positions of transcription start 
sites. Finally, it was of primary importance to test the ability of the 5' 
flanking sequence to drive expression of a downstream gene. Reporter gene 
expression assays were used to determine the functional ability of the 5' 
sequences of CTYR4.3 in transiently transfected cells. The activity of four 
constructs containing fragments of the 5' flanking sequence linked to the 
luciferase reporter gene were assessed in both pigment-producing and non-
pigment-producing cell types, in an attempt to establish the minimum promoter 
sequence required for tissue-specific expression of the chicken tyrosinase gene. 
78 
3.2. MATERIALS AND METHODS 
3.2.1. Nucleotide sequence data analysis 
All computer analyses were performed using the Genetics Computer Group ,Inc. 
(Madison, WI, USA) Sequence Analysis Software Package Version 8.0. Direct 
comparisons between the 5' flanking sequence of CTYR4.3 and promoter sequences 
from other vertebrate tyrosinase genes were performed using the BESTFIT 
function. The search for consensus transcription factor binding sites was 
performed using the FINDPATTERNS function of GCG and a file provided by GCG, 
TFsites, containing transcription factor binding sites drawn from different 
datasets (see Appendix III for details and references of these datasets). 
Potential primer sequences for use in primer extension experiments were analysed 
for self-complementarity using the FOLD and SQUIGGLES functions of GCG. 
3.2.2. Primer extension analysis 
3.2.2.1. Preparation of RNA templates 
Embryonic tissues from which template RNA was extracted, were obtained as 
follows: fertilized chicken eggs (Black Australorp X New Hampshire Red or White 
Plymouth Rock X Pile Game breed) were incubated in a humidified incubator set at 
37°C. After 9-10 days embryos were removed and eye, skin, brain and. musculo-
skeletal tissues were dissected in Ca2•/Mg2•-free Hanks Balanced Salt Solution 
(pH 7.4). RPE tissue was obtained from dissected eyes by mechanical detachment 
from the neural retina, followed by careful separation from the choroid. RPE 
tissue isolated in this manner was examined using light microscopy to confirm 
that it was free of choroidal tissue. 
Cytoplasmic RNA (referred to below as total RNA) from tissues or cell cultures 
was isolated exactly according to Sambrook et al (1989, pp 7.12-7.13). The RNA 
was checked for signs of degradation by electrophoretic analysis on 1.1% 
denaturing formaldehyde agarose gels. 
for poly(A+) RNA by oligo-dT cellulose 
Sambrook et al (1989, pp 7.26-7.29). 
Where indicated, samples were enriched 
affinity chromatography as described in 
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3.2.2.2. Primer design and synthesis 
The criteria used to select the primer sequence were adapted from a set of rules 
prescribed by Innes and Gelfand (1990) for the design of PCR primer sequences, 
as follows: 
1. Primers should be 17-28 bases in length; 
2. Base composition should be 50-60% (C+G); 
3. Primers should end (3') in a C or G, or CG or GC which prevents "breathing" 
of ends and increases efficiency of priming; 
4. Runs of three or more Cs or Gs at the 3'-ends of primers may promote 
mispriming at G- or C-rich sequences (because of stability of annealing), and 
should be avoided; 
5. Primer self-complementarity i.e. the ability to form secondary structures 
such as hairpins, should be avoided. 
A 20-mer oligonucleotide sequence, 5'-GTGGACGGCTGAAGGATGAC-3', complementary to 
the exon 1 sequence found at nt positions +50/+31 downstream of the ATG site 
within CTYR4.3 and complying with the above criteria, was synthesised by E. 
Bates (Dept of Biochemistry, UCT). Before proceeding with the primer extension 
experiments the oligonucleotide was tested for its ability to prime a DNA 
sequencing reaction using a CTYR4.3 DNA template. 
3.2.2.3. Primer extension reactions 
The amounts of RNA used as template for primer extension depended on whether the 
samples were enriched for mRNA or not, and on the abundance of melanocytes 
present in the starting material, that is, 1 µg of mRNA from whole eye 
(containing both pigmented choroid and RPE layers), 10 µg of mRNA from skin 
(melanocytes at 1 in 40 keratinocytes), or 40 µg of total RNA from RPE layers 
(100% pigmented cells). Corresponding amounts of body mRNA or brain total RNA 
were used as negative control~. Primer extension reactions were carried out 
according to Sambrook et al (1989, pp 7.80-7.83) with a few modifications: 10 
pmoles of unlabelled primer was hybridised to template RNA at 24°C overnight in 
annealing buffer. The primer was extended using 25 units Stratascript Reverse 
transcriptase (Stratagene) in Reverse transcriptase buffer (50mM Tris HCl, pH 
8.3; 75mM KCl; 3mM MgCl2; lOmM OTT; 0.6mM dGTP, dATP, dTTP; 10 units RNase 
Inhibitor (Boehringer Mannheim); 1 µl (10 µCi) [a32p]-dCTP (Amersham)) at 37°C 
for 120 min or 42°C for 90 min (Ausubel et al, 1987). The RNA templates were 
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removed by digestion using 50 µg/ml RNase A at 37°C for 30 min and phenol-
chloroform extraction. Products were then run on 6% polyacrylamide/8M urea gel 
alongside a sequencing reaction in which the same primer was extended using 
CTYR4.3 DNA as a template. 
3.2.3. Construction of promoter-reporter gene recOlli>inants 
Chicken tyrosinase 5' flanking sequences of varying length were inserted into 
the multiple cloning site of the promoterless luciferase reporter plasmid, pGL2-
Basic (Promega Corporation; Appendix D). The constructs described below are 
depicted in Fig. 3.5. To generate TYR2.1-LUC, a 5' EcoRI- 3' HindIII fragment 
containing 2123 nt of 5' flanking sequence of CTYR4.3 was excised from 
Exonuclease III deletion derivative 5.25 (previously shown in Fig. 2.10), in 
which the 3' end of the insert is 3 nt upstream of the ATG site. Deletion clone 
5.25 was first cut with fcoRI and the fcoRI terminus of the 2123 bp insert was 
made blunt by a "filling in" reaction using Klenow polymerase. The 2123 bp 
fragment was then released from the pUC19 vector by digesting with HindIII and 
ligated to a SmaI-HindIII-cut pGL2-Basic vector. To generate TYRI.1-LUC, a 1149 
bp fragment of the 5' flanking sequence of CTYR4.3 was excised from TYR2.l-LUC 
by ·digestion with SacI (5') and HindIII (3'), and inserted into SacI-HindIII-cut 
pGL2-basic vector. The 504 bp fragment of 5' flanking sequence , that was used 
to construct plasmid TYR0.5-LUC, was obtained by cutting TYR2.l-LUC with A7w44I, 
blunt-ending the A7w44I terminus and then releasing the 504 bp fragment by 
digesting with HindIII. The 5'blunt-3'HindIII fragment was ligated into a SmaI-
HindIII-cut pGL2-Basic vector, as before. The plasmid TYR0.2-LUC was generated 
by partial digestion of TYR2.l-LUC using AsnI. This enzyme cuts the plasmid at 
4 sites, 2 of which fall within the 2123 bp insert, and are 1875 nt apart. 
Partial digestion was achieved by removing samples prematurely from a digestion 
reaction (that is, 10-20 mins after addition of AsnI) and terminating the 
reaction by adding gel-loading buffer. Digested DNA was separated on an agarose 
gel to identify the band of plasmid DNA that was cut only at the 2 sites within 
the 2123 bp insert, thus releasing a 1875 bp fragment. The resulting 5799 bp 
fragment contained 5' flanking sequences consisting of 203 bp proximal to the 
ATG site plus 45 bp derived from the extreme 5' terminus of CTYR4.3, as well as 
intact pGL2-Basic sequences (5553 bp) (see Fig. 3.1). The 5799 bp fragment was 










Asnl digestion time (min) 
M O' 5 ' 1 O' 15 ' 20 ' 30' 45 ' 60 ' M 
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._ 5799 bp TYR0.2-LUC fragment 
._ 2568 bp J 
._ 1875 bp 
'- 1649 bp 




Fig. 3.1: Partial Asnl digestion of TYR2.l-LUC to generate TYR0.2-LUC. 
A 1% low gelling temperature agarose gel showing the fragments derived by 
partial digestion of TYR2.l-LUC DNA with AsnI. Complete digestion by AsnI 
results in four fragments of 2568, 1875, 1649 and 1582 bp. A band containing 
the partially digested 5799 bp fragment (comprising the 2568, 1649 and 1582 bp 
sub-fragments) has been excised from the lanes containing samples digested for 
10-20 min. This fragment was recircularised to generate TYR0.2-LUC. M, fcoRI 
digest of the molecular weight marker, pAT15 (a plasmid containing a HindIII 
fragment of pox DNA [K.R. Dumbell, University of Cape Town, S.A.]). 
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The digested fragments used to construct the TYR-LUC plasmids were 
electrophoresed on gels consisting of 1% Nusieve GTG low melting point agarose 
(FMC Bioproducts). Gel fragments containing the desired pieces of DNA were 
excised and used directly for "in-gel" ligation and transformation of£. coli 
Xll-blue cells (Stratagene) according to FMC Bioproducts' instructions. 
Diagnostic restriction enzyme digests were performed to verify the composition 
of the promoter-reporter gene plasmids. Prior to transfectio~ plasmid DNA was 
prepared by the alkaline lysis maxi-preparation procedure and purified by 
centrifugation in cesium chloride-ethidium bromide gradients (according to 
Sambrook et al, 1989, pp 1.38-1.39; 1.42). 
3.2.4. Cell Culture 
MQTNC c_ells [MC29 immortalised quail trunk neural crest cells (Fauquet et al, 
1990) obtained from Dr Mireille Fauquet (Paris, France)] were grown in 
Dulbecco's modified Eagle's medium (Highveld Biological, SA) containing 10% 
heat-inactivated foetal calf serum (Delta Bioproducts) and 100 µg/ml each of 
penicillin and streptomycin (Highveld Biological, SA). A human hepatoblastoma 
cell line, Hep G2 (ATCC no. HB 8065) was grown in Dulbecco's modified Eagle's 
medium containing 10% foetal calf serum (which had not been heat-treated) 
without antibiotics. Primary cultures of chicken retinal pigment epithelial 
(RPE) cells were established according to Eguchi and Okada (1973). Briefly, RPE 
tissue was dissected from the pigmented eyes of chicken embryos (at embryonic 
day 5 or 6) as described in section 3.2.2.1. Isolated RPE sheets were incubated 
with 0.25% trypsin in ca2+_ and Mg2+-free Hanks balanced salt solution (Sigma) 
for ±45 min at 37°C with gentle agitation. A cell suspension was obtained by 
trituration of the trypsinised tissue using a fine-bore polished pasteur 
pipette. Cells from four eyes were plated in 2 x 100 mm diameter dishes 
(Corning) in 10 ml Eagle's MEM (Sigma) containing 10% heat-inactivated foetal 
calf serum with antibiotics as above. To ensure that subcultures consisted 
primarily of RPE cells, pigmented foci from confluent dishes were picked using a 
tungsten needle, trypsinised, replated and expanded. 
All cells were grown at 37°C in a humidified incubator with 5% CO2 • 
Manipulation of cells was conducted in a laminarflow tissue culture hood. Media 
and additives that were not purchased as sterile solutions, were sterile-
filtered using 0.22 tan filters or autoclaved before use. 
3.2.5. Northern blot hybridisation analysis 
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Cytoplasmic RNA was extracted from confluent dishes of RPE, MQTNC and Hep G2 
cells according to Sambrook et al (1989, pp 7.12-7.13). The RNA was separated 
on a 1.1% denaturing formaldehyde agarose minigel at 5 V/cm for 1 h, stained for 
2.5 min with± 0.01% ethidium bromide and photographed on a Spectroline 
transilluminator. The gel was rinsed twice in lOxSSC for 20 min and then the 
RNA transferred onto a nitrocellulose membrane (Hybond C, Amersham) by 
capillarity using lOxSSC as blotting buffer. The gel was blotted overnight, 
after which the towelling was replaced and the blotting continued for a further 
3 h. Transfer onto the membrane was checked by transillumination and the 
position of the rRNA bands marked with pin-pricks. The RNA was then fixed onto 
the membrane by baking at 80°C for 2' h. Hybridisation was carried out according 
to Davis et al (1986) in a hybridisation oven (Hybaid). Blots were 
prehybridised for 16 h. A 1.5 kb fcoRI-PstI fragment of chicken tyrosinase cDNA 
(April et al, 1996) was labelled with [a-32p]-dCTP using a Random-primed DNA 
labelling kit (Boehringer Mannheim) for use as probe. Radiolabelled probe was 
separated from unincorporated label on a Sephadex G-50 column. Denatured probe 
was added to the hybridisation bottle (at a final concentration of 1 x 106 
cpm/ml) and hybridisation carried out for 16 h. Blots were then washed under 
moderate stringency conditions (final wash at 55°C in lxSSC, 1% SOS for 10 min) 
and exposed to autoradiographic film at -80°C. 
3.2.6. Transient Transfections 
MQTNC and Hep G2 cells were seeded at 3 x 105 cells/60 mm diameter dish 24 h 
before transfection. RPE cells were seeded at 1 x 106 cells/60 mm diameter dish 
48-72 h before transfection, because of their poor plating efficiency and 
relatively slow grgwth. Culture medium was replaced with 4.5 ml of fresh medium 
3-7 h before transfection. Cells in duplicate dishes were co-transfected with 
luciferase and pRSV-8-gal plasmids using the calcium phosphate precipitation 
method that utilises HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic 
acid)-buffered saline (HBS), according to Gorman et al (1982) and Kingston 
(1987). Briefly, fine, milky calcium phosphate-DNA precipitates were prepared 
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by mixing a solution containing DNA-CaCl2 with 2 x HBS-sodium phosphate (pH 7.1) 
under a continuous stream of air bubbles. The precipitate was allowed to stand 
at RT for 30 min, after which it was mixed with vigorous pipeting and added 
dropwise (500 µ1/dish) over the surface of the medium covering the cells. The 
cells were exposed to the precipitate overnight for 16 h (RPE cells) or 18 h 
(MQTNC and Hep G2) after which the medium containing the precipitate was 
removed, the cells were rinsed twice using phosphate-buffered saline (PBS) and 
fed with 5 ml fresh medium. At 48 b post-transfection, cells were washed twice 
in PBS, and lysed in situ by incubating the cells in 400 µl of reporter lysis 
buffer (Promega Corporation) for 15 min. All visible cell debris was then 
scraped to one edge of the dish using a rubber policeman, and transferred to an 
eppendorf tube. Cell lysates were centrifuged in a microfuge at 10000 g for 2 
min at 4°C to remove nuclei and insoluble proteins. The supernatant fluid was 
transferred to a fresh tube after which it was either assayed directly for 
reporter gene activity or frozen at -80°C. 
Controls: In all experiments transfections were performed in duplicate for each 
luciferase plasmid to be tested. To control for efficiency of uptake of DNA in 
different dishes in a single experiment, the luciferase plasmids were 
cotransfected with pRSV-8-gal, a plasmid containing the 8-gaJactosidase (B-gal) 
reporter gene under the control of a Rous sarcoma virus promoter (Edlund et al, 
1985). To control for transfection efficiency between different cell types, one 
set of duplicate dishes in each transfection experiment was transfected with a 
pGL2-Control vector (Promega Corporation, Appendix D), which contains both SV40 
promoter and enhancer sequences. To control for background luciferase 
expression due to the pGL2-Basic vector backbone, one set of duplicate dishes in 
each transfection experiment was transfected with the pGL2-Basic vector. 
3.2.6.1. Reporter gene expression assays 
Protein concentrations were determined using either the Biuret reaction 
according to Bradshaw (1966) or a BioRad protein assay kit (when a more 
sensitive detection method was required). BSA made up in reporter lysis buffer 
was used as a protein standard. Equal amounts of protein from each dish were 
assayed for luciferase activity using a luciferase assay kit (Promega) and a 
luminometer (Bio-Orbit 1253 luminometry system). B-gal activity in cell lysates 
was assayed according to Herbomel et al (1984) and used as a measure of relative 
transfection efficiency. Luciferase activity (number of light units/mg protein) 
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was normalised by dividing by B-gal activity (OD420/hr/mg protein). To enable 
comparison of results from different experiments and using different cell types, 
each result was finally expressed as a relative luciferase activity, that is, 
relative to the activity obtained using the pGL2-Control plasmid, thus, the mean 
of the normalised luciferase activity obtained using a particular luciferase 
plasmid expressed as a percentage of the mean value obtained using pGL2-Control. 
3.2.6.2. Transfections using equimolar versus equal microgram amounts of DNA 
Cells were initially transfected with equal microgram amounts of each promoter-
luciferase construct, that is 7 µg of construct plus 2 µg of pRSV-B-gal per dish 
of cells (results of which are indicated in Fig. 3.8 by solid bars for 
transfection experiments 12-18). However, because of the difference in size 
between constructs (for example, TYR2_.l-LUC (7674 bp) and TYR0.2-LUC (5798 bp)), 
the cells transfected with the bigger constructs would receive fewer copies of 
the potentially transcribable DNA than cells transfected with the smaller 
construct (1.38 pmoles versus 1.83 pmoles, respectively). Subsequent 
transfection experiments were performed using equimolar amounts of each 
construct (1.38 pmoles) made up to 7 µg with carrier plasmid (non-transcribable, 
promoterless pBLCAT3; Luckow and Schutz, 1987) (Fig. 3.8; hatched bars shown for 
experiments 18-22). As can be seen from the results of experiment 18 (Fig. 
3.8.b) where transfections with equimolar versus equal microgram amounts of DNA 
were compared within one experiment, slight differences in expression could be 
detected. For instance, the relative expression of TYR2.l-LUC was slightly 
increased and TYR0.2-LUC slightly decreased when using equimolar amounts of DNA. 
In general, however, the variation in expression of luciferase obtained using 
these slightly different amounts of DNA was no more striking than the inter-
experimental variation obtained using "equal microgram" amounts of DNA and 
therefore considered to be negligible. 
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3.3. RESULTS 
3.3.1. Seguence Analysis 
Two types of sequence analysis were undertaken to identify putative cis-acting 
regulatory elements in the 5' flanking sequence. The first entailed searching 
for regions of homology between the 5' flanking sequence of CTYR4.3 and other 
vertebrate tyrosinase genes that might thus contain functionally significant 
regulatory elements common to all tyrosinase gene promoters. The second type of 
sequence analysis involved screening CTYR4.3 for any potential consensus 
transcription factor binding sites found in the transcription factors datasets 
represented in TFsites. 
3.3.1.1. Alignment of the 5' flanking sequences of vertebrate tyrosinase genes. 
The search for homologous tyrosinase promoter sequences involved a BESTFIT 
comparison of CTYR4.3 to 5' flanking sequences of human, mouse, quail, turtle, 
and frog tyrosinase genes (see Table 3.1). A cDNA sequence encoding Medaka fish 
tyrosinase was recently isolated, but a genomic DNA sequence encoding a fish 
tyrosinase gene has not yet been cloned. Nevertheless, the cDNA sequence 
represents an RNA transcript that includes 321 nt of 5' untranslated sequence 
between the ATG site and its transcription initiation site (Inagaki et al, 
1994). Although most of the important transcription regulatory sequences are 
usually found upstream of the transcription start site, for the purposes of 
completion, attempts were made to align this 321 nt of 5' untranslated sequence 
with the tyrosinase 5' flanking sequence from other vertebrates. 
Two regions in CTYR4.3 were found to be homologous to the tyrosinase gene 
promoters of other vertebrates. These highly conserved sequences will be 
referred to as the proximal and distal conserved regions. The positions of 
these regions within CTYR4.3, are highlighted in Fig. 3.2 (shaded boxes). An 
alignment of the most highly conserved sequences within the two above mentioned 
regions, with the corresponding tyrosinase promoter sequences from other 
vertebrates is shown in Fig. 3.3. A 129 nt stretch positioned at nt -337 to -
209 in CTYR4.3 constitutes the proximal conserved region (Fig. 3.3.a). Here, 

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Homology to the quail and turtle sequences over this region is higher and 
extends beyond 129 nt. Homology between CTYR4.3 and the entire 519 nt of the 
quail promoter was 92%. The region of "bestfit" between CTYR4.3 and turtle 
promoter sequences, however, showed only 67.5% homology and was found over a 
stretch of 480 nt proximal to the ATG site. The Inr sequence is included at 
the 3' end of the proximal conserved region and interestingly, the homology 
between manvnalian and lower vertebrate tyrosinase promoters ends abruptly 
immediately downstream of the Inr. The second conserved region within the 
vertebrate tyrosinase 5' flanking sequences was found at a more distal 
position (nt -1237 to -1122 in CTYR4.3; Fig. 3.3.b). Here CTYR4.3 shares 70% 
homology with a sequence at approximately -1900 nt in the human tyrosinase 
promoter and 60% homology with a mouse sequence beginning at nt -1225. The 5' 
flanking sequences reported for the q~ail and turtle do not extend as far 
upstream as their mammalian counterparts, therefore homology to this second 
region could not bec~~ithin these sequences. Surprisingly, neither the 
frog nor the Medaka fish tyrosinase 5' flanking sequences could be aligned 
with the above sequences due to insufficient homology. 
Interestingly, the human, mouse and quail promoter sequences aligned in Fig. 
3.3 contain elements that have been previously reported to play a role in the 
regulation of tyrosinase gene transcription. These include the Inr, SPl-
binding site and M-box in the proximal conserved region, and TOE enhancer of 
the human sequence in the distal conserved region (Yamamoto et al, 1992; Ganss 
et al, 1994; Bentley et al, 1994; Yasumoto et al, 1994). The poJtions and 
~ sequences of the putative chicken homologues are indicated in Fig. 3.3 (boxed 
sequences) and in Fig. 3.2 (boxed sequences within shaded areas). 
The M-box, an 11-bp motif (AGTCATGTGCT) common to mammalian tyrosinase 
promoters, was termed the proximal melanocyte-specific element (p-MSE) by 
Yamamoto et al (1992). They found three similar motifs in the~' flanking 
sequence of both the quail and snapping turtle tyrosinase genes. An analysis 
of CTYR4.3 revealed three p-MSEs at similar positions to those in the quail 
promoter i.e. at nt positions -320, -383, and in the complementary strand at -
36 (Fig. 3.2, sequences in bold print). The p-MSE at nt position -320 lies 
within the proximal conserved region (Fig. 3.3.a) and its position corresponds 
exactly to the mammalian M-box. 
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Because of the significant role of the CATGTG motif in the functioning of the 
TOE, Inr and M-box and its presence in some of the reported p-MSE sequences 
(see Table 3.2), CTYR4.3 was screened for further CATGTG motifs. Two were 
identified, one of which is situated at nt position -1543 and the other in the 
complementary strand at nt position -2054. These motifs and their flanking 
sequences also represent p-MSE-like sequences (see Table 3.2). 
3.3.1.2. Identification of potential transcription factor binding sites in the 
5' flanking sequence of CTYR4.3 
The search for transcription factor binding sites in CTYR4.3 using consensus 
sequences from the TFsites datasets, revealed many putative sites. However, 
the results presented below are restricted to include only those that may be 
involved in basal transcription or i~ the response to humoral factors 
mentioned in chapter one. The significance of the rolesof the remaining sites 
in tyrosinase gene transcription remains to be determined and is beyond the 
scope of this project. The positions of these potential sites in the 5' 
flanking sequence of CTYR4.3 and the transcription factors that recognise them 
are listed in Appendix III. 
Four potential TATA box motifs were identified in the 5' flanking sequence, 
one of which is found at nt position -553 and thre~~far upstream at nt 
positions -1574, -1661 and -1711. The most proximal TATA box appeared four 
times in the FINDPATTERNS results, fitting the following consensus sequences: 
TATAAA, TATAAAA, TATAA/TAA/T, ATATAA. One putative AP-I-binding site was 
identified at nt position -1933 which fits the consensus sequences TGANTA/cA 
and CTGAATCAC. A sequence identical to the URE (TGACAACA) consensus was found 
in the complementary strand at nt position -731. Several motifs (ATTCCTCTGT, 
TGTTCT, TGTCCT, TGTTCACT) that have been reported to form part of 
glucocorticoid receptor-binding sites (in other words, GREs), were identified 
in CTYR4.3 at nt positions -471, -476, -818, -1319 and -1811. The positions 
within CTYR4.3 of the abovementioned elements are indicated in Fig. 3.2 
(sequences underscored with a dashed line). No consensus sequences for AP-2-




Comparison of p-MSE sequences reported for vertebrate tyrosinase gene 
promoters. 
Mouse -186 AGTCATGTGCT -176 M-box 
Quail -26 AGTGTTATGCT -36 cs 
-321 AATCATGTGCT -311 M-box 
-382 AGACAACTGCT -372 
Turtle -49 ATTCATGCACT -39 
-293 AGTCATCTTCT -303 cs 
-463 AGCAAATTTCT -473 cs 
Frog -89 GAACATGTGAT -79 
-171 ATTCCTGTGAT -161 
CTYR4.3 -26 AGCATAACACT -36 cs Q-homologue 
-223 CAACATGTGATAATCA -209 Inr 
-320 AATCATGTGAT -310 M-box/Q-homologue 
-383 AGCCAACTGCT -373 Q-homologue 
-1205 GGTCATGTGAT -1195 TDE 
-1543 TCTCATGTGTA -1533 
-2044 CCTCATGTGCC -2054 cs 
Note: The CATGTG motifs are in boldface type. Numbering is from the ATG 
translation start site. cs indicates that the element is present in the 
complementary strand. Q-homologue = the homologue of a p-MSE reported for the 
quail sequence. The positions of the seven p-MSE sequences identified in 
CTYR4.3 are shown in Fig. 3.2 (printed in boldface). 
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3.3.2. Transcription start site analysis 
To determine whether the 2125 nt of the 5' flanking untranslated sequence of 
chicken tyrosinase in clone CTYR4.3 does contain information necessary for 
transcription of tyrosinase, it was important to show that transcription start 
sites exist within this sequence. Therefore, primer extension analysis was 
used to map the 5' ends of RNA transcripts of chicken tyrosinase to reveal the 
positions of the transcription start sites. 
Pigmented tissues dissected from chick embryos including skin, whole eyes and 
retinal pigment epithelial cell layers, were used as a source of tyrosinase 
transcripts. As a negative control, either mRNA extracted from musculo-
skeletal tissues i.e. the body of an embryo minus eyes, skin, brain, gut, 
liver, kidney, heart and limbs, or t~tal RNA from embryonic brain was used. 
Unlabelled primer was annealed to the template RNA and extended using reverse 
transcriptase and a nucleotide mix in which cold dCTP was replaced with 32p_ 
dCTP. To determine the sizes of the primer extension products, they were run 
on a sequencing gel alongside a sequencing reaction in which the same primer 
was extended using CTYR4.3 DNA as a template. The number of nt by which the 
primer had been extended and thus the position of the 5' end of each product 
could then be deduced. 
Typical autoradiographs showing primer extension products obtained using 
different RNA templates are shown in Fig. 3.4. Each figure represents a 
portion of the sequencing gel showing the position of some of the products 
that could be obtained in repeat experiments, for instance the products with 
5' ends at nt positions -62 and -71. As primer extension was carried out 
using incorporated label as opposed to end- labelled primer, the procedure was 
prone to non-specific incorporation of the labelled nucleotide and thus high 
background on autoradiographs. This is because any short RNA or single-
stranded DNA molecule present in the reaction mix could potentially serve as a 
random primer . Therefore, several primer extension runs were attempted under 
different conditions (such as varying the amount of primer or cold dCTP 
included in the reaction) in order to detect specific extended products above 
non-specific background on autoradiographs. The optimised conditions under 
which the 20-mer primer was annealed to the template RNA and extended, are 
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Fig. 3.4. Primer extension analysis to determine the transcription initiation 
site(s) of the chicken tyrosinase gene. (a) Primer extension analysis of 
poly(A+) RNA isolated from pigmented chick embryo eye. Lane 1, Primer 
extension products obtained using the "optimised" experimental conditions 
described in the materials and methods. The products seen above the 
background smear that were repeatable are indicated by arrowheads. These 
correspond to transcription start sites at nt positions -62 and -71. The 
sequencing ladder of the complementary strand of CTYR4.3 obtained with the 
same primer, was used to locate the position of transcription start sites. 
Lane 2, a primer extension reaction performed under non-optimal conditions, 
which resulted in very high background. The experimental conditions employed 
were those typically used during first strand cDNA synthesis, which involve 
fewer manipulations but are less stringent. (b) Primer extension analysis of 
poly(A+) RNA isolated from pigmented skin of chick embryos, using the 
"optimised" experimental conditions. The products corresponding to 
transcription start sites at nt positions -62, -71 and -143 are indicated by 
arrowheads. A very faint sequencing ladder of the complementary strand of 
CTYR4.3 obtained with the same primer, was used to locate the position of 
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Fig. 3.5 : Maps of the tyrosinase promoter - luciferase reporter gene constructs 
used for transient transfection. TYR2.l-LUC contains the entire 5' flanking 
sequence cloned to date for the chicken tyrosinase gene. TYRI.1-LUC was 
constructed to specifically exclude the TOE-like element. TYR0.5-LUC 
containing the proximal 504 nt of 5' flanking sequence, was constructed to 
compare promoter activity with that of the 519 nt quail promoter, which has 
been functionally analysed (Akiyama et al, 1994) . TYR0.2-LUC was constructed 
to specifically exclude the putative M-box, SPl-binding site and Inr element. 
The positions of other potentially important sites within the constructs are 
indicated. Details of the construction may be found in section 3.2.3. 
96 
Data presented in Fig. 3.2 were derived from the combined results obtained 
from several different primer extension experiments. Five potential 
transcription start sites were identified (these are circled and indicated in 
bold) at nt positions -62, -71, -143, -200 and -248, with the product 
corresponding to the start site at nt position -62 being most consistently 
obtained. It should be noted that in some experiments ·additional 
transcription start sites were noticed, but these were not reproduced in 
repeat experiments and thus could not be considered to be authentic sites. 
However, one cannot rule out the possibility that minor species of tyrosinase 
transcripts may be initiated at these isolated sites. Interestingly, 
different potential start sites were obtained for eye- versus skin-derived 
tyrosinase transcripts. Using skin mRNA, primer extension products were 
obtained with 5' termini at the three most proximal sites, whereas products 
that correlated with all five transc~iption start sites were obtained when 
using eye- and/or RPE-derived RNA. None of the signals produced by the five 
repeatable products was notably stronger than the others and thus a 
predominant start site was not apparent amongst the five sites indicated. 
These results suggest that the transcription start site for the chicken 
tyrosinase gene is heterogeneous. 
3.3.3. Functional analvsis of the 5' flanking seguence of CTYR4.3 in 
transfected cells 
The aim of the transfection experiments was twofold: firstly to confirm that 
the 5' flanking region of CTYR4.3 can function as a promoter, and secondly, to 
begin to assess the significance of the conserved promoter elements (M-box, 
Inr, TOE) in the functioning of the chicken tyrosinase promoter. 
To this end, reporter gene recombinants were constructed in which a series of 
putative chicken tyrosinase promoter sequences progressively deleted from the 
5' end, were cloned upstream of the luciferase reporter gene. The positions 
of the deletion endpoints relative to the putative regulatory elements are 
shown in Fig. 3.5. 
Initially, attempts were made to generate the promoter deletions by 
Exonuclease III digestion. However, progressive deletions could only be 
generated from the 3' end of CTYR4.3 and all attempts to generate progressive 
deletions from the 5' end of CTYR4.3 were unsuccessful. Specific promoter 
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fragments were therefore 
that was greatly limited 
CTYR4.3. As a result of 
obtained by restriction ~nzyme digestion, an approach 
Ul\tq_v,e 
by the availability of"'r~striction enzyme sites in 
cloning limitations, it should be noted that TYR0.2-
LUC contains the 5' flanking sequences between nt positions -205 and -3, as 
well as 45 bp from the extreme 5' end (-2125/-2080) of CTYR4.3. 
3.3.3.1. Characteristics of cell types used in transient transfection 
experiments 
Functional analysis of the mammalian melanocyte-specific gene promoters has 
been facilitated by the availability of melanoma cell lines and immortalised 
melanocytes. There are, however, no equivalent avian cell lines available. 
The most concentrated source of pigmented cells in vertebrates is the RPE cell 
layer in the eye, and therefore prima~y cultures of RPE cells derived from 
chicken embryos were initiated for this study. These could be used as 
"tyrosinase-positive" cells for transient transfection experiments, as the 
cells are visibly pigmented (see Fig. 3.6.a) and continue to express the 
tyrosinase gene in culture as shown by Northern blot hybridisation analyses 
(see Fig. 3.7 and April et al, 1996). 
A recently established quail neural crest-derived cell line, MQTNC (Fauquet et 
al. 1990), was also explored for its potential for use as a tyrosinase-
positive cell line. These quail trunk neural crest cells were immortalised by 
infection with the avian myc-carrying MC29 retrovirus. Transformation of 
avian cells by MC29 either blocks or maintains differentiation, depending on 
the cell type. Fauquet et al (1990) have shown that illlllortalisation of the 
quail neural crest cells by MC29 does not suppress the appearance of 
catecholaminergic traits within the subpopulation originally destined to give 
rise to the catecholaminergic neurons. Fauquet et al (1990) observed 
differentiated melanocytes in some of their original irmnortalised cell 
cultures, indicating that a subpopulation of these heterogeneous cells have 
melanogenic potential. The MQTNC cultures used in this study were, however, 
visibly unpigmented (see Fig. 3.6.b and c) and therefore attempts were made to 
detect tyrosinase gene expression in these cells by Northern blot 
hybridisation using a radiolabelled chicken tyrosinase cDNA probe. As can be 
seen in Fig. 3.7, a single hybridisation signal was obtained in the 10 µg 
sample of total RNA extracted from cultured RPE cells (lane three), but no 
signals could be detected in 
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Fig. 3.6: (a) Primary cultures of chicken RPE cells. The characteristic 
"cobblestone" morphology of RPE cells is seen clearly on the left-hand side of 
the micrograph. All cells in this confluent culture are visibly pigmented. 
The cells were visualised with bright-field illumination. Magnification, X 
275. 
Fig. 3.6: (b-e) The phenotype of MQTNC and Hep G2 cells in culture. MQTNC 
cells (band c) and Hep G2 cells (d and e) were visualised with both phase-
contrast (band d) and bright-field illumination (c and e). The cells are 
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Fig. 3.7: Northern blot hybridisation analysis of tyrosinase gene expression 
in RPE, MQTNC and Hep G2 cells. (a) Electrophoretic analysis of RNA extracted 
from MQTNC cells (20 µg, lane l; 10 µg, lane 4), Hep G2 cells (20 µg, lane 2; 
10 µg, lane 5) and RPE cells (10 µg, lane 3). The 18S and 28S ribosomal RNA 
bands are clearly evident in all samples, indicating that the RNA is intact. 
The intensity of ethidium bromide staining confirms that approximately equal 
amounts of RNA were analysed in lanes 1 and 2, and in lanes 3,4 and 5. (b) 
Northern blot hybridisation of the RNA that was separated on the gel in (a) . 
A 1.5 kb fcoRI/PstI fragment of the chicken tyrosinase cDNA was radiolabelled 
and used as a probe. A hybridising RNA transcript of approximately 2.5 kb in 
size was detected only in the RPE RNA sample (lane 3), confirming that these 
cells are "tyrosinase-positive". It should be noted that these RPE cells had 
been in culture for 4 weeks and passaged twice. 
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either the 10 µg or 20 µg sample of total RNA extracted from MQTNC cells 
(lanes four and one, respectively). There is a possibility that the 
conditions used above may not have been sufficiently sensitive to detect a 
rare transcript within a subpopulation of the heterogeneous MQTNC cells, and 
thus, at this stage, it is not known for certain whether these cells are 
tyrosinase-negative or -positive. Attempts are currently being made to 
determine whether a subset of these cells are expressing the tyrosinase gene 
using in situ hybridisation (T. Franz and S. Kidson, personal conununication). 
Despite the uncertainty about the melanogenic potential of the MQTNC cells, it 
was deemed worthwhile to test tyrosinase promoter activity in these cells. 
This decision was made because of the interesting possibility that if the 
chicken tyrosinase promoter is active in MQTNC cells, its activity may be 
regulated differently in these neural_ crest-derived cells than in RPE cells 
which are derived from the optic cup. Furthermore, Fauquet and Boni (1993), 
who have focused on the catecholaminergic neurons that arise from neural crest 
cells, have shown that MQTNC cells are easily transfected using the calcium 
phosphate-mediated technique, and have successfully analysed the activity of 
tyrosine hydroxylase promoter-reporter gene constructs in MQTNC cells by 
transient transfection. This method of transfection also proved to be 
successful when tested on the primary RPE cell cultures initiated for this 
study, but required a few modifications because of the greater sensitivity of 
primary cultures to manipulation and their relatively slow growth rate. 
Quail fibrosarcoma (QT6; ATCC no. 1708-CRL) cells were to be used as an avian 
"tyrosinase-negative" cell line. However, these cultures proved to be 
difficult to maintain in culture and to transfect using the calcium phosphate-
mediated method. Hep G2 cells (human hepato-blastoma cells, ATCC no. HB8065; 
Fig. 3.6.d and e) were used as an alternative as they grow well in culture and 
are easily transfectable using the calcium phosphate-mediated method. 
Furthermore it has previously been shown by Northern blot hybridisation 
analysis that Hep G2 cells do not express tyrosinase (Kwon et al, 1987). This 
was confirmed by the lack of hybridisation signals in Hep G2 RNA samples 
probed with a radiolabelled chicken tyrosinase cONA sequence (Fig. 3.7, lanes 
two and five). 
To determine optimal conditions for calcium phosphate-mediated transfection of 
RPE, MQTNC and Hep G2 cells, a series of pilot experiments (transfection 
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experiments 1 to 11, results not shown) was conducted. Parameters that were 
varied included the seeding density of cells, the amount of DNA transfected, 
and the length of exposure of the cells to the calcium phosphate-DNA 
precipitates. The effects of using different methods of DNA purification 
(that is, Wizard Maxiprep DNA Purification [Promega Corporation] versus 
purification by centrifugation in cesium chloride-ethidium bromide gradients) 
and glycerol shocking were also assessed. The conditions that were finally 
used to test chicken tyrosinase promoter activity are specified in the 
materials and methods section 3.2.6. 
3.3.3.2. Tyrosinase promoter activity in RPE, MQTNC and Hep G2 cells 
Promoter activity of 5' flanking sequences derived from CTYR4.3 was then 
assessed in transfection experiments _12 to 22. Results of individual 
experiments are shown in Fig. 3.8 (a-c). The results were not pooled because 
of the inter-experimental variation, but as can be seen from the graphs, 
similar results were obtained on each occasion for the different cell types. 
The first aim of the transfection experiments was to show that the 5' flanking 
sequences of CTYR4.3 are able to function as a promoter. Transfections with 
all constructs containing 5' flanking sequences of CTYR4.3 resulted in 
luciferase activities significantly greater than those observed when using the 
promoterless luciferase construct (pGL2-Basic, indicated by a "O" on the x-
axis of each experiment). These results confirm that the 5' flanking 
sequences of CTYR4.3 possess promoter activity. The level of expression 
driven by the various promoter fragments, however, differed markedly in the 
different cell types. In the tyrosinase-negative Hep G2 cells, low levels of 
expression were observed with all constructs (Fig. 3.8.b). A similar result 
was reported by Hughes et al (1995) who observed promoter activity above 
background of a 529 bp human tyrosinase promoter in Hep G2 cells. Greatly 
increased luciferase activities were observed with some constructs in the RPE 
and MQTNC cells; but surprisingly, the highest levels of expression were 
driven by different constructs in these two cell types (as will be described 
below). 
In RPE cells, in all three transfection experiments, the highest level of 
luciferase activity was obtained with TYR0.2-LUC, the construct containing the 
smallest (0.2 kb) promoter fragment (Fig. 3.8.a). Indeed, this was the only 
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promoter fragment with significantly higher activity in RPE cells than in Hep 
G2 cells, indicating that it must contain elements that can direct both basal 
transcription and RPE-specific expression of a downstream gene. Because 
deletion of promoter sequences between -0.5 and -0.2 kb resulted in this 
significant increase in promoter activity, it is possible that there is a 
strong negative regulatory element located between nt positions -0.5 and -0.2 
kb. 
Somewhat surprisingly, the 2.1 kb, I.I kb and 0.5 kb fragments had lower 
promoter activity than the 0.2 kb fragment. When comparing the activities of 
TYR2.l- and TYRI.1-LUC, it was noted that in all three experiments TYR2.1-LUC 
activity was higher (by 15-40%) than that of TYRI.1-LUC. This suggests the 
possibility of a positive regulatory element located between -I.I and -2.1 kb 
from the ATG site. 
Interestingly, the promoter fragments have very different activities in MQTNC 
cells. In all cases, the longest construct, TYR2.l-LUC, had the highest 
activity. Deletion of sequences upstream of -1.1 kb resulted in a dramatic 
reduction in promoter activity, especially in experiments 12 and 20, where 
activity dropped by 79% and 86%, respectively (See Fig. 3.8.c). This suggests 
the presence of a strong positively acting element located upstream of the -
I.I kb deletion endpoint, which appears to mediate a stronger positive effect 
in the MQTNC cells than in the RPE cells. The expression driven by the 
smaller promoter fragments containing 0.5 kb and 0.2 kb of chicken tyrosinase 
promoter sequences, remained at a relatively low level in MQTNC cells, 
comparable with the levels obtained in the Hep G2 cells. Moreover, the 0.2 kb 
fragment displayed the weakest promoter activity in these cells, in contrast 
to its high activity in RPE cells. Thus transcription driven by the chicken 
tyrosinase promoter appears to be regulated differently in RPE cells and MQTNC 
cells. 
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Fig. 3.8 : (a) Activities of chicken tyrosinase gene promoter deletion mutants 
in RPE cells. Cells were transfected with either equimolar (hatched bars) or 
equal microgram amounts {solid bars) of each promoter-luciferase construct 
{The reason for this is discussed in the materials and methods section 
3.2 .6.2). Results were normalised with respect to B-gal activity in the same 
extract and are expressed as a percentage of the luciferase activity obtained 
with pGL2-Control, shown as units of relative luciferase activity. The 
figures 2.1, 1.1, 0.5, 0.2 and O on the x-axis represent the constructs 
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Fig. 3.8: (b) Activities of chicken tyrosinase gene promoter deletion mutants 
in Hep G2 cells. Cells were transfected with either equimolar (hatched bars) 
or equal microgram amounts (solid bars) of each promoter-luciferase construct 
(The reason for this is discussed in the materials and methods section 
3.2.6.2). Results were normalised with respect to 8-gal activity in the same 
extract and are expressed as a percentage of the luciferase activity obtained 
with pGL2-Control, shown as units of relative luciferase activity. The 
figures 2.1, 1.1, 0.5, 0.2 and O on the x-axis represent the constructs 
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Fig. 3.8: (c) Activities of chicken tyrosinase gene promoter deletion mutants 
in MQTNC cells. Cells were transfected with either equimolar (hatched bars) 
or equal microgram amounts (solid bars) of each promoter-luciferase construct 
(The reason for this is discussed in the materials and methods section 
3.2.6.2). Results were normalised with respect to B-gal activity in the same 
extract and are expressed as a percentage of the luciferase activity obtained 
with pGL2-Control, shown as units of relative luciferase activity. The 
figures 2.1, 1.1, 0.5, 0.2 and O on the x-axis represent the constructs 
TYR2.l-LUC, TYRl.1-LUC, TYR0.5-LUC, TYR0.2-LUC and pGL2-Basic, respectively. 
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3.4. DISCUSSION 
3.4.1. Comparison of vertebrate tyrosinase gene promoters 
Sequence analyses, primer extension and transient transfection experiments 
were undertaken in this study to characterise the 5' flanking sequence cloned 
in CTYR4.3 and to assess its promoter activity. The purpose of this section 
is to put forward an interpretation of the results from these experiments and 
to discuss their significance to tyrosi~ase gene regulation in chickens and 
lower vertebrates in general. 
Sequence alignments were performed to assess the similarity of the chicken 
tyrosinase 5' flanking sequence to th~ well characterised promoter regions of 
tyrosinase genes from other vertebrates. Results indicate that the chicken 
tyrosinase gene promoter is most closely related to those of the quail and 
turtle tyrosinase genes. Furthermore, the chicken promoter sequence appears 
to be more closely related to the mammalian tyrosinase sequence than to the 
frog and medaka fish tyrosinase 5' flanking sequences which, surprisingly, 
could not be aligned with the tyrosinase gene promoter sequences of any other 
vertebrate. This finding is supported by the report of Morrison et al (1994), 
who constructed a phylogenetic tree based on cDNA sequence data to illustrate 
the evolutionary relationships between the members of the tyrosinase gene 
family. Their tree groups the chicken, mouse and human tyrosinase gene 
sequences together on a branch separate from that of the frog sequence (See 
Fig. 3.9). 
Alignment of sequences from human, mouse, chicken, quail and turtle tyrosinase 
gene promoters in this study revealed two conserved regions, here named the 
proximal and distal conserved regions. The mammalian tyrosinase sequences 
present in these conserved regions have previously been analysed in other 
studies and shown to contain important regulatory elements (discussed in 
section 1.3). These regulatory elements include the Inr and SPl-binding site, 
which are required for basal transcription, and the M-box (p-MSE) and TOE, 
which are enhancers that mediate melanocyte-specific upregulation of 
tyrosinase gene expression. These sequence similarities raise the possibility 
that tyrosinase gene expression in chickens (and other avians), reptiles and 
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Fig. 3.9: Phylogeny of the vertebrate members of the tyrosinase gene family. 
Groups sharing common ancestry are bracketed. Tyr, tyrosinase; Strep. a., 
Streptomyces antibioticus; Strep. g., Streptomyces glaucescens. (After 
Morrison et al, 1994.) 
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cis- and trans-acting factors, and that these may well be distinct from those 
employed in the lower vertebrates, namely, amphibians and fish. 
In support of this idea are the results of some "cross species" analyses of 
vertebrate tyrosinase promoters. For instance, Yamamoto and co-workers have 
shown that 5' flanking sequences from quail and turtle tyrosinase genes can 
direct melanocyte-specific expression in the mouse system (cited in Jackson, 
1994) and similarly that the mouse tyrosinase promoter can function 
melanocyte-specifically in cultured chicken cells (Akiyama et al, 1994). On 
the other hand, it has been reported that the mouse tyrosinase promoter is 
able to direct melanophore-specific expression of a downstream sequence in 
transgenic fish (Matsumoto et al, 1992). Thus, while there is very little 
sequence similarity between mammalian and fish tyrosinase promoters, 
functionally they appear to employ si~ilar mechanisms to achieve melanocyte-
specific expression. 
3.4.2. Transcription of the chicken tyrosinase gene is initiated at 
heterogeneous start sites 
Transcription start site analysis was performed in an attempt to determine the 
3' boundary of the chicken tyrosinase gene promoter. Using primer extension, 
several potential transcription start sites were mapped in the 5' flanking 
sequence between nt positions -62 and -248 from the ATG site. 
Several technical problems were encountered during transcription start site 
analysis. Tyrosinase mRNA transcripts, due to their rarity, are notoriously 
difficult to detect in whole tissue sample; especially skin samples (Mochii et 
al, 1992; April et al, 1996; Steel et al, 1992). The use of pigmented cell 
lines to obtain sufficient quantities of transcripts, has relieved this 
problem for in vitro studies of mammalian tyrosinase mRNA. However, as 
mentioned earlier, there are no such avian cell lines available. A further 
problem was the relatively high backround at autoradiographs from the primer 
extension analyses; this high background could have masked the extended 
products, and have been responsible for the inconsistency in results obtained 
from different experiments. It is unlikely that the heterogeneous results 
arose by reverse transcription of degraded RNA templates or that they 
represent products caused by premature halting of the reverse transcriptase 
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due to secondary structure formation by GC-rich templates because the chicken 
tyrosinase gene sequence is 52% AT-rich over the proximal 248 nt upstream from 
the ATG site. The authenticity of these primer extension results would, 
however, be strengthened if the results could be confirmed using techniques 
such as RNase or SI nuclease protection.I Nevertheless, the identification of 
these heterogeneous transcription start sites for the chicken tyrosinase gene 
is supported by several observations. 
Firstly, there is a lack of consensus in the literature regarding the 5' 
terminus reported for different avian tyrosinase gene transcripts. A 
transcription start site was reported for the quail tyrosinase gene at the 
CACT sequence 81 nt upstream from the ATG site (Akiyama et al, 1994). In 
CTYR4.3 this site is exactly conserved in sequence and relative position from 
the ATG, and thus may also function as a transcription start site for chicken 
tyrosinase. However, since ~kiyama et al (1994) do not indicate whether the 
location of this site was derived empirically or by extrapolation (see section 
1.3.1), the authenticity of this site is questionable. Two groups of 
investigators have isolated chicken tyrosinase cDNA sequences from libraries 
generated using RNA from RPE cells (Mochii et al, 1992) or · neural crest-
derived melanocytes (April et al,1996). April et al (1996) found the 5' 
terminus of their longest clone to be at -42 nt upstream of the ATG, whereas 
Mochii et al (1992) report that the 5' terminus of two independent RPE 
tyrosinase cDNA clones is at nt position -108. Whilst the 5' terminus of a 
cDNA molecule is not necessarily a good indication of the position of the 
transcription start site since this depends on the efficiency of the reverse 
transcription during cDNA synthesis, one can nevertheless deduce that the 
transcription start sites from which the tyrosinase RNA transcripts originate 
would lie upstream of the cDNA 5' termini. Given the fact that these cDNA 
clones represent RNA transcripts of melanocytes from different tissues (viz 
RPE and neural crest-derived melanocytes), the different 5' termini may 
reflect the use of alternative promoters in these tissues and not simply sites 
at which cDNA synthesis may have stopped prematurely. In summary, putative 
avian transcription start sites are located at nt position -81 and at a second 
site 5' to nt position -108. Possibly a third site (distinct from the site at 
I. With RNase protection in mind, a DraI/HindIII fragment containing ±430 nt 
of 5' flanking sequence and ±170 nt of exon 1, was excised from CTYR4.3 
exonuclease deletion clone IO.IO (see Fig. 2.10). This fragment, cloned into 
a pGEM-3 vector (Promega Corporation), is being used to generate riboprobes 
for RNase protection. 
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-81) may be found 5' to nt position -42. The proximity of the five 
transcription start sites identified in CTYR4.3 to the 5' termini of the cDNA 
sequences is encouraging. The two proximal start sites are positioned at 18 
nt and 27 nt upstream of the cDNA terminus at -41 nt, respectively and close 
to the CACT site at -81 nt, while the 3 distal start sites are positioned 35 
nt, 92 nt and 140 nt upstream from the cDNA terminus at -108 nt. 
The identification of heterogeneous start sites for chicken tyrosinase 
transcripts is consistent with the absence of a TATA box in the proximal 5' 
flanking sequence of CTYR4.3. As mentioned in chapter 1 (section 1.3.1), the 
binding of a TATA element by transcription factor TFIID serves to direct 
accurate transcription initiation by RNA polymerase II at a single site 
approximately 30 nt downstream of the TATA element. Thus, for TATA-less 
promoters transcription has been foun~ to occur from more heterogeneous sites 
(reviewed by Smale and Baltimore, 1989). Although several TATA motifs were 
identified in the 5' flanking sequence of CTYR4.3 that match sites in the 
transcription factors database, the most proximal of these is at -552 nt from 
the ATG site, that is, more than 200 nt from the most distal transcription 
initiation site. These therefore cannot be functioning as TFIID binding 
sites. Similar conclusions can be drawn for TATA elements in the quail and 
turtle tyrosinase 5' flanking sequences. A similar search of these sequences 
revealed that the most proximal TATA box is found at nt position -288 from the 
ATG site in the quail and at -289 in the turtle sequence. The TATA box is 
unlikely to play a role in transcription that is initiated at the quail start 
site (CACT) at -81 nt reported by Akiyama et al (1994), as it lies too far . 
upstream of this site . Although TATA motifs have been reported for the mouse 
and human tyrosinase genes, these genes lack a canonical TATA box (Bentley et 
al, 1994) and there has been speculation that the TATA boxes might also not be 
f unctioning as true TFIID binding sites. 
By what mechanism then would RNA polymerase II bind and initiate transcription 
at the TATA-less tyrosinase gene promoter? As has been discussed in chapter 
one (section 1.3.1), previous studies of mammalian tyrosinase gene regulation 
implicate an SPI-binding site and an initiator region containing a 
functionally significant E-box and octamer motif and an Inr element. These 
elements fall within the proximal conserved region which was also identified 
within the chicken, quail and turtle tyrosinase gene promoters. 
Interestingly, the position of the proximal conserved region relative to the 
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ATG site is not conserved between mammals and lower vertebrates - in the mouse 
and human tyrosinase promoters the Inr element (which lies at the 3' boundary 
of the proximal conserved region) is found 80 nt upstream of the ATG site, 
whereas in CTYR4.3, the quail and turtle tyrosinase promoters, it is found 
approximately 200 nt upstream of the ATG site. Within the proximal conserved 
region, however, the positions of the putative regulatory elements are 
maintained relative to each other. The chicken Inr E-box and octamer motifs 
are identical to the human counterparts. In addition, the sequence at the 3' 
terminus of the Inr region (5'TCAGATT) fits the Inr consensus motif exactly 
(as is the case for the homologous mouse, quail and turtle sequences) and lies 
5 nt upstream of the putative transcription start site at nt position -200. 
Furthermore, the nonconsensus SPl-binding sequence (5'CGGGGGTGGGG) closely 
resembles the quail element (5'AGGGGGTGGGA) which was found by Bentley et al 
(1994) to be functional (see Fig. 3.3). Given the striking homology, it is 
tempting to speculate that in the absence of a TATA box, these elements may 
play a major role in transcription initiation at the chicken tyrosinase gene 
promoter. However, results from the promoter analyses in the tyrosinase-
expressing RPE cells indicate that this might not necessarily be the case and 
furthermore raise the possibility that the additional 120 nt between the Inr 
and ATG site may be functionally significant. 
3.4.3. Chicken tyrosinase promoter activity in transfected RPE cells 
Results from all of the transfections of tyrosinase promoter-reporter gene 
constructs in RPE cells show that the progressive removal of promoter 
sequences from the 5' terminus results in an initial decrease followed by 
little change in expression of the luciferase reporter gene. This trend is 
altered drastically by. the marked increase in expression observed on 
transfection with the shortest construct, TYR0.2-LUC. This increase in 
expression was surprising given that the promoter sequences in TYR0.2-LUC 
exclude the putative Inr region, SPl-binding site and M-box motif. There are 
two possible explanations for this result. The first possibility is that 
deletion of sequences between -506 and -206 results in the removal of negative 
regulatory elements that are responsive to RPE-specific transacting factors. 
The second possibility is that the high levels of expression observed when 
using TYR0.2-LUC are due to the inclusion of an upstream (distal) 45 bp 
sequence (nucleotides -2125 to -2080) that was ligated to the 200 bp (-205 to 
-3) proximal sequence. (This was brought about by the cloning limitations 
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described in section 3.3.3. The promoter sequence of the TYR0.2-LUC construct 
is thus 247 bp in length.) Thus it is possible that the extra 45 bp sequence 
contains a strong positive regulatory element that is responsible for the high 
level of activity of the TYR0.2-LUC construct. Each of these hypotheses will 
be considered separately below. 
Hypothesis one: there is a strong negative regulatory element between nt 
positions -506 and -206. The removal of such an element would result in 
increased expression driven by factors binding to regulatory elements within 
the proximal 200 bp of 5' flanking sequence. This would imply that the most 
proximal 200 bp fragment of 5' flanking sequence is sufficient to drive high 
levels of reporter gene expression in pigment-producing cells. As the Inr E-
box and SPI-binding motifs are not included in TYR0.2-LUC, these highly 
conserved motifs appear not to be ess~ntial for transcription initiation at 
the chicken tyrosinase promoter in this case, in spite of their significant 
role in the mammalian tyrosinase promoters. What elements might then be 
responsible for directing transcription initiation at the four putative start 
sites found within the 200 bp fragment? Sequence analysis reveals no further 
potential TATA boxes or SPI-binding sites in this promoter fragment. A search 
for putative Inr elements using the PyPyANT/APyPy consensus, however, revealed 
a site at nt position -84/-78 (5'TCACACT) that overlaps the position of the 
quail transcription start site (CACT at -81) reported by Akiyama et al (1994). 
Although this site does not overlap any of the transcription start sites 
identified in CTYR4.3 by primer extension, it is found just 5' of 
transcription start site 2 (at nt position -71) and may well prove to play a 
role in basal transcription of the chicken tyrosinase gene. The putative TE-
I element and the most proximal p-MSE are also found within this sequence (see 
Fig. 3.5). These two elements are direct homologues of the quail elements 
which were identified by Yamamoto et al (1992) and Akiyama et al (1994), but 
their functional significance in avian tyrosinase gene transcription 
regulation has not yet been assessed. Binding at either the TE-1, pMSE or 
other as yet unidentified elements within the proximal 200 bp of chicken 
promoter may prove to be necessary to direct transcription initiation from one 
or more of the four putative start sites or to confer tissue-specificity on 
the promoter activity. 
The presence of a negative regulatory element positioned within TYR0.5-LUC 
(between nt -206 and -506) would be consistent with the identification of such 
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elements in the mammalian tyrosinase promoters. Using deletion analysis and 
mutagenesis, a negative regulatory element was identified in the human 
sequence at 115 nt from the Inr and in the mouse sequence at 125 nt from the 
Inr (Bentley et al, 1994; Ganss et al, 1994) (see section 1.3.2 and Fig. 1.7). 
More recently, Eisen et al (1995) showed that binding at the octamer element 
within the proximal conserved region by transcription factor Brn-2/N-Oct3, 
appears to mediate down-regulation of the tyrosinase gene promoter (see 
section 1.3.1). Since the degenerate octamer in the chicken sequence is 
identical to the human motif, binding by a chicken POU domain protein similar 
to Brn-2/N-Oct3 may also repress chicken tyrosinase promoter activity. 
Detection of N-Oct3 mRNA at elevated levels in melanoma cells as compared to 
levels in normal human melanocytes, suggests that Brn-2/N-Oct3 is associated 
with dedifferentiating melanogenic cells. This, together with other evidence 
provided by Eisen et al (1995), raises the possibility that Brn-2 may play an 
important role in melanocyte differentiation and transformation. Of relevance 
to this point is the observation that the cultures of RPE cells that were 
maintained for the transfection experiments became progressively less 
pigmented with time. Possibly, a protein such as Brn-2/N-Oct3 is upregulated 
in these depigmenting RPE cells in culture, which then binds to the tyrosinase 
gene promoter and progressively down-regulates its activity. 
Hypothesis two: an alternative explanation for the high levels of expression 
obtained from TYR0.2-LUC, is that it is due to the presence of the 45 bp 
fragment included in the construct upstream of the 200 bp of proximal promoter 
sequence. In other words, it is possible that there is no negative regulatory 
element in TYR0.5-LUC, and that the deletion of ±300 nt between TYR0.5-LUC and 
TYR0.2-LUC may actually cause a decrease in expression which one might expect 
to accompany the removal of the conserved M-box, SP1-6inding and Inr E-box 
motifs. The high levels of expression from TYR0.2-LUC would then simply be 
the result of the serendipitous placement of a potential regulatory sequence 
adjacent to the 200 bp fragment, which, due to its unnatural physical 
proximity, could stimulate transcription initiation from the 200 bp fragment. 
Given that the 200 bp promoter sequence has the potential to initiate basal 
levels of transcription (as discussed in the paragraph above), the 45 bp 
fragment may be supplying a tissue-specific enhancer element. Furthermore, 
the promoter elements responsible for RPE-specific gene expression 
have not yet been identified and thus one cannot exclude the 
possibility that the 45 bp fragment may contain such elements. 
Sequence analysis of the 45 bp fragment revealed the presence of 
several putative regulatory elements (see Table 3.3): firstly, the 
3' end of the fragment contains a TATA-like sequence that might 
provide the core basal promoter; secondly, there exists a site 
recognised by the POU domain factor Pit-1. It is possible that RPE 
cells contain multiple POU domain proteins of unknown binding 
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specificity and function that may be able to recognise this 
sequence. Finally, an ATF site is present which may be functional 
in these cells. 
The explanations above raise the possibility that there are two regulatory 
regions capable of directing basal transcription in the chicken tyrosinase 5' 
flanking sequence: one that is undefined but responsible for the expression 
driven by the 0.2 kb promoter, and a second "mammalian-type" regulatory region 
positioned in the 0.5 kb promoter, 5' to the 0.2 kb endpoint that is comprised 
of the conserved Inr and SPl-binding elements. The upstream regulatory region 
may be active under certain circumstances, for instance in the absence of an 
inhibitory factor such as Brn-2/N-Oct3, and would possibly direct 
transcription initiation at the more distal start sites identified in CTYR4.3. 
These "alternative promoters'' may be used in different melanin-producing 
tissues. Alternative promoters have been proposed for the human and mouse 
tyrosinase genes (Ruppert et al, 1988; Yamamoto et al, 1989; Giebel et al, 
1991; Ponnazhagan et al; 1994); transcription start site analyses of the 
mammalian tyrosinase genes have revealed a common site at -80 nt from the ATG 
(see section 1.3.1), which is overlapped by the Inr element at the 3' terminus 
of the proximal conserved region. Additional transcription start sites have 
also been mapped in the mammalian sequences by some but not all investigators. 
Giebel et al (1991) suggest that the discrepancy in number and position of 
start sites reported may reflect differences between the human or mouse 
pigment cell lines used in each case. Thus several start sites are available 
in tyrosinase genes, but the site(s) used may depend on the cell type and 
trans-acting factors that are available. 
To date there have been only two other reports on the functional analysis of 
promoter sequences from lower vertebrate tyrosinase genes (Akiyama et al, 
1994; Miura et al, 1995). Miura et al (1995) simply showed that the proximal 
748 bp of 5' flanking sequence of the frog tyrosinase gene can drive 
transcription of a reporter gene in cultured frog melanophores. Akiyama et al 
(1994) assessed the promoter activity of quail tyrosinase 5' flanking 
sequences in cultured chicken cells using two constructs, containing 519 nt 
and 369 nt of 5' flanking sequence, respectively (detailed in section 1.3.2). 
They found that the proximal 369 bp of 5' flanking sequence could drive low 
levels of expression of a reporter gene (mouse tyrosinase cDNA) in cultured 


























































































































































































































































































































































































































































































































































































were obtained using the 519 bp promoter fragment, and this expression was found 
exclusively in the melanocytes. Thus, 519 bp of quail tyrosinase promoter is 
sufficient for appropriate tissue-specific expression in melanocytes of neural 
crest-derived origin. The lower level of expression driven by the 369 bp fragment 
in melanocytes suggests that a positive regulatory element is missing from this 
sequence but is present in the 519 bp fragment. The activation of reporter gene 
expression in the fibroblasts and hepatocytes using the truncated promoter 
sequence also suggests the loss of sequences necessary for repression of 
tyrosinase promoter activity in the non-melanin-producing cells. 
Functional analysis by transient transfection of the proximal 500 nt of the 
chicken tyrosinase promoter in this study gives results that are not easily 
reconciled with the results of Akiyama et al (1994). Given the difference in 
length between TYR0.2-LUC and the 369 nt quail promoter fragment, and the fact 
that interpretation of the results of transfection experiments using TYR0.2-LUC is 
complicated by the presence of the extraneous 45 bp fragment in this construct, it 
would be premature to compare the activities of these two constructs. The chicken 
5' flanking sequence (506 nt) contained in TYR0.5-LUC, however, is roughly 
equivalent in length and nucleotide sequence to the 519 nt quail promoter 
sequence. Unlike the equivalent quail sequence, the activity of the chicken 506 
nt promoter sequence was not tissue-specific, but was observed in both RPE and Hep 
G2 cells, although consistently at higher levels in the RPE cells. Although these 
promoter sequences are 92% homologous, the conflicting results may nevertheless be 
due to the slight differences in sequence. This has been demonstrated previously 
for the mouse and human tyrosinase promoters. Using transient transfections 
Shibata et al (1992) showed that proximal promoter sequences of human and mouse 
tyrosinase genes were not functionally equivalent, in spite of their sequence 
similarity. The discrepancy in results may also be due to the use of different 
systems to test promoter activity. Akiyama and coworkers made use of a retroviral 
vector, RCANBP, that includes the Rous sarcoma virus (RSV) long-terminal repeat 
(LTR i.e. viral promoter sequences) and po] sequences derived from the Bryan high-
titre strain of RSV, but apparently requires an internal promoter to control the 
expression of .the reporter gene. Although infections using vector alone (RCANBP) 
were included as negative controls, Akiyama et al do not indicate whether they 
tested for background activity of the retroviral vector linked to the reporter 
(RCANBP-mouse tyrosinase cDNA) in infected cultured chicken cells. Therefore, it 
is not known whether background reporter activity contributes to the activity 
driven by the different quail promoter fragments. It has been reported that 
proviral sequences within the LTR and pol regions do influence the levels of 
expression of reporter genes driven 
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from an inserted promoter (Petropoulos and Hughes, 1991), but it is not clear 
whether these "enhancer" sequences affect the activities of the two quail promoter 
fragments in different ways. Another factor to consider is that the conflicting 
results may stem from the use of cultured chicken melanocytes for the retroviral 
infections, which were neural crest-derived, as opposed to RPE cells used for the 
chicken promoter analyses. 
3.4.4. Chicken tyrosinase promoter activjtv in MOTNC cells 
Prior to using the MQTNC cells for transfection, an attempt was made to test 
whether they have melanogenic potential. However, results from melanin formation 
assays (data not shown) and Northern blot analyses suggest that they do not have 
melanogenic potential. Transfection of such cells with the tyrosinase promoter-
reporter constructs would possibly give results characteristic of a "tyrosinase-
negative" cell line. In line with this expectation, similar levels of expression 
were seen in MQTNC cells and Hep G2 cells transfected with TYRl.1-LUC, TYR0.5-LUC 
and TYR0.2-LUC. However, an unexpectedly high level of transcriptional activity 
was obtained using TYR2.l-LUC. This suggests the presence of positive factors in 
the MQTNC cells that are able to transactivate the full-length tyrosinase promoter 
sequence, and therefore raises the possibility that these cells may be 
premelanogenic. In further support of this idea, there is a striking ~esemblance 
between the profile of the histogram representing the MQTNC transfection results 
and that obtained when melanoma cells were transfected with human tyrosinase 
promoter-reporter constructs (Shibata et al, 1992). The results of Shibata et al 
led to the identification of the TOE, a strong upstream enhancer element in which 
the E-box plays a central role. A TOE-like element is present in the chicken 
promoter within the distal conserved region at approximately -1200 nt upstream of 
the ATG site (see Fig. 3.3.b). While only the central nucleotides of the human 
TOE enhancer are conserved in CTYR4.3, these include the CATGTG motif which plays 
an essential role in the functioning of the enhancer. Given that this element is 
excluded from all of the constructs except the TYR2.l-LUC construct, the 
transfection results suggest that the chicken TOE-like element may well mediate 
the high level of MQTNC-specific transcriptional activity seen for the 2.1 kb 
promoter sequence. 
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Thus if the quail cells do have melanogenic potential, the different promoter 
activities in these cells and the RPE cells raises the possibility that tyrosinase 
gene expression in neural crest-derived melanocytes and RPE melanocytes is 
regulated differently in vitro. At a first glance, these deductions seem 
reasonable. However, another interesting explanation is also possible. The MQTNC 
cells were i11111ortalised using a myc-carrying retrovirus. Myc proteins are bHLH-
ZIP transcription factors that bind to E-box motifs (CANNTG) and activate 
transcription of linked genes (reviewed by Meichle et al, 1992). Myc proteins 
bind preferably to the sequence CACGTG, but have also been shown to bind at CATGTG 
sites with lower affinity. The raised levels of Myc proteins in the MC29-infected 
MQTNC cells (that is, the endogenous c-Myc plus v-Myc shown by immunostaining in 
Fig. 3 a and b of Fauquet et al, 1990) may facilitate binding of Myc to the E-box 
motif within the TOE-like element of TYR2.l-LUC. This may well be responsible for 





In recent years, there have been significant advances in the understanding of 
the mechanisms involved in regulating expression of the mammalian tyrosinase 
gene. Not only have factors required for melanocyte-specific expression been 
identified, but most exciting is that the findings are beginning to reveal the 
link between the level of tyrosinase gene expression and the differentiated 
state of the melanocyte. For example, transcription factors such as Mi and 
Brn-2/N-Oct3 have been shown to be associated with melanocytes in different 
states of differentiation. The detection of Brn-2 mRNA in melanoblasts and at 
elevated levels in melanoma cells, suggests that Brn-2 is associated with 
immature or dedifferentiating melanogenic cells (Eisen et al, 1995). Mi, on 
the other hand, is associated with active pigment-producing melanocytes, and 
its expression is down-regulated in transformed melanocytes (Yavuzer et al, 
1995). Both factors have been shown to regulate tyrosinase gene expression 
via elements found within the 5' flanking region of the tyrosinase gene 
(Bentley et al, 1994; Ganss, 1994; Yasumoto et al, 1994; Yasumoto et al, 
1995). 
It is still unclear whether any of the mechanisms regulating tyrosinase gene 
transcription in mammals are at play in lower vertebrates. The present study 
on the chicken tyrosinase gene promoter sequence represents the most extensive 
analysis of a lower vertebrate tyrosinase gene promoter to date. The results 
begin to reveal whether there is conservation of regulatory mechanisms between 
higher and lower vertebrates. 
4.1. FUNCTIONAL ANALYSIS OF THE CHICKEN TYROSINASE PROMOTER IN RPE CELLS 
Perhaps the most controversial result from this study is that the putative 
regulatory elements in the chicken tyrosinase gene promoter which are highly 
conserved and almost entirely responsible for promoter functioning in mammals, 
are apparently not essential for high levels of tissue-specific expression in 
chicken RPE cells. Thus, deletion of promoter sequences that include the 
potential Inr, SPl-binding site and M-box resulted in unexpectedly high 
expression of the reporter gene in RPE cells. This is in direct contrast to 
121 
equivalent studies with the mammalian promoters which show that deletion or 
mutation of these sequences, especially the Inr, results in dramatic reduction 
in promoter activity {Bentley et al, 1994; Ganss et al, 1994; Yasumoto et al, 
1994). 
Two possible explanations for the unexpectedly high expression from the 
TYR0.2-LUC construct were put forward in the previous chapter {see section 
3.4.3.). The first was that deletion to 0.2 kb of the promoter sequence may 
result in the removal of a negative regulatory element. A more detailed 
functional analysis of the sequences between nt position -506 and the ATG site 
would shed further light on this issue. The second suggestion was that the 
high level of expression may be due to the presence of an additional 45 bp 
fragment in the TYR0.2-LUC construct that has potential enhancer activity. To 
exclude anomalous effects that may have been caused by the presence of the 
distal 45 bp sequence in TYR0.2-LUC, it will be necessary to assess the 
promoter activity of a construct from which this 45 bp sequence is eliminated. 
Assume for the moment that the 45 bp fragment plays no role in this issue and 
that the 200 bp of proximal promoter is indeed sufficient to drive tissue-
specific transcription in RPE cells. This would suggest the existence of 
regulatory mechanisms that are unique to avians and possibly other lower 
vertebrates. In this regard it is interesting to note that while the 
tyrosinase gene promoter sequences of avians {chicken and quail) and turtle 
can be aligned, these cannot be aligned with the amphibian and fish sequences. 
This raises the possibility of an avian/reptile grouping distinct from a 
amphibian/fish grouping. 
When comparing the results of avian and mammalian transfection experiments, it 
may be significant that the present studies were carried out in RPE cells 
whereas equivalent mammalian studies were carried out in epidermal melanocytes 
or melanoma cells. Therefore, perhaps the conflicting results arising from 
this study reflect the functional differences between RPE cells and epidermal 
melanocytes. Epidermal melanocytes are required to continue synthesizing and 
secreting melanin throughout their lifespan; therefore the tyrosinase gene 
must remain activated throughout this period. On the other hand, RPE cells 
cease synthesizing melanin early in development {Hu and Mah, 1979; Boissy et 
al, 1988) suggesting that the tyrosinase gene becomes down-regulated. Thus 
there must be regulatory factors present in RPE cells but not in epidermal 
melanocytes (and vice-versa) that account for the different levels of 
tyrosinase gene expression. This hypothesis could be readily tested by gel 
shift analyses of nuclear extracts from RPE and epidermal melanocytes. 
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4.2. VALIDITY OF TRANSFECTION STUDIES IN THE I"'10RTALISED QUAIL NEURAL CREST 
CELL LINE 
The aim of transfecting the immortalized quail neural crest cells was to 
determine whether the chicken tyrosinase gene promoter would be active in 
these cells, and if so, whether the level of activity would reflect 
differences in regulation of melanocyte-specific genes in pigment cells of 
different embryonic origin. Results showed that in contrast to the activities 
observed in RPE cells, only the full 1ength 2.1 kb 5' flanking sequence had 
significant promoter activity in these cells. A simple interpretation of the 
results would be that transcription driven by the chicken tyrosinase gene 
promoter is regulated differently in RPE cells and neural crest-derived cells. 
However, this interpretation is questionable in the light of uncertainties 
regarding the validity of the use of the MQTNC cells. Firstly, their 
melanogenic potential is uncertain and secondly, the effect of high levels of 
myc expression in these cells is not known. As suggested earlier, it is 
possible that Myc may transactivate the 2.1 kb tyrosinase promoter via the E-
box motif in the TOE-like element at nt position -1200. To pursue this 
question further, studies involving gel shift assays and site-directed 
mutagenesis of the TDE could be carried out. If the results from such studies 
suggest that Myc is not responsible for the high levels of expression of the 
reporter gene, the next step would be to investigate further the melanogenic 
potential of the immortalised neural crest cells. 
The attempts so far to determine the melanogenic potential of the immortalised 
quail neural crest cells by Northern blot hybridisation and melanin formation 
assays suggest that they do not display any melanogenic characteristics. It 
may be possible, however, to select for and enhance the differentiation of the 
melanogenic subpopulation of the neural crest cells (if they are still 
represented) by addition of exogenous factors such as a-MSH, endothelin-1 or 
steel growth factor. (Steel factor is the cognate ligand for the c-kit 
tyrosine kinase receptor. Addition of chicken recombinant steel factor to 
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developing quail neural crest cells in culture, has been shown to enhance the 
differentiation rate of melanocyte precursors [Lahav et al, 1994].) 
If attempts to induce melanogenesis in the inrnortalised quail cells is 
unsuccessful, a more viable option would be to repeat the transfection 
experiments in an established avian neural crest-derived melanocyte cell line. 
No such cell line is available, however, and attempts to date in our 
laboratory to generate bulk cultures of avian melanocytes, using the technique 
described by Oetting et al (1988), have been unsuccessful (S.Kidson, personal 
conrnunication). (This technique involves the addition of Buffalo rat liver 
cell (BRL-3A)-conditioned medium (containing Steel factor) to neural crest 
cells dissociated from somites. Thus the success of this procedure depends on 
the differential survival of melanoblasts and the concomitant death of all the 
other somitic cells and it would seem_ that it is quite difficult to establish 
conditions ideal for this differential survival.) 
A third option would be to carry out the transfection studies in melanocytes 
derived from another vertebrate. Attempts to transfect murine B16 melanoma 
cells and SV40-immortalised mouse melanocytes (S. Prince, Dept Anatomy and 
Cell Biology, UCT) using the calcium phosphate-mediated technique, were 
unsuccessful. Other transfection methods such as electroporation could be 
explored. It should be remembered, however, that although others have 
successfully carried out "cross species" analyses, the results from this study 
suggest that elements which are important for regulating mammalian tyrosinase 
gene expression may not be essential for expression of the avian gene (in RPE 
cells, at least). Therefore, results from any cross-species transfection 
studies would have to be interpreted with caution. 
4.3. THE MICROPHTHALMIA PROTEIN - A CENTRAL FACTOR REGULATING TRANSCRIPTION OF 
THE TYROSINASE GENE IN MN14ALS AND LOWER VERTEBRATES? 
As discussed in chapter one, the microphthalmia protein (Mi/MITF) has been 
identified as a promising candidate for a transcription factor that co-
ordinately activates the melanocyte-specific tyrosinase gene family. Mi/MITF 
is able to transactivate the mammalian tyrosinase and TRP-1 gene promoters via 
binding to CATGTG E-box motifs within the TDE, Inr region and M-box elements 
(see section 1.3.2). These elements are highly conserved in the promoters of 
the chicken, quail and turtle tyrosinase genes which suggests that they may 
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also function as Mi/MITF binding sites in these vertebrates. However, the 
role or even the existence of a Mi/MITF-like protein in lower vertebrates 
remains to be demonstrated. The cDNA sequences encoding mouse Mi and human 
MITF have been cloned (Hodgkinson et al, 1993; Hughes et al, 1993; Tachibana 
et al, 1994}, but to date no Mi/MITF gene sequences have been reported for a 
lower vertebrate. Moreover, the results of the present study leads one to 
further question whether Mi/MITF has a functional role in avian melanocyte-
specific gene expression (because the very elements to which Mi/MITF is 
reputed to bind appear to be unnecessary for transcription of the tyrosinase 
gene in RPE cells}. 
Encouraging, however, is the report of the isolation of several clones from a 
chicken melanocyte cDNA library that cross-hybridise to a human MITF cDNA 
probe (C.S. April et al, personal com~unication}. These clones are currently 
being sequenced. Successful cloning of a chicken Mi/MITF-like gene sequence 
would confirm that Mi/MITF is expressed in chicken melanocytes and provide the 
means to test directly whether it can transactivate the avian tyrosinase gene 
promoter. 
If Mi/MITF proves to be one of the key factors co-ordinating the expression of 
melanocyte-specific genes, the next task would be to dissect out the upstream 
events that regulate Mi/MITF gene expression. This would ultimately lead us 
closer to solving the central developmental question of what determines the 
melanocyte lineage. 
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APPENDIX I - MODIFIED TECHNIQUES USED 
1. Preparation of a radiolabelled probe by nick translation 
Nick translation was carried out according to Rigby et al (1977) as follows: 
0.8-1 µg of DNA was mixed with 2.5 µl 10 x nick translation buffer (0.5 M 
Tris.Cl, pH 7.5; 0.1 M MgS04; 1 mM dithiothreitol; 0.5 mg/ml BSA), 5 µl [a-
32p]-dCTP (3000 Ci/mMol, Ammersham) and 20 µM dATP, dGTP, dTTP in a total 
volume of 25 µl. Single stranded breaks (nicks) were introduced into the DNA 
by digestion with 0.02 µg/ml DNAse I for 10 min at RT. The nicks were then 
repaired using 1.5 units DNA polymerase, for 1 hat 15°C. Radio-labelled 
probe was separated from unincorporated [a-32p]-dCTP by passing the reaction 
mixture over a Sephadex G50 column of 5 ml bed volume, equilibrated with 10 mM 
TrisCl, 0.1 mM EDTA pH 7.5. The reaction mixture separates into 2 peaks of 
radioactivity (monitored using a hand-held Geiger counter). The first peak 
containing the probe was collected in a volume of approximately 1 ml. The 2nd 
peak containing unincorporated nucleotides was discarded. An aliquot (10 µl) 
of probe was counted in 10 ml Instagel using a scintillation counter 
programmed for 1 min counts on a 32p channel. Probes with specific activities 
> 1 x 107 cpm/ug DNA were generated in this way. 
2. Large-scale preparation of bacteriophage DNA 
An overnight culture of£. coli strain LE392 in LB broth containing 10 mM MgSO, 
was seeded from a liquid N2 stock. The following day, this culture was 
diluted 1:500 in LB broth containing 0.4% maltose. After 6 h of shaking at 
37°C, 1 ml was removed to an Eppendorf tube, 50 µl phage (from plate lysate 
stock) was added and allowed to adsorb to the bacteria for 15 min at 37°C. 
This was innoculated into two 500 ml Ehrlenmeyer flasks containing 200 ml of 
LB broth plus 10 mM MgS04. The cultures were shaken overnight at 37°C to 
allow lysis to occur. If lysis was not apparent the following morning (i.e. 
no floculent debris visible), the cultures .were exposed to ultra-violet light 
for 10 min, then shaken at 37°C for a further 2-4 h. Lysed cultures were 
treated with 2.5 ml chloroform, left shaking for 10 min, decanted into 
centrifuge tubes (avoiding chloroform transfer) and centrifuged at 6000 g for 
10 min at 4°C. To each supernatant (200 ml), 3.85g NaCl, 1 µg/ml pancreatic 
DNase I and 1 µg/ml RNase was added. Mixtures were incubated at 37°C for 30 
min (to allow for digestion of nucleic acids released from the lysed bacteria) 
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then placed on ice for 5 - 10 min. Bacteriophage particles were precipitated 
by adding very slowly, 50 ml polyethylene glycol (50% PEG 6000 in 0.5 M NaCl) 
and stirring on a magnetic stirrer at 4°C overnight (or for a minimum of 2 h). 
Bacteriophage were recovered by centrifugation at 6000 g for 30 min at 4°C. 
Pellets were resuspended in 5 ml of 10 mM MgS04 using a pipette with a wide-
bore tip. The PEG and bacterial debris were removed from the bacteriophage 
suspension by adding an equal volume of chloroform, vortexing the solution for 
30 sand then centrifuging at 3000 g for 15 min at 4°C. The aqueous phase 
containing bacteriophage, was removed and centrifuged at 25 000 rpm for 1 hat 
4°C in a Beckman vTi 65.2 rotor. The glassy pellet (which was spread down one 
side of the tube) was resuspended in 2 ml SM by gentle agitation on a rocking 
platform overnight at 4°C. 
To extract the DNA from bacteriophage particles: 50 µg/ml Proteinase Kand 
0.5% SOS was added to the bacteriophage suspension in a 15 ml corex tube. The 
mixture was incubated in a waterbath at 37°C for 15 min, then at 65°C for 45 
min. After cooling to RT, the mixture was extracted once using 1 volume of 
TE-buffered phenol, twice using 1 volume of phenol: chloroform: isoamyl 
alcohol:: 25: 24: 1 and finally, once using 1 volume of chloroform: isoamyl 
alcohol:: 24: 1. The aqueous phase was decanted and the nucleic acid 
precipitated by adding 1/10 volume 3M sodium acetate (pH 7.0) and 1 volume 
isopropanol and storing the solution at -70°C for 10 min or at -20°C 
overnight. The nucleic acid was collected by centrifugation at 4000 g for 30 
min at -20°C, the pellets were washed with 70% ethanol and recentrifuged for 
10 min. Pellets were dried at RT and resuspended in 1 ml TE. The DNA was 
quantified and the purity determined spectrophotometrically. The DNA was 
characterised by restriction enzyme digestion followed by electrophoresis on 
0.6% agarose gels in TAE buffer (40 mM Tris-acetate, 1 mM EDTA). To get rid 
of contaminating RNA, the extracted DNA sample was digested with 55 µg/ml 
DNase-free RNase A for 30 min at 37°C. One tenth volume 3M sodium acetate 
was added, after which the samples were re-extracted with phenol: chloroform: 
isoamyl alcohol, precipitated, resuspended and re-quantified. 
3. Plasmid mini-preparation for sequencing 
The following procedure was adapted from a method supplied with the QIAGEN 
plasmid mini-preparation kit, and makes use of the buffer recipes recommended 
by the manufacturer (DIAGEN GmbH, Germany). 
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E. coli cultures containing the desired plasmid were grown overnight in 5 ml 
LB broth containing 100 µg/ml ampicillin. Bacteria were harvested by 
centrifugation at 3 000g for 10 min at RT, resuspended in 0.3 ml buffer Pl 
· (100 µg/ml RNase A in 50 mM Tris HCL, 10 mM EDTA, pH 8.0, 4°C), and lysed by 
adding 0.3 ml buffer P2 (200 mM NaOH, 1% SDS, RT), mixed by inversion and 
incubated at RT for 5 min. Chromosomal DNA was precipitated by adding 0.3 ml 
buffer P3 (2.55 M Kac, pH 4.8, RT) and mixing by inversion. Bacterial debris 
and chromosomal DNA was removed by centrifugation at 10 OOOg for 15 min at 
4°C. The supernatant fluid containing plasmid was transferred to a fresh tube 
and recentrifuged as before. The supernatant was divided into two aliquots 
(of approximately 0.4 ml each) to which 0.4 ml of buffered phenol (Tris HCL, 
pH 8.0) and 0.4 ml of chloroform:isoamyl alcohol (24:1) was added. The phases 
were gently mixed by inversion (not by vortexing) and then separated by 
centrifugation at 10 OOOg for 2 min at 4°C. The non-aqueous phase and 
denatured protein layer was removed and the aqueous phase re-extracted as 
before. The aqueous phase was extracted for a third time with 
chloroform:isoamyl alcohol before precipitating the plasmid DNA with 0.6 
volumes of isopropanol for 30 min at RT. Following centrifugation at 15 OOOg 
for 30 min at RT, the DNA pellets were washed with 70% ethanol, dried (8 min 
in a Kartell vacuum drier) and dissolved in 30 µl ultra-pure water (BDH). The 
DNA was reprecipitated overnight at -20°C using 0.1 volume of 4 M LiCl and 2.5 
volumes of absolute ethanol. Plasmid DNA was collected by centrifugation at 
10 OOOg for 15 min at 4°C, washed, dried and resuspended in 10 µl ultrapure 
water. One microlitre of the DNA was subjected to diagnostic restriction 
enzyme digestion and analysed for quantity and quality by agarose gel 
electrophoresis. The remaining high purity plasmid DNA (approximately 4-5 µg 
in 20 µl ultrapure water) was used for sequencing with a Sequenase version 2.0 
kit. 
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2 3 • 5 6 2 3 • 5 
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L___J 
EcoAI Sacl Kpnl Smal 
Xmal 
M13mp111 
2 3 • 2 3 • 5 6 7 
Thr Mot lie Thr Pro Ser Lou His Ala Cys Arg 
ATG ACC ATG An ACG CCA AGC nG CAT GCC TGC AGG 
Hindlll Sphl Pstl 
In M13mp18, the EcoAI site lies immediately downstream from P/ac-
In M13mp19, the Hindlll site lies immediately downstream from P/ac-
Xmnl 357 
Bacteriophage 
M13mp18 / M13mp19 
(7.25 kb) 
I 4000 Eco47111 3039 
6 7 8 9 10 11 12 
Asp Pro Lau Glu Ser Thr Cys 
GAT CCT CTA GAG TCG ACC TGC 
BamHI Xbal Sa/I Pstl 
Accl 
Hincll 
8 9 10 11 12 13 1• 
Sar Thr Lau Glu Asp Pro Arg 
TCG ACT CTA GAG GAT CCC CGG 













1• 15 16 17 18 7 ' 6 
His Ala Ser Leu Ala Lou Ala 
CAT GCA AGC nG GCA CTG GCC 
Sphl Hlndlll 
18 17 18 5 8 7 8 
Pro Ser Ser Aln Ser Leu Ala 



































APPENDIX III - TRANSCRIPTION FACTOR BINDING SITES IDENTIFIED IN CTYR4.3 
Results of a search conducted using the FINDPATTERNS function of GCG and the transcription factor binding sites recorded in the GCG file, TFsites. TFsites is a composite from the following datasets: TFD (release 7.4) SITES dataset file, 1/95 and Transfac (release 2.2) SITES dataset selected entries, 12/94 (Nucleic Acids Res 21 (1993) 3117-8; J Biotechnol 35 (1994) 273-380; In Gene transcription: A practical approach (1993) 321-345). 
Note: nt numbering of CTYR4.3 is from +l to +3122 instead of -2125 to +997. 
Transcription factor Consensus sequence 
binding site and nt position in CTYR4.3 
GCRE TGACTC 
104: TTTAA TGACTC TACAG 
GCRE /Rev GAGTCA 
1,525: TTGTA GAGTCA CCTTG 
1,999: TAGCA GAGTCA GTGGT 
LVb_RS /Rev TATCCTG 
1,935: AAGTG TATCCTG TGTGT 
NFI_CS1 /Rev TTGGCNNNNNKCCA 1,888: GACAC TTGGCTTTCATCCA CAACA 
NFI_CS3 TGGNNNNNNGCCA 1,345: CCTGA TGGGAGAAAGCCA GAAGT 
NFI_CS3 /Rev TGGCNNNNNNCCA 
1,889: ACACT TGGCTTTCATCCA CAACA 
PEBP2_RS /Rev GCGGTC 
2,061: TTGGA GCGGTC AGAGA 
PRL conserved_motif CCTGAWWA 
863: ATCTC CCTGAATA TCTGA 
PRL_conserved_motif /Rev TWWTCAGG 1,493: TAGAT TTATCAGG GGCTT 
MRE_CS2 /Rev GNGYGCA 
1,450: GATTT GGGTGCA GGTTT 2,429: GTGGG GAGTGCA AGTTT 
TATA-box.2 TATAAA 
415: TTGAA TATAAA CATAA 1,573: TGAAA TATAAA AAAAG 
TATA-box.2 /Rev TTTATA 
157: TGTTG TTTATA GATGG 
FSE2.1 GAGAGGA 
2,355: TGACA GAGAGGA TTGGC 
BGP1_RS1 /Rev CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
C/EBP_CS1 TKNNGYAAK 1,300: TTGTC TGGAGTAAT GTTCT 
CK-2 /Rev TACCTGA 
1,338: GGTGC TACCTGA TGGGA 
CK-8-mer AANCCAAA 1,587: AGACC AAGCCAAA TAATT 
CK-8-mer /Rev TTTGGNTT 
2,438: GCAAG TTTGGCTT CTCAG 
TATA-box.1 /Rev ATTATA 
708: CCGTG ATTATA TCTGT 
his3-Tr-TATA TATAAA 


























157: TGTTG TTTATA GATGG 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
HCWATHAAA 
1,475: AGTTA TCTATTAAA ATAGT 
CAGGTCC 
1,377: GTTTC CAGGTCC TGCTA 
TAATTTA 
1,150: CGACA TAATTTA AGTGC 
1,595: CCAAA TAATTTA TCATG 
2,905: AACCC TAATTTA CTCAG 
AATAAAT 
680: AATAA AATAAAT CAAAC 
1,839: TTTAC AATAAAT GCCTT 
TCCTGCAG 
1,125: TAAAC TCCTGCAG TTTTA 
CCACCA 
2,895: ACACC CCACCA ACCCT 
TAATCAG 
1 ,. 912 : TGTGA TAATCAG ATTAA 
TCNTACTC 
1,774: TTTAA TCTTACTC CTTCT 
TCTTACTC 
1,774: TTTAA TCTTACTC CTTCT 
GGGTAGGA 
1,958: ATCCA GGGTAGGA ATGGG 
GATTGGC 
2,360: GAGAG GATTGGC CTTCT 
YCSCCMNSSS 
2,234: GCTGT CCGCCCTGGG ATGGA 
SSSNKGGSGR 
1,868: AGTCG GGGGTGGGGG AAAAA 
1,869: GTCGG GGGTGGGGGA AAAAG 
AGGAAG 
215: ATTAA AGGAAG CCTTT 
2,219: TGCTG AGGAAG GAGTG 
CTTCCT 
1,005: CCTGC CTTCCT GAGAT 
CACGCW 
1,322: CAAAG CACGCA GAGTT 
2,203: GCAAA CACGCA GAGCT 
TTTGTA 
1,519: TTCAC TTTGTA GAGTC 
AGGATGT 
2,123: CTGTG AGGATGT TTCTG 
MYWATCWY 
87: GTGTG ACTATCTC ATGTT 
829: GAGTC CCTATCAC AGGCA 
855: CAGAG ATAATCTC CCTGA 
RWGATWRK 
705: TTTCC GTGATTAT ATCTG 
852: ACTCA GAGATAAT CTCCC 
1,812: ATCAT GTGATAGG CAGAA 
1,908: AACAT GTGATAAT CAGAT 
CTATCA 
830: AGTCC CTATCA CAGGC 
TGATAG 
1,813: TCATG TGATAG GCAGA 
133 
134 
NF-El.4 /Rev GAGATAA 
852: ACTCA GAGATAA TCTCC 
NF-El.5 TATCTT 
1,686: CTCTT TATCTT TTTTA 
NF-El.5 /Rev AAGATA 
424: AACAT AAGATA TTAAA 
2,795: TACAG AAGATA ACAGG 
NF-El.6 TATCTC 
89: GTGAC TATCTC ATGTT 
NF-El.6 /Rev GAGATA 
852: ACTCA GAGATA ATCTC 
2,786: AACGT GAGATA CAGAA 
NF-El.7 /Rev GTGATGA 
927: GTCAT GTGATGA CCTGC 
2,805: AACAG GTGATGA GAATT 
NF-El.8 CCAATCT 
3,035: ACTAT CCAATCT GACTT 
PUT2_UAS.l GAAGCCAA 
882: GCGTA GAAGCCAA CAGGA 
PUT2_UAS.1 /Rev TTGGCTTC 
2(439: CAAGT TTGGCTTC TCAGG 
STE6.1 ATGTAATT 
2,571: GGACT ATGTAATT GCTAC 
STE6.2 /Rev GTGTAAAT 
1,943: CCTGT GTGTAAAT GCATC 
BARl.1 ATGTAATT 
2,571: GGACT ATGTAATT GCTAC 
BARl.2 /Rev ATGTAATT 
2,571: GGACT ATGTAATT GCTAC 
MAT-alpha-2_CS1 ATGTAATT 
2,571: GGACT ATGTAATT GCTAC 
a-actin_us GTCGCC 
1,606: ATCAT GTCGCC ATCCT 
a-actin_US /Rev GGCGAC 
2,469: TGAAA GGCGAC TGAGA 
actin_5c_US TATAAAA 
1,573: TGAAA TATAAAA AAAGA 
Ad2MLP_US.3 TATAAA 
415: TTGAA TATAAA CATAA 
1,573: TGAAA TATAAA AAAAG 
Ad2MLP_US.3 /Rev TTTATA 
157: TGTTG TTTATA GATGG 
Ad2MLP_US.4 TATAAAA 
1,573: TGAAA TATAAAA AAAGA 
Ad2MLP_US.5 TATAAAA 
1,573: TGAAA TATAAAA AAAGA 
RC2-CYC1.2 GATGACC 
929: CATGT GATGACC TGCTG 
RC2-CYC1.2 /Rev GGTCATC 
2,155: CTGCT GGTCATC CTTCA 
GALl-TATA ATATAA 
414: ATTGA ATATAA ACATA 
1,572: TTGAA ATATAA AAAAA 
GALl-TATA /Rev TTATAT 
709: CGTGA TTATAT CTGTT 
GCN4-HIS3.1 TGACGA 






































AGTCA TTACTC TTGTA 
TAATC TTACTC CTTCTC 
CTAAT TTACTC AGCC 
GAGTAA 
GTCTG GAGTAA TGTTC 
TGACTC 
104: TTTAA TGACTC TACAG 
GAGTCA 
1,525: TTGTA GAGTCA CCTT~ 
1,999: TAGCA GAGTCA GTGG 
TGACTC 
104: TTTAA TGACTC TACAG 
GAGTCA 
1,525: TTGTA GAGTCA CCTTG 
1,999: TAGCA GAGTCA GTGGT 
TGACTC 
104: TTTAA TGACTC TACAG 
GAGTCA 
1,525: TTGTA GAGTCA CCTTG 
1,999: TAGCA GAGTCA GTGGT 
TGACTC 
104: TTTAA TGACTC TACAG 
GAGTCA 
525 TTGTA GAGTCA CCTTG l, : TAGCA GAGTCA GTGGT 1,999: 
CAGTCA TGCAG 112: CTCTA CAGTCA 
266: CTCAT CAGTCA CATTT 
TGACTA 
85: AGGTG TGACTA TCTCA 
TAGTCA 
1 022 • CTCTG TAGTCA TTACT 
' . AGTAA TAGTCA TTTTC 1,630:
AGAAATG 
339: GTTTC AGAAATG TGTCA 
CATTTCT CATTC 272: AGTCA CATTTCT 
GATTGG 
2,360: GAGAG GATTGG CCTTC 
CCAATC 
3,035: ACTAT CCAATC TGACT 
GAAGGGAAAA 
3,005: CAGGG GAAGGGAAAA GCTGA 
GATTGG 
2,360: GAGAG GATTGG CCTTC 
CCAATC 
3,035: ACTAT CCAATC TGACT 
TATAAA 
415: TTGAA TATAAA CATAA 
1,573: TGAAA TATAAA AAAAG 
TTTATA 




























798: CACTC CTTTCC CATTG 
3,092: AACTG CTTTCC AGATT 
GGAAAG 
166: TAGAT GGAAAG GTTGA 
1,551: GTCTG GGAAAG TCAGC 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
GAGTCA 
1.525: TTGTA GAGTCA CCTTG 
1,999: TAGCA GAGTCA GTGGT 
TGACTC 
104: TTTAA TGACTC TACAG 
CACTCA 
846: ACTGG CACTCA GAGAT 
2,045: TTTCA CACTCA GGTCA 
AAGTCA 
1,359: GCCAG AAGTCA AGGTn 
1,554: TGGGA AAGTCA GCTTA 
TGACTT 
3,041: CAATC TGACTT TAGGT 
GAATCA 
194: TATCT GAATCA CTGAC 
736: GCATG GAATCA GACAA 
ATTCCTCTGT 
315: AGGAG ATTCCTCTGT TAACC 
ATTCCTCTGT 
315: AGGAG ATTCCTCTGT TAACC 
ATTCCTCTGTT 
315: AGGAG ATTCCTCTGTT AACCA 
TTTTAAC 
384: ATTTT TTTTAAC TTTGA 
GCACTC 
845: CACTG GCACTC AGAGA 
GAGTGC 
2,225: GGAAG GAGTGC TGTCC 
2,429: GTGGG GAGTGC AAGTT 
TGTCCT 
1,657: TTCAC TGTCCT TATGT 
AGGACA 
1,973: GGGGA AGGACA TTGGA 
2,449: TTCTC AGGACA AAACT 
2,517: TGAGA AGGACA AGTTC 
2,948: AGGTA AGGACA GGCAA 
AGAAGTCA 
1,357: AAGCC AGAAGTCA AGGTn 
TATCCTG 
1,935: AAGTG TATCCTG TGTGT 
GTTTTAA 



























2,234: GCTGT CCGCCC TGGGA 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
TGGAAAG 
165: ATAGA TGGAAAG GTTGA 
CTTTCCA 
3,092: AACTG CTTTCCA GATTT 
TGGAAAG 
165: ATAGA TGGAAAG GTTGA 
CTTTCCA 
3,092: AACTG CTTTCCA GATTT 
TGGAAAG 
165: ATAGA TGGAAAG GTTGA 
CTTTCCA 
3,092: AACTG CTTTCCA GATTT 
ACAGCTG 
1,183: AACCA ACAGCTG TCCCn 
CAGCTGT 
329: TTAAC CAGCTGT TTCAG 
1,184: ACCAA CAGCTGT CCCnC 
ACAGCTG 
1,183: AACCA ACAGCTG TCCCn 
CAGCTGT 
329: TTAAC CAGCTGT TTCAG 
1,184: ACCAA CAGCTGT cccnc 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
TGTTCT 
807: CCCAT TGTTCT TTCTG 
1,308: AGTAA TGTTCT GAGCA 
AGAACA 
2,550: AGCAA AGAACA TCCCC 
TGTTCT 
807: CCCAT TGTTCT TTCTG 
1,308: AGTAA TGTTCT GAGCA 
AGAACA 
2,550: AGCAA AGAACA TCCCC 
TGTTCACT 





1,886: AAGAC ACTTGG CTTTC 
TTTAAA 
1,693: TCTTT TTTAAA CAACA 
CCGCCC 
2,234: GCTGT CCGCCC TGGGA 
GGAKGA 
617: TCACA GGAGGA ACACT 
2,026: AGTTG GGAGGA ~X~ 
2,347: GGAGT GGATGA AGGTA 




TCMTCC GAGAT TGTTA TCCTCC 
GGCTT TCATCC ATTCAACAGC GCTGG TCATCC 
137 
alpha-factor_stim_element /Rev TGTTTCA 

























564: TGTTA TCCTCC GAGAT 
GGAGGA 
617: TCACA GGAGGA ACACT 
2,026: AGTTG GGAGGA AAAGT 
TNATTGG 
2 ,053: TCAGG TCATTGG AGCGG 
TGTGTTT 
1,420: AATTT TGTGTTT TCCCA 
YCCTGA 
862: AATCT CCCTGA ATATC 









278: ATTTC TCATTC AGAGT 
292: GTTTC TCATTC ATACA 
GAATGR 
20: TGAAG GAATGA AAAGT 

























1 869 • GTCGG GGGTGGGG GAAAA 
' . CAGTT GGGAGGAA AAGTT 2,025:
CTATTC 
479: AAGTT CTATTC TGGTT 
GAATAG 
1,739: ATGCC GAATAG CCAAC 
ATTCTTA 
373: CTTGT ATTCTTA TTTTT 
TATAAAAA 
1,573: TGAAA TATAAAAA AAGAC 
CACTCA 
846: ACTGG CACTCA GAGAT 
2,045: TTTCA CACTCA GGTCA 
TGANTMA 
193: CTATC TGAATCA CTGAC 
TKANTCA 
193: CTATC TGAATCA CTGAC 
1,920: TCAGA TTAATCA g~~~ 
2,909: CTAAT TTACTCA 
CTGAATCA 
192: ACTAT CTGAATCA CTGAC 


























618: CACAG GAGGAA CACTA 
2,027: GTTGG GAGGAA AAGTT 
2,218: TTGCT GAGGAA GGAGT 
2,280: CAACA GAGGAA CCTGC 
TTCCTC 
316: GGAGA TTCCTC TGTTA 
TATAWAW 
465: TTAAA TATATAT TTAAG 
552: GAAAA TATATAT TGTTA 
1,573: TGAAA TATAAAA AAAGA 
WTWTATA 
464: CTTAA ATATATA TTTAA 
551: AGAAA ATATATA TTGTT 
GSSWGSCC 
2,881: TACAT GGGTGGCC AACAC 
RGAGAGGNT 
2,354: ATGAC AGAGAGGAT TGGCC 
BRGATTAW 
1,091: GAAAA GAGATTAAA GCAAC 
ATTGGCC 
2,361: AGAGG ATTGGCC TTCTG 
NGGAYGT 
2,123: CTGTG AGGATGT TTCTG 
ACRTCCN 
2,553: AAAGA ACATCCC CAGCA 
TATTAAAA 
1,477: TTATC TATTAAAA TAGTA 
TTATTTTTTT 
377: TATTC TTATTTTTTT TAACT 
AGCTCTCT 
450: TGTAT AGCTCTCT ACTTA 
CAGGTG 
2,802: GATAA CAGGTG ATGAG 
TKASTCA 
2,909: CTAAT TTACTCA GCCCA 
RCAGNTG 
1,183: AACCA ACAGCTG TCCCn 
2,391: GACAT GCAGATG CAGAG 
2,801: AGATA ACAGGTG ATGAG 
CANCTGY 
329: TTAAC CAGCTGT TTCAG 
1,101: TAAAG CAACTGC AACAA 
1,184: ACCAA CAGCTGT CCCnC 
1,746: ATAGC CAACTGC TGCCC 
2,419: GGGTT CAACTGT GGGGA 
SMGGAWGY 
2,122: TCTGT GAGGATGT TTCTG 
TGGCGA 
2,837: GGGAC TGGCGA GATGC 
TCGCCA 
1,607: TCATG TCGCCA TCCTA 
CTGGRAA 
1,548: CTGGT CTGGGAA AGTCA 
TTYCCAG 
961: ATCGT TTCCCAG CAGAG 
1,373: TnTCG TTTCCAG GTCCT 
2,016: AAGCA TTCCCAG TTGGG 
3,093: ACTGC TTTCCAG ATTTT 
ATTTNNNNATTT 
1,635: TAGTC ATTTTCTCATTT TTATG 
139 
140 
HiNF-A_RS /Rev AAATNNNNAAAT 
541: ACTGA AAATTAGAAAAT ATATA 
HNF-5_CS TRTTTGY 
2,133: GTTTC TGTTTGC CATGG 
HNF-5_CS /Rev RCAAAYA 
743: ATCAG ACAAACA ACAGT 
2,198: TCTGT GCAAACA CGCAG 
MCBF_RS /Rev AGGAATG 
18: GCTGA AGGAATG AAAAG 
1,962: AGGGT AGGAATG GGGAA 
NFI_CS6 /Rev TGGCNNNNNKCCR 
1,889: ACACT TGGCTTTCATCCA CAACA 
NF-GMb_CS /Rev TAYCTGA 
189: AATAC TATCTGA ATCAC 
869: CTGAA TATCTGA GGCGT 
1,338: GGTGC TACCTGA TGGGA 
PEA3_CS AGGAAR 
215: ATTAA AGGAAG CCTTT 
1,038: CTTGT AGGAAA AAATA 
2,028: TTGGG AGGAAA AGTTT 
2,219: TGCTG AGGAAG GAGTG 
PEA3_CS /Rev YTTCCT 
1,005: CCTGC CTTCCT GAGAT 
PuF_RS GGGTGGG 
1,869: GTCGG GGGTGGG GGAAA 
Spl_CS4 /Rev MYYMGCCYM 
2,912: ATTTA CTCAGCCCA GCATC 
keratinocyte_cs AARCCAAA 
1,587: AGACC AAGCCAAA TAATT 
keratinocyte_cs /Rev TTTGGYTT 
2,438: GCAAG TTTGGCTT CTCAG 
P2I_CS ACATRAS 
75: GCGGC ACATGAG GTGTG 
420: TATAA ACATAAG ATATT 
1,926: TAATC ACATAAG TGTAT 
P2I_CS /Rev STYATGT 
92: ACTAT CTCATGT TTTAA 
584: CTCTT CTCATGT GTAGC 
922: GCACG GTCATGT GATGA 
1,661: CTGTC CTTATGT AACTG 
P2II_CS AGGGKTA 
1,201: CTTCA AGGGGTA ATTTC 
p53_CS RRRCWWGYYY 
2,518: GAGAA GGACAAGTTC CTTGC 
AntP_CS /Rev TAATGNNNNT 
101: TGTTT TAATGACTCT ACAGT 
1,230: ACTTC TAATGGTTTT CATAT 
ATF_CS /Rev TGACGAW 
4: TAT TGACGAT AGGCT 
GT-2B_RS CCAGCTG 
328: GTTAA CCAGCTG TTTCA 
IBP-l_CS2 AAGTGA 
3,056: TACTT AAGTGA AGGTG 
IBP-l_CS2 /Rev TCACTT 
976: AGCTC TCACTT ATTTC 
1,515: GTTTT TCACTT TGTAG 
GATA-l_CS2 WGATAMS 
1,407: AAGTC TGATACC AAATT 
2,796: ACAGA AGATAAC AGGTG 
GATA-l_CS2 /Rev SKTATCW 
141 
1,471: ATGGA GTTATCT ATTAA 
NF-mu-El_CS /Rev GCCANCTG 
1,744: GAATA GCCAACTG CTGCC 
TFIIIA_CS /Rev YTCNRNCCNG 
2,912: ATTTA CTCAGCCCAG CATCA 
GAGA-E74A.1 CTCTCTT 
577: GATGG CTCTCTT CTCAT 
CAP-box CTTYTG 
2,367: TTGGC CTTCTG TCTTT -
CAP-box /Rev CARAAG 
GCATC 948: CCCAG CAAAAG 
1,356: AAAGC CAGAAG TCAAG 
1,820: ATAGG CAGAAG ATTAA 
2,792: AGATA CAGAAG ATAAC 
histone_CAP_box YCATTCR 
278: ATTTC TCATTCA GAGTT 
292: GTTTC TCATTCA TACAG 
URE_(l) /Rev TGTTGTCA 
AGTCT 1,395: AATAC TGTTGTCA 
CNBP-SRE /Rev CRCSSCAS 
2,891: GCCAA CACCCCAC CAACC 
HNF-5_site RCAAAYA 
743: ATCAG ACAAACA ACAGT 
2,198: TCTGT GCAAACA CGCAG 
HNF-5_site /Rev TRTTTGY 
2,133: GTTTC TGTTTGC CATGG 
ZRE7 TTGCTCA 
224: AGCCT TTGCTCA TCAGT 
1,165: GCAAT TTGCTCA CAAGT 
ZRE7 /Rev TGAGCAA 
1,313: TGTTC TGAGCAA AGCAC 
ZRE6 TGTGTCA 
344: AGAAA TGTGTCA TATGA 
ZRE5 TGTGCAA 
2,195: GAGTC TGTGCAA ACACG 
ZRE5 /Rev TTGCACA 
GGTTT 640: ATAGA TTGCACA 
ZRE4/TGTG2 /Rev TGTGTCA 
344: AGAAA TGTGTCA TATGA 
ZRE3/TGTG1 /Rev TGTGTCA 
TATGA 344: AGAAA TGTGTCA 
ZRE2 TGAGCAA 
1,313: TGTTC TGAGCAA AGCAC 
ZRE2 /Rev TTGCTCA 
224: AGCCT TTGCTCA TCAGT 




1,942: TCCTG TGTGTAA 
CCAAT_site_4 GATTGG 
2,360: GAGAG GATTGG CCTTC 
CCAAT_site_4 /Rev CCAATC 
TGACT 3,035: ACTAT CCAATC 
undefined_site_2 TTTCCA 
1,373: TnTCG TTTCCA GGTCC 
3,093: ACTGC TTTCCA GATTT 
undefined_site_2 /Rev TGGAAA 
165: ATAGA TGGAAA GGTTG 
betaP-Fl /Rev TTTATC 
142 
1,492: GTAGA TTTATC AGGGG 
1,598: AATAA TTTATC ATGTC 
1,684: TTCTC TTTATC TTTTT 
betaE-F3 GGGTGGGG 
1,869: GTCGG GGGTGGGG GAAAA 
site_d5(m) AACAGGTG 
2,800: AAGAT AACAGGTG ATGAG 
site_k CAGGTC 
1,377: GTTTC CAGGTC CTGCT 
2,049: ACACT CAGGTC ATTGG 
site_k /Rev GACCTG 
932: GTGAT GACCTG CTGAT 
CT-II CTAATG 
1,229: AACTT CTAATG GTTTT 
D6 ATGAATA 
2,871: CACTG ATGAATA CATGG 
D4 CATTCAT 
293: TTTCT CATTCAT ACAGT 
D3 GATGCAT 
2,659: GTCTG GATGCAT TATTA 
D3 /Rev ATGCATC 
1·, 949: TGTAA ATGCATC CAGGG 
Dl ATGAAAA 
22: AAGGA ATGAAAA GTCTT 
Dl /Rev TTTTCAT 
1,236: AATGG TTTTCAT ATAGC 
HB3 GAAAAAGAAAAA 
1,062: AAAAA GAAAAAGAAAAA AGAAA 
CAAT_site(l) /Rev ATTGGC 
2,361: AGAGG ATTGGC CTTCT 
TATA_(3) /Rev TCTTATA 
1,270: GGCTT TCTTATA AGGTG 
RIPE3b CTTCAGCC 
2,162: TCATC CTTCAGCC GTCCA 
RIPE3b /Rev GGCTGAAG 
12: CGATA GGCTGAAG GAATG 
GR-intron-site-2 /Rev GGCACA 
72: GATGC GGCACA TGAGG 
2,585: CTACT GGCACA TATGC 
GR-intron-site-3 TGTCCC 
1,188: ACAGC TGTCCC nCCTT 
GR-intron-site-4 GACACA 
2,681: CTCGA GACACA CTCTT 
GR-intron-site-4 /Rev TGTGTC 
344: AGAAA TGTGTC ATATG 
Total finds: 360 
Total length: 3,122 
Total se~uenc;::es: 1 
CU time: 10.81 
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